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SUMMARY 
In 2006 and at the start of 2007 the Slovak government approved two strategic documents 
on legal drugs: The 2006–2010 National Action Plan for Problems with Alcohol and the 
National Programme for Tobacco Control. A new statute of the Board of Ministers for Drug 
Dependencies and Drug Control entered into force, extending the Ministerial Board’s area of 
competence to include these psychoactive substances. 
The Twinning part of the project Support for the Implementation of the 2004–2008 National 
Programme for the Fight against Drugs was completed and the Final Report of the project 
made recommendations for the next period. At present there is a new project under the EU 
Transition Facility focussed on the re-socialisation of persons with drug addictions – 
Improving and broadening the re-socialisation and rehabilitation care for persons addicted to 
psychoactive substances. 
In 2006 new cycles of population surveys were carried out by the Public Opinion Research 
Institute of the Statistical Office (PORI SO) and the school survey Tobacco-Alcohol-Drugs. 
Results show that there has been an increase in lifetime prevalence for marihuana use in the 
population aged 15–64, although the increase is not as great as in the 1998–2002 period; in 
2006 it increased to 16.1%. Results of the school survey (10–19) show greater prevalence of 
experimentation with marihuana among 14-year-olds and this experimentation increases with 
age (38.8% prevalence in 19-year-old students).  
The rising trend in ecstasy use continued (4.3% in 2006). The lifetime prevalence of drugs 
representing a more serious risk to health and society, such as heroin, pervitin 
(methamphetamine powder) and cocaine, remains low and stable at around 1%. 
The falling trend in the number of people receiving treatment for problems with illegal drugs 
continued. In 2006 the reporting to Treatment Demand Indicator has slightly changed - poly-
drug use began to be reported. The most common drug for which persons received drug 
treatment was heroin, followed by methamphetamine (pervitin) – among first treatment 
pervitin was the first followed by heroin – then marihuana and poly-drug use. There are 
regional differences in the drug use. Bratislava region strongly exceeds the other regions of 
Slovakia in all epidemiological indicators. According to information from treatment, opioids 
dominate in West Slovakia, while marijuana use is stronger in Central Slovakia, especially in 
the Žilina region. Use of volatile substances is greater in East Slovakia compared to other 
regions. 
The population of problem drug users was estimated to be 13 800 – 34 500 persons in 2006. 
At most only third of them are in contact with low threshold harm-reduction services whose 
purpose is to reduce the social and health effects of (problem) drug use. Despite efforts to 
broaden their services, there is a problem with maintaining the long term sustainability of 
these programmes, resulting from financial instability and other problems (available 
personnel, lack of client interest).  
Compared to 2005, there has been a slight fall in total reported drug-related deaths. Most 
such deaths are due to pharmaceutical drugs, in particular benzodiazepines, and take place 
in higher age groups (over 35 years). Opioids and volatile substances are also frequent 
among causes of death. In 2006 there was a fall in the number of deaths directly caused by 
medicines and the number was the same as the number for opiate overdoses.  
The rate of HIV infections for intravenous drug users remained below 1%. In 2006, one new 
HIV case was detected in an intravenous user. Testing for infection diseases of drug users 
entering treatment was carried out above the framework of basic duties in centres for the 
treatment for drug dependencies. The prevalence of Hepatitis-C antibodies in patients 
receiving treatment in Bratislava was over 45% since 2003 (the most recent data is for 2005). 
Testing of users who are not in contact with health-care facilities is not at present a routinely 
available service.  In 2006 and at the start of 2007, studies were successfully implemented or 
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prepared focused on testing drug users and identifying the prevalence of HIV and hepatitis 
infection among intravenous drug users. 
The rise in the number of drug-related offences continued in 2006 though the number of 
arrests fell slightly. In 2006 it became compulsory for the Police Force to record crimes 
committed and perpetrators by type of drug. Most drug crimes were committed in relation to 
marihuana, methamphetamine (pervitin) and heroin.  
The number of drug seizures compared to 2005 increased by 9.8%. 59% of all seizures in 
2006 (1 868) were seizures of marihuana. At the same time there was a fall in the quantity of 
marihuana, methamphetamine and heroin seized.  
The number of seizures of cocaine and the quantity of cocaine seized were both slightly 
higher than in the previous year. Tablets sold as ecstasy were increasingly likely to contain 
1-(meta-chlorophenyl) piperazine (mCPP) as their main active ingredient. 10 368 tablets 
were seized, on sale at a relatively low price of SKK 100–200 per tablet. 
The prices of marihuana, hashish, cocaine, heroin and LSD remained relatively stable in 
2006 while prices of ecstasy and methamphetamine fell. 
 
TRENDS 
Marihuana, methamphetamine and heroin are drug that are characterised by such indicators 
as: largest numbers of drug-users in treatment, largest numbers of perpetrators of drug 
crimes and the larges proportion of drugs seized. In the case of marihuana also the highest 
prevalence in the population, especially the 15–34 age group.  
The situation with regard to heroin use is more or less stable. The lifetime prevalence of 
heroin use in the general population remains approximately the same and low; the number of 
opioid users in treatment is falling; increased consumption has not been observed in the 
drugs market; prices have remained at the same level and in the last year there was a fall in 
the number of heroin seizures and a fall in the volume of heroin seized.  
Although public opinion surveys showed a slight fall in the prevalence of pervitin 
(methamphetamine) use in the general population, there was an increase in the prevalence 
among 15–24 age group. The largest number of persons receiving treatment for the first time 
was pervitin users, with an average age of 23 years. According to the Presidium (central 
headquarters) of the Police Force, pervitin production is expanding and spreading to other 
regions – East Slovakia. The concentration of active substances, and the number of seizures 
of pervitin have been rising for a long time, as did the volume seized until 2005 (in 2006 there 
was a slight fall in the volume seized).  
According to police reports there is an increase in the availability of ecstasy and according to 
population surveys there is an increase of experimenting with ecstasy especially among 
young people. The lifetime prevalence of cocaine has remained low, at around 1%, but there 
has been a very slight increase since 1998. In 2006 there was also an increase in the 
reported number and volume of cocaine seized and the number of cocaine users receiving 
treatment also increased in 2006.  
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Part A: Development and new trends  
This part of the National Report gives an overview of the situation in 2006 and new 
developments and trends regarding the year 2007, which are covered mainly in chapter 1 but 
are also relevant with regard to sudden changes in infectious diseases, drug-related deaths 
and the like. It also includes the results of the most important national research and studies.  
1 National policy and its context 
In its manifesto of August 2006, the new Slovak government affirmed its commitment to the 
original foundations of drug policy established by UN Conventions, the conclusions of the 
special General Assembly of the United Nations in 1998 and the current European drugs 
strategy 2005–2012 and the European drug action plan. The Slovak government thus 
continues to take responsibility for the creation and implementation of the national strategy, 
the definition of its objectives, rules and principles, including the appropriate legislative 
framework.   
The strategy is formulated in the document “National programme for the fight against drugs” 
(hereinafter referred to as “the NPFD”). Currently implemented third NDFD is covering the 
period 2004–2008 and was further developed into Action Plans of ministries and regional 
offices in 2005. The medium term achievement of its goals and objectives was evaluated in 
2007. 
The Board of Ministers for Drug Dependencies and Drug Control (hereinafter referred to as 
“the Ministerial Board”) is an advisory body to the government on issues of drug policy. Its 
members are ministers with responsibility for relevant areas and the prosecutor general. At 
the start of 2007 the government approved a new statute, giving the Ministerial Board 
responsibility for the legal drugs – alcohol and tobacco. 
The executive of the Ministerial Board – the General Secretariat of the Board of Ministers for 
Drug Dependency and Drug Control (hereinafter referred to as “the General Secretariat”) is 
responsible for coordination, methodological guidance and control of the implementation of 
drug policy at a central and regional level and also provides for the representation of the 
Slovak Republic on drug issues in international institutions at the EU and UN level.  
Government Resolution 534/2002 established the National Monitoring Centre for Drugs 
(hereinafter referred to as “the NMCD”) under the General Secretariat as the national contact 
point for the specialised European Union agency – the European Monitoring Centre for 
Drugs and Drug Addiction with the task of monitoring the psychotropic drug situation at a 
national level. In 2007, new organisational regulations for the Government Office were 
approved, detaching the NMCD from the General Secretariat and establishing the NMCD as 
an independent unit. In this way the coordination and decision making function of drug policy 
was separated from the monitoring function of drug epidemiology. 
The “National Action Plan for Alcohol Problems” was adopted in 2006 and the “National 
Programme for Tobacco Control” was adopted in May 2007.  
1.1 Legal framework 
1.1.1 Legislative development 
 
Act 475/2005 on imprisonment and Act 221/2006 on custody 
The new legislation gives a better specification of the rights and duties of prison inmates 
when serving sentences or awaiting trial. The aim was to create a legislative framework that 
would reduce the risk of drug infiltration in prisons. It sets more precise conditions for the 
exercise of certain rights and the performance of certain obligations by prisoners and the 
powers of prison staff to minimise the negative effect of the prison environment, in particular 
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with a view to strengthening measures for fighting drugs. For example, conditions for visits, 
the receiving of packages and letters and bans on receiving or sending items through third 
parties were specified. The amendments also made changes to the rules for cashless 
transactions to limit opportunities for drug dealing and introduced an obligation for prisoners 
to undergo personal searches and tests for the presence of drugs in the body1.  
Psychological services were introduced for drug users on remand suffering from withdrawal 
symptoms that can not overcome themselves; before the amendment the law did not support 
the provision of psychological services. The greatest need for such services was in the time 
of enforced withdrawal immediately upon admission of a drug user into prison. A legislative 
framework has been created to establish Special Treatment Units2 for convicted drug users, 
in which the prison creates conditions for the convicts to overcome a crisis or receive court-
ordered or voluntary treatment. 
Amendment of Act 372/1990 on misdemeanours  
Act 211/2006 on amendments and supplements to Act 372/1990 allows deputies of the 
National Council of the Slovak Republic (hereinafter referred to as “the NC SR”) to be 
prosecuted for breaking the law, in particular for driving motor vehicles under the influence of 
alcohol or other addictive substances. Before the amendment was passed, politicians were 
protected from such prosecution by parliamentary immunity. The amendment was passed in 
response to events that have taken place in recent years and received widespread attention 
in the media, leading to widespread public criticism of the status of deputies of the NC SR 
with regard to their liability for breaches of road traffic regulations as compared to other road 
users. 
Amendment of Act 140/1998 on medicines and health care aids/instruments  
Act 342/2006 increased the supervision of medicines, supervision of the market and 
penalties for breaches of applicable regulations. The act strengthened requirements for all 
subjects handling medicines and health aid instruments, especially for the holders of licences 
to provide medical care. It also modifies relevant provisions of the law on advertising3. Under 
the new legislation it is forbidden to present any form of advertising containing narcotic or 
psychoactive substances or precursors4.  
Act 124/2006 on occupational health and safety  
In 2006 a new act on occupational health and safety was passed5. This did not introduce 
significant changes in the area of drugs. The legislation left intact previous rules on the duties 
of employees and employers in the area of drugs, alcohol and tobacco. (Ban on using and 
being under the influence of the stated substances during working time, obligation of 
employees to undergo tests for the presence of such substances in the body6, obligation of 
the employer to check for compliance with the stated provisions and so on.)  
 
At present an amendment to Appendix 1 of the Act 139/1998 on narcotics, psychoactive 
substances and precursors, as amended, is going through the legislative process. This will 
add a new psychoactive substance, 1-(meta-chlorophenyl) piperazine (mCPP), to the first 
category of psychoactive substances. The amendment was approved by Government 
Resolution 380 dated 25 April 2007 and submitted to the National Council of the Slovak 
Republic. The decision to outlaw mCPP was based on experience in practice of an increased 
number of seizures and the impossibility of prosecuting those who traffic in this substance7. 
                                                 
1 Before the act was amended, the provisions were included in various regulations of lesser legal force. 
2 Such units already existed but the amendment gave their establishment a legislative foundation 
3 Act 147/2001 
4 The full text of the law on medicines and health aids/instruments was issued as Act 545/2006 
5 The act came into effect on 1.7. 2006.  
6 The persons authorised to order employees to undergo testing is defined by the law or an internal regulation of 
the employer. 
7 The amendment was approved by the National Council 13th September 2007 
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1.1.2 Law implementation 
There is not a great deal of qualitative information available on practical responses to drug 
crime. In 2006 the Open Society Foundation began a research programme to evaluate the 
implementation of Sections 171 and 172 (1) of the penal code, Act 300/2005 (hereinafter 
referred to as “the New Penal Code”). The project focuses on the evaluation of 
consequences of the New Penal Code and the Code of penal Procedure implementation, 
particularly as they affect drug users. It includes three sub-studies, one of which focuses on 
the practical application of the stated drug sections and analyses the characteristics and 
procedure of penal proceedings. The research will be carried out through semi-structured 
interviews with specialists in the field of penal law (police officers, investigators, prosecutors, 
judges, defence lawyers) and an analysis of case files.  
The other two sub-studies focus on identifying the consequences and the extent to which the 
implementation of the stated drug sections influence drug users - their life, health, social 
inclusion, social status and so on. It works with the statements and observations of 
representatives of the medical and helping professions acquired in focus groups. In addition 
it studies the epidemiological situation, the trends in drug use, drug availability, patterns of 
use and finally trends in the application of drug law based on statistical data published by law 
enforcement agencies. The final report of the project is scheduled for publication in 2009 
(See also Chapter 13.2.1 – Main recent studies). 
The practical drug law application by law enforcement authorities can also be seen through 
statistics published by these authorities on the number of arrests, prosecutions and 
convictions for drug-related crime. It is as described in more detail in chapter 8. 2 - Drug-
related crime.  
1.2 Institutional framework, strategies and policies 
1.2.1 Coordination and institutional framework 
1.2.1.1 Coordination at the national level 
The advisory body of the Slovak government, responsible for coordination, initiatives and 
control in the area of drug policy is the Board of Ministers for Drug Dependency and Drug 
Control (“the Ministerial Board”). Two meetings of the Ministerial Board took place in 2006. 
The most important documents presented at the spring meeting included the Rules for 
Financing the Drug Policy of the Government for the next period, which was later on adopted 
by the government in April 20068 and the Report on the Implementation of the Slovak-
German-Czech Twinning Project aimed at support for the implementation of the NPFD. 
At the autumn meeting, the new chairperson of the Ministerial Board – the deputy prime 
minister for knowledge society, European affairs, human rights and minorities – confirmed 
the foundation of state drug policy given in the manifesto of the new government coalition.  
The government will pay particular attention to the development of programmes to prevent 
drug addiction, giving priority attention to children and young people and issues of the 
treatment, re-socialisation and reintegration of drug addicts with an emphasis on the further 
employment and housing. The new government will be much more active in issues of 
prevention and the growing risk of addiction to legal drugs, especially alcohol and tobacco. 
This objective was incorporated into the new Statute of the Ministerial Board, extending its 
mandate to cover the legal drugs alcohol and tobacco, which was subsequently approved by 
the government in February 20079. 
                                                 
8 Resolution 288 of 5 April 2006  
9 Resolution 147 of 21 February 2007 
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The executive of the ministerial board with responsibility for coordinating the performance of 
tasks adopted by the ministerial board and providing for the implementation of government 
drug policy is the General Secretariat of the Board of Ministers for Drug Dependency and 
Drug Control in the Government Office (the General Secretariat), which used to include the 
National Monitoring Centre for Drugs (NMCD). On 1st June new organisational regulations of 
the Government Office came into force, under which the NMCD is an independent 
department reporting directly to the deputy prime minister for knowledge society, European 
affairs, human rights and minorities and organisationally subordinate to the head of the 
Slovak Republic Government Office. This measure contributed to the separation of the 
coordination and decision making function in the drug policy and the monitoring function of 
drug epidemiology; the status of the NMCD has been clearly defined not only in the context 
of the Government Office, but also in the individual components/elements of the drug 
information system in Slovakia, in which it functions as the national coordinator for drug 
information networks. As a national focal point of the REITOX network (the European 
Information Network on Drugs and Drug Addiction), the NMCD monitors the situation with 
regard to psychoactive substances at a national level and provides information on drugs in 
the Slovak Republic in order to ensure the direct and regular exchange of information 
required by the EMCDDA.  
 
1.2.1.2 Coordination at a regional level 
Coordination of state drug policy at the local and regional level is the role of regional 
authorities (the territorial state administration). Every regional authority employs a local 
coordinator who coordinates responses to the drug problem – prevention, treatment, re-
socialisation. Methodological direction is provided by the General Secretariat. (For more 
detailed information see the 2006 Report, chapter 1.2.2 – Coordination and institutional 
framework.)  
In 2007, Government Resolution 165 of 28 February 2007 approved the dissolution of the 
stated regional authorities with effect from 30 September 2007. In this resolution the 
government also took note of the material prepared by the Ministry of Interior under the title 
“Report on the analysis of developments and the current situation in public administration”, 
which included a request of the General Secretariat that the drug problem should remain the 
responsibility of the proposed local offices in regional capitals. The National Council of the 
Slovak Republic also took note of the stated material, in the form of “Information on the 
results of the analysis of development and the current situation in public administration and 
proposed measures”, in resolution 277 of 21 March 2007. The Ministry of Interior 
subsequently proposed an organisation structure for the local offices in regional capitals that 
did not include provision for drug issues. At present the deputy prime minister for knowledge 
society, European affairs, human rights and minorities together with the General Secretariat 
is working to have the position included in accordance with the above resolutions.  
Support to the coordination at a regional level 
Various projects are used to support the improvement in the implementation of drug policy, 
the development of coordination and cooperation on drug issues at a local and regional level 
For example, in 2006, still in the framework of the twinning project, Support for the 
Implementation of the NPFD – component 4, the NMCD in cooperation with the General 
Secretariat, compiled and disseminated a methodological manual “Assistance and practical 
support in defining the characteristics of the drug situation at the regional level”.  
In 2007 (January – September) implementation of the project “Educational Activities on drug 
issues”10 took place. The main aim of this project was to raise the professional level of 
persons responsible for the creation of rug policy at a local and regional level. A further aim 
of the project is to increase the qualifications of persons responsible for reducing drug crime 
                                                 
10 Under the Transition Facility, supported by EU funding and national co-financing under the Technical 
Assistance for the project Support for the Implementation of the NPFD.  
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in the Ministry of Defence within the competence of the Military Police11. The project includes 
the preparation of methodological guidelines, the first entitled “Rules and criteria for the 
creation and evaluation of regional anti-drug policy” and the second “Investigating drug 
crime”.  
A specific complex project to provide regional support for drug policy at a regional level is the 
project “Concept for activating regional resources in the creation, implementation and 
evaluation in the drug policy of the Prešov region”12. Its aim is to create a concept to identify 
resources in the region (expertise, personnel, institutions and auxiliary resources) and to 
define their skills and abilities for implementing drug activities. It also defines the status of 
such resources and their involvement in the creation, implementation and evaluation of drug 
activities in the region. 
1.2.2 National strategic documents 
1.2.2.1 National anti-drug strategy - NPFD 2004–2008 
In April 2007, the government discussed and took note of13 the “Report on the medium-term 
achievement of the objectives and tasks of the NPFD drug strategy in the period 2005–
2006”. It was based on the evaluation reports of the individual ministries represented in the 
ministerial board and the 2005 National Report on Drugs for REITOX. The Report on the 
medium term achievement was also discussed at the 2007 spring meeting of the ministerial 
board.14  
In the area of demand reduction, the report states that drug prevention was incorporated into 
the curriculum of individual subjects and became an integral part of the education process15 
in elementary and secondary schools; there was improved coordination and cooperation 
between preventative and counselling facilities of the ministries of education, health care and 
social affairs and the police in individual areas. Furthermore, a series of successful measures 
were implemented in health care and the social sector to provide assistance to addicts and 
vulnerable groups and reintegrate them into society. In the area of supply reduction, 
measures are being taken to support various forms of judicial cooperation, legislation has 
been improved and there is better control over legal production of narcotic and psychotropic 
substances to prevent the illegal trafficking of such substances.  
The report indicates rising cannabis use among young people and increasing numbers of 
crimes committed in relation to the production, distribution and consumption of drugs, and 
also increased numbers of arrests.  
The report emphasises the need to change current methods of financing and create a stable 
system for financing drug strategies and programmes. The government already approved16 
Rules for the financing of drug policy in 2006. These Rules are to be developed by 2009 to 
take into consideration the new NPFD for the 2009–2012 period. The report also emphasises 
the need for increased participation in the performance of tasks related to drug problems at a 
regional and local level and calls for the reinforcement and further development of 
cooperation and coordination between state and local authorities, civil activities and the 
practical and scientific sectors in implementing drug policy   
                                                 
11 In 2006 another project was carried out to increase the professional skills of the Military Police “Training and 
Education for Military Police Specialists in Detecting and Solving Cases of Drugs Crime”. Specialists from the 
police criminalistics-expertise institute and the customs authority participated as lectors. 24 military police officers 
took part. 
12 Supported by EU funding and national co-financing under the Technical Assistance for the project Support for 
the Implementation of the NPFD.  
13 Government Resolution 314 dated 4 April 2007 
14 Government Resolution 314 dated 4 April 2007 
15 Ministry of Education 2007, materials for the education sector for the medium term evaluation of implementation 
of the 2004–2008 NPFD within the area of responsibility of the Ministry of Education 
16  Resolution 288 of 5 April 2006 
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1.2.2.2 The National Action Plan for Alcohol-related Problems 
Government resolution 974 of 29 November 2006 approved the 2006–2010 National Action 
Plan for Alcohol Problems submitted by the Ministry of Health.  
The National Action Plan for Alcohol Problems (hereinafter referred to as “NAPAP”) contains 
objectives, basic principles and key aspects of this issue. It has been prepared in accordance 
with the Framework for Alcohol Policy in the World Health Organisation European Region17. 
The NAPAP sets out the importance of prevention in particular as regards the prevention of 
alcohol-related harm to children and young people, in transport and in the workplace. 
Emphasis was also given to ensuring the availability of treatment for persons suffering from 
alcohol problems, especially addiction syndrome. The key roles of NAPAP include two main 
objectives that focus on changing the attitudes of people to the consumption of alcohol and 
to those who consume alcohol. One focuses on disseminating throughout society the view 
that every person is entitled to “situational abstinence”. The aim is to change the social 
stereotype under which there are certain social circumstances in which drinking alcohol is the 
rule and not drinking is an eccentricity; or in another words to make socially unacceptable the 
pressure and repeatedly offer of alcohol to someone who has once refused it. The second 
important target for the NAPAP is to change the attitudes of health professionals towards 
patients with alcohol addiction. (Okruhlica Ľ., Stowasserová N., 2007) Performance of tasks 
under the NAPAP will be reviewed every two years in a report that the Ministry of Health will 
submit for consideration by the government; the first report will be issued by 30 April 2008.  
 
1.2.2.3 National Programme for Tobacco Control 
The government approved the National Programme for Tobacco Control in May 2007 
(resolution 398 of 2 May 2007). Its main objective is to achieve twice the annual reduction in 
the number of smokers compared to the current reduction. The programme provides a 
framework for measures at a national and regional level to reduce the prevalence of smoking 
and protect people against passive smoking; it is expected to contribute to the construction of 
a tobacco-free social environment and support multi-sectoral cooperation in reducing supply 
and demand for tobacco products. Under the national programme, such approach should be 
applied that leads to stricter control of tobacco, especially in the sphere of legislation and tax 
policy. Implementation is directed by the Ministry of Health.  
In 2008, the minister of health will present a draft action plan developed under the National 
Programme for Tobacco Control. 
1.2.2.4 Strategy document on doping 
In 2006 there was also discussion of a new national strategy for the fight against doping, but 
no final document on this matter was completed.  
 
1.2.2.4 New concept of counselling services in the education sector 
At the start of the year, Government Resolution 283 of 21 March 2007 approved the new 
concept of counselling services in the education sector “The concept of the educational-
psychological counselling system and its practical implementation.” The aim of the concept is 
to define and improve the counselling system in education for the prevention of 
developmental problems in children – including drug problems. The concept will also be used 
in the preparation of a new education act.  
 
                                                 
17 
http://www.rokovania.sk/appl/material.nsf/0/97EE1E2DD1B8C97BC125722D00363C95/$FILE/Zdroj.ht
ml (accessed 21.08.2007) 
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1.3 Implementation of policies and strategies  
Support to the Implementation of the 2004–2008 National Programme for the Fight 
against Drugs in the Slovak Republic 
The twinning part of the project Support to the implementation of the 2004–2008 NPFD 
supported by EU funds and national co-financing was officially completed and the results 
achieved were presented at the final conference in December 2006. (Further information on 
the project is given in the 2005 and 2006 Reports.)  
The final report, submitted in April 2007, made the following recommendations: 
- Establish the position of “drug policy coordinator” in those ministries that do not yet have 
such a position, in order to create a flexible network and strengthen personnel capacity at 
a national level. In this context it should be noted that the government instructed18 the 
ministers who are members of the ministerial board to take the appropriate organisational 
and personnel measures in order to ensure more effective implementation of drug policy.  
- To create in ministries budgets for the approved drug Action plans in the areas of 
competence of the ministries and to recommend that they be placed under the control of 
the “ministerial drug policy coordinators” (this could strengthen their competence and 
ability to finance planned activities). 
- Civil society involved in the system of assistance for drug addicts, as represented by 
NGOs, should be strengthened and provided with reliable financial foundations. Quality 
standards should be applied for those who want to obtain public funding.  
- The report further recommends that regional drug coordinators should be based in 
community administration rather than the state administration. Their areas of competence 
should be reviewed and they should have their own budget to finance activities according 
to local needs. It is however generally necessary that cooperation at the national level 
should be preserved. 
- There should be discussion and clarification of the method of financing for activities 
relating to drug problems and cooperation with the Anti-Drug Fund, and development and 
implementation of measurable methods of financing.  
- For the implementation of secondary (selective) prevention, the report recommends 
amending the legal framework with regard to young users, who break the law for the first 
time. The aim should be to provide young offenders with assistance, which is more 
effective than prison, while they can still avoid becoming criminals for life.  
- For maintaining the process in the future the report states that it will be necessary to 
develop conditions for international cooperation where relevant representatives could 
take part e.g. in the European network in the field of prevention and treatment. 
 
Two technical assistance sub-projects begun in 2006. One of them addressed the creation of 
new opportunities for making use of the drug information portal, simplification of its 
administration, increased efficiency in communication between organisation and institutions 
cooperating with the General Secretariat and the NMCD. The second is the project 
“Education activities on drug problems” – see part 1.2.1.2 – Coordination at a regional level. 
Two funding rounds of the project Grant Scheme provided a total of EUR 920,304 to 25 
subjects. All subjects have begun implementation of their projects, which should be 
completed in the third quarter of 2007. 
 
                                                 
18 Government Resolution 314 dated 4 April 2007  
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“Improving and broadening the care for the re-socialisation and rehabilitation of 
persons addicted to psychoactive substances”. 
This project under the 2006 Transition Facility was approved by the European Union in 2006. 
EU funds amount to EUR 950,000 and national co-financing provided EUR 200,000. The aim 
of the project is to develop quality standards for the provision of professional assistance to 
addicts and use them to increase the quality of personnel and institutional resources in re-
socialisation facilities by improving their professional readiness and skills for working with 
persons addicted to psychoactive substances in order to raise the standard of the provided 
services.  The partners in the project are France as the senior partner and Finland as the 
junior partner. 
The project was developed by the General Secretariat in cooperation with the Ministry of 
Labour, Social Affairs and Family (hereinafter referred to as “MLSAF”) and the Association of 
Re-socialisation Centres. It will be implemented by means of three components – Twinning, 
Technical Assistance and a Grant Scheme. The project began officially on 8 August 2007 
and will continue until January 2009. The final beneficiaries of the project are the MLSAF, the 
regional governments and municipal authorities, as the establishing authorities of re-
socialisation centres, and re-socialisation centres themselves.  
The twinning part of the project is aimed at the preparation of an analysis of the current 
situation in re-socialisation facilities, the preparation of staff and professional standards for 
re-socialisation centres and the implementation of continuing education and training for 
employees of such facilities. Technical assistance will be used in the project to provide for 
project education activities. The grant scheme is intended to finance projects submitted by 
non-governmental organisations, non-profit organisations and local authorities that provide 
re-socialisation and rehabilitation treatment for persons addicted to psychoactive substances. 
In order to qualify for financing under the grant scheme, projects must lead to the 
improvement and broadening of services provided by the facilities, including assistance in 
returning to normal life.  
 
Another important project coordinated by the Slovak Republic, the Centre for the Treatment 
of Drug Dependencies in Bratislava, is a project aimed at improving access to treatment for 
people with alcohol and drug problems – IATPAD (Improvement of Access to Treatment for 
People with Alcohol- and Drug- Related Problems). For more information on the project see 
chapter 13.2.1. – Main recent studies and chapter 5.1 – Treatment system.  
1.4 Budget and public expenditure 
Information on drug related public expenditure is covered in chapter 11 –Public expenditure.   
1.5 Social and cultural context  
1.5.1 Public opinion on drug issues  
According to research carried out in 2006, the adult population does not tend to see drug 
addiction as a threat (Public Opinion Research Institute (PORI) of the Statistical Office, 
2006). Just under a quarter of respondents see it as a large threat. Slovak society sees 
drugs mainly in terms of rising crime and considers strict drug laws as the most effective 
measure (55% of respondents) and increased activity of the police and customs control 
(53%) (PORI at SO, 2006).  
Slovaks would welcome greater interest on the part of the EU in initiating measures against 
organised crime, the fight against terrorism and in the fight against drug abuse, at levels that 
are higher than the EU average (Eurobarometer, 2006). 
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Fig. 1.1: Comparison of the opinions of Slovak citizens on the role of the EU with the EU average in various areas 
(Eurobarometer, 2006) 
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A large majority of adults reject any legalisation of any kind of drugs. The majority opinion is 
that any legalisation would increase the number of addicts and demand for drugs; but also 
that drugs and alcohol cause nearly the same problems for society (PORI at SO, 2006). 
In another Eurobarometer survey, 16% Slovaks approved of the legalisation of marihuana – 
placing the country eighteenth out of 2519. The low rate of agreement with the legalisation of 
marihuana is confirmed by the results of other opinion polls, for example 9.8% of the 15–26 
age group (Institute of Information and Prognoses of Education (IIPE), 2006), In the NMCD 
survey20 (focussed solely on the use of cannabis) nearly 81% of the population (15–64) 
fundamentally or partly disagree with the opinion that people should be allowed to smoke 
marihuana/hashish, and this number rises to 87% in the 15–24 age group. 
Several surveys show that in Slovakia marihuana is considered to be the least dangerous 
drug, especially among young people. More than half of young people (15–29 years) 
consider that trying it once or twice in a lifetime represents little or no risk (PORI at SO, 
2006).    
 
                                                 
19 The greatest agreement was from respondents in the Netherlands (49%), the least in Finland (8%), in the 
Czech Republic 32% of respondents agreed. 
20 The extent of marihuana use in Slovakia and the screening of marijuana users with problems is discussed in 
Chapter 2 – Drug Use in the Population 
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Fig. 1.2.: Little or no risk from occasional use of cannabis, cocaine, heroin and ecstasy as declared by 
respondents aged 15–29 in Bratislava (PORI at SO, 2006) 
54 56 56 53 54
59
20
17141416 18
9 10 10 9 10
11
26 26
30
0
10
20
30
40
50
60
70
1998 1998 2000 2002 2004 2006
%
Marihuana
Cocaine
Heroin
Ecstasy
 
As regards regular drug use, the percentage of young respondents in Bratislava who 
consider drug use as with little or no risk is much lower – compared to the data shown in fig. 
1.2. In 2006, 12% of respondents saw regular marihuana use as a low risk activity; the 
proportion varied in surveys from year to year – from 16% in 1996 to 25% in 2002. 
1.5.2 Attitudes to drug users  
The majority of the Slovak population (60%) continues to think that drug users are sick 
people or eccentric people dissatisfied with the lifestyle of the majority (54%). The second 
opinion predominates mainly among younger group of the population. Overall the dominant 
opinion remains that drug addicts should be required to undergo treatment for their addiction 
(PORI at SO, 2006). 
Since 2000 there has been a strong increase in the number of those who would not remain in 
a relationship with a person who underwent treatment for drug or alcohol addiction, up to 
69% (from the previous 50%) and married couples would insist on their addicted spouse 
undergoing treatment (71%).  
 
Marijuana, the media and society 
At the end of 2005 and the start of 2006 a number of products appeared on the Slovak 
market that drew attention to themselves by the use of the characteristic marihuana leaf 
(posters, figures smoking joints, place mats, t-shirts, lighters). A number of food products 
also appeared promoting as “marijuana” products despite containing no THC. The presence 
of such products in ordinary shops may give consumers the impression that marijuana is a 
normal, legal and socially acceptable product.  
The image of marihuana as a low risk drug is, although rare, supported by statements in the 
media that popularise its natural origin and a positive relaxation and therapeutic effects on 
the secondary symptoms of certain serious chronic illnesses. They also emphasise freedom 
of choice in the use of this illegal drug. 
The general secretariat reacted to some comments in the media by asking the ethics and 
regulatory authorities for the given media to investigate them. The first case was the 
publication of a recipe involving marihuana in the former Live weekly, and its 
recommendation that smoking cannabis produces a faster effect than eating it. The 
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independent ethics authority (the Press Council) gave the weekly a serious warning. In the 
second case the Regulatory Authority for Radio and Television Broadcasting rejected the 
General Secretariat’s complaint against the imbalanced broadcast “For and Against”, which 
was in favour of marijuana.      
The issue of the cannabis drink freely available in a chain of supermarkets21 was reopened in 
June 2006 (in the context of the International Day against Drug Abuse and Illegal 
Trafficking). Measures taken by the General Secretariat and support from the media lead to 
the product’s removal from the market.  
 
                                                 
21 2006 Report, p. 6  
2. Drug Use in the General Population and specific sub-groups 
 
Surveys of drug use in the general population are a good guide into the current situation and 
in its development if the surveys are conducted continuously. The results in individual survey 
cycles document the trend, whether rising, falling or stabilising.  In the national context they 
contribute to our understanding of the problem of drug use and the formulation of strategic 
approaches and measures.  
The highest level of international22 comparability of survey results is provided by the following 
surveys carried out in Slovakia in 2006: survey by the Public Opinion Research Institute 
(PORI) at the Statistical Office; the NMCD survey on estimates of the prevalence of 
marihuana use and the Tobacco-Alcohol-Drug (TAD) survey in part 2, where the 
questionnaire for students aged 16–19 is identical to the ESPAD questionnaire. 
This chapter is based mainly on the results of population and school surveys carried out in 
Slovakia in 2006 (summarised in Table 2.1) 
Table 2.1: Summary of population and school surveys in 2006 
Name of survey/ 
publication 
 
Institution 
 
No. 
respondents 
Selection 
method 
Age  
group 
Survey 
method 
Field 
phase 
in  2006 
Output for 
EMCDDA  
 
Index: 
o = repeated 
p/ = periodicity  
 
       
Prevalence of drug 
use in Slovakia 
and public opinion 
on problems 
related to drug 
addiction 
 
O – P/2   
PORI at SO N=1305 
 
 
 
quota 15-64 
 
 
 
 
Face-to-face  
Standardised  
interview23  in 
home of 
respondent 
Octobe
r 
ST 01 
 
Prevalence of 
marihuana use in 
Slovakia and 
screening of 
marihuana users 
with problems 
––––––––––- 
Publication 
planned in 2007 
NMCD N=3039 
 
 
quota 15-64 
 
  
CATI   
Standardised 
interview by 
telephone – 
fixed line and 
mobile 
network 
Novem
ber 
ST 01 
CAST 
Opinions and 
attitudes of young 
people to drug 
consumption in 
relation to 
individual regions 
of Slovakia  
IIPE  N= 1526 quota  15-26 Face- to face  
Standardised 
interview in 
home of 
respondent 
June  / 
Tobacco-alcohol-
drugs 1  
 
Coordinator24  
A. Nociar  
N=6620 (+) Stratified 
random 
selection 
10-15 Anonymous 
questionnaire 
given in 
April  ST 02 
/ TAD 1 
                                                 
22 Comparability with the European model questionnaire (EMQ), or ESPAD 
23 Guided interview supported by a questionnaire containing 83 questions relating to the subject matter of the 
survey and 7 demographic questions. All but 4 questions are closed and answers are given on a scale. An 
analysis of the items in the PORI at SO questionnaire, which is basically the same as the 1995 draft questionnaire 
of the Epidemiology Group of the Pompidou Group at the Council of Europe, showed that 61 questions were 
identical with the EMQ before adjustment (version published in Handbook of GPS, 2002 pp. 62-65). As regards 
content 50 items of the EMQ are covered by 25 questions in the PORI at SO questionnaire. 
24 The Research Institute for Child Psychology and Pathopsychology became the coordinating authority for the 
implementation of TAD and ESPAD in 2006. Other participating institutions: the Public Health Authority; the IIPE; 
the PORI at SO, the Ministry of Education and the NMCD. 
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O –P/4  
Unpublished 
classes 
Tobacco-alcohol-
drugs 2  
 
O – P/4 
Unpublished  
Coordinator  
A. Nociar 
N= 6935 Stratified 
random 
selection 
16-19 Anonymous 
questionnaire 
given in 
classes 
April  ST 02/ 
/ TAD 2 
 
2.1 Drug use in the general population 
 
2.1.1. Marijuana 
The Slovak population has the greatest experience is marihuana/hashish use. Growth has 
slowed down since 2002. The greater prevalence of marihuana use compared to other drugs 
relates to its perceived and actual availability, low price, simple “production” (chapter 10 – 
Drug Markets) and underestimation or ignorance of the possible risks, especially those  
resulting from occasional use. For a certain age group, marijuana use is also a symbol of 
rebellion, an expression of freedom and refusal to conform, especially for young adults (15–
34) and youth (15–24). Experimental and casual use is seen as part of a modern lifestyle, 
culture and youth values (NMCD, 2007c).      
This section gives results on the prevalence of marihuana use in the general population 
based on two surveys carried out in November 2006 – the PORI at SO survey and the 
NMCD survey.  
2.1.1.1 Results of the PORI at SO survey  
 
Methodology  
This survey has investigated prevalence of marijuana use in the population six times since 
1996.  The methodology was described in the 2006 Report chapter 2.  
For the purposes of comparison with the European situation and the EMCDDA, since 2000 
research data have been reprocessed in order to respect the different age group given in ST 
0125. Survey data given in this chapter apply for the population aged 15–64 and then for its 
age subgroups. In this case, the sample for ages 15–64 was 1 305 respondents.  
Results 
The estimated lifetime prevalence26 for marijuana use recorded in the last survey cycle was 
16.1%, which shows increased experimentation with this drug compared to the previous 
survey (15.6%). The increase is much less rapid than in the period 1998–2002 (See the 2006 
Report, chapter 2.1 – Drug use in the population).  
In the age group 15–24 the ten year period 1996–2006 show sharp growth in lifetime 
prevalence of marijuana use and slight growth in last year27 prevalence. However the current 
use of the drug, in the last 30 days (LMP), shows an unchanged stable rate of around 5% 
(Fig. 2.1.).  
Fig. 2.1: Development trend in the prevalence of marihuana use in the 15–24 age group (Luha J., ST 01 for 
REITOX (1996 – 2006), SO SR, 2006) 
                                                 
25 The only identical age group is the 15–24 age group since 1996 
26 Lifetime prevalence (LTP) means experience in drug use at any time in the past (respondent has tried drugs 
one or more times in their life) 
27 Last year prevalence (LYP) means experience with drugs in the last 12 months 
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Men are found to have a higher prevalence. Gender differences shrink, however, as age 
decreases. In the 15–64 age group the ratio of men is three times higher, but in the 15–24 
age group, the ratio of men to women is 2:1 (see the following table). The declining 
difference between genders can also be seen in the TAD survey data, where the ration of 
boys and girls in lifetime prevalence is 1.5:1 in the 16–19 age group and 1.2:1 in the 14–15 
age group (TAD2, Table 2.10) 
Table 2.2 a): Prevalence of marihuana use in the 15–64 age group by gender in 2006 (Luha J., ST 01 for REITOX 
(1996 – 2006), SO SR, 2006) 
Used marihuana Adults 15–64 % 
Men 15–64 
% 
Women 15–64 
% 
Some time in life (LTP) 16.1 23.6 9.2 
In the last year (LYP) 6.9 10.4 3.6 
In the last month (LMP)  2 3.2 0.9 
 
Table Tab.2.2 b):  Prevalence of marihuana use in the 15–34 age group by gender in 2006, (Luha J., ST 01 for 
REITOX (1996 – 2006), SO SR, 2006) 
Used marihuana Adults 15–34 % 
Men 15–34 
% 
Women 15–34 
% 
Some time in life (LTP) 28.6 39.0 17.1 
In the last year (LYP) 14.7 20.4 8.4 
In the last month (LMP)  4.2 6.2 1.9 
 
Table 2.2 c):  Prevalence of marihuana use in the 15–24 age group by gender in 2006, (Luha J., ST 01 for 
REITOX (1996 – 2006), SO SR, 2006) 
Used marihuana Young people 15 – 24 % 
Men 15–24 
% 
Women 15–24 
% 
Some time in life (LTP) 31.3 39.0 22.3 
In the last year (LYP) 20.4 26 13.9 
In the last month (LMP)  6 8.4 3.1 
 
2.1.1.2 NMCD Survey  
Methodology  
The survey conducted by the National Monitoring Centre for Drugs focussed on the use and 
abuse of marijuana. The sample (n=3039) included a larger number of young adults in the 
15–34 age group (n=2020), which was subsequently weighted within the whole 15–64 age 
group (Luha J., Sádovská M., 2007). Respondents were contacted by telephone using the 
CATI method. 
For the first part of the standardised interview used questions from the EMQ relating to 
marihuana and the second, “abuse” part of the interview used the French CAST (Cannabis 
Abuse Screening Test) module, which is a fast screening method to identify users who could 
have psychological or psycho-social problems as a result of intensive consumption of 
marihuana. CAST28 comprises 6 questions and is one of 4 current EMCDDA test scales for 
identifying the effects of intensive marihuana use and near clinical diagnosis of the 
symptoms of intensive marihuana use. The objective of the NMCD survey was to determine 
whether there is a real need for selective prevention or other measures for marihuana-using 
populations. 
The NMCD survey (2006) filtered questions relating to intensity of use (CAST) according to 
last month prevalence. In this it differs from other surveys (France, Spain), where the target 
group was very young people (15–19 years) and the CAST questions were given to 
respondents who had used marihuana/hashish during the last 12 months.   
Results 
As Fig. 2.2 shows, among young adults aged 15–34 (n=2020), lifetime prevalence was 
22.4% and last year prevalence 8.3%. Of those who had tried marihuana, most were in the 
15–24 age group. Current use (LMP) of marihuana was reported by 3.6% of respondents (73 
persons after weighting, originally 77 respondents). In the 35–64 age group only one current 
user was identified.  
Fig. 2.2:  Prevalence of cannabis use in the population by individual age groups, (NMCD, 2006) 
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28 At the annual EMCDDA meeting of national experts on population surveys in June 2006 CAST was presented 
as a reliable instrument for the quick selection of users who may have problems resulting from intensive use.   
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Attitude and perception of risk  
In the cited survey 73.1% of respondents mainly or strongly felt that people should not be 
permitted to use marihuana or hashish and 13% were undecided. 89.4% of respondents felt 
that regularly smoking marihuana or hashish represented a medium or high risk and 10.6% 
felt that there was no risk or only a small risk. 
Age of first use  
More than half of respondents (56.1%) who admitted having used marihuana/hashish at 
some time, were 17 or younger at the time of first use. The age mentioned most frequently 
for first use of marihuana/hashish was in the 15–17 range. The average age for first use was 
17.72 years; the lowest age given was 11 and the highest 32 years. 
Frequency of use among current marihuana users 
Results for the question: “How often have you used marihuana or hashish in the last 30 
days?” are given in the following table. % of users is given in relation to the 15–34 age group 
(n=2020). 
Tab. 2.3: Frequency of cannabis use for current users (Luha J., Sádovská M., 2007)  
Frequency of cannabis use in last 30 days % 
Every day or nearly every day 0.3 
Several times a week 0.9 
at least once a week 0.8 
Less than once a week 1.7 
 
In the young adult group (15-34 years) 3.6% stated that they currently use 
marihuana/hashish. Based on the partial score in the 6 CAST questions, the survey found 
that 0.9% of respondents could be considered consumers whose use of marihuana would 
cause certain socio-psychological problems (based on a score of 4+).  
The authors of CAST also defined a medium level of risk in marihuana use, represented by a 
score of 2+. If this level of risk is accepted the proportion of respondents rises to 1.6%. The 
following problems were mentioned most frequently: an unsuccessful attempt to reduce the 
dose or completely give up the use of marihuana/hashish, memory problems, use of 
marihuana in the morning (needing to calm down and relax in the morning contradicts the 
proclaimed social and recreational function of the drug).     
More detailed results of the survey will be given in a publication whose working title is 
Distribution of Marihuana Use in Slovakia and Screening of Marihuana Users with Problems.  
It will also include a study comparing the results of the surveys by the NMCD and the PORI 
at SO relating to marihuana. 
Table: 2.4: Comparison of estimates of prevalence in individual age groups in the two surveys (Luha J., Sádovská 
M., 2007)  
  NMCD PORI at SO 
15 - 64  LTP 11.7* 16.1* 
 LYP 4.1* 6.9* 
 LMP 1.7 2 
15 - 34 LTP 22.4* 28.6* 
 LYP 8.3* 14.7* 
 LMP 3.6 4.2 
15 - 24 LTP 28.7* 31.3* 
 LYP 13.1* 20.4* 
 LMP 5.4 6 
* Significant difference identified by a two-tailed Fisher test, P=0.000. 
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All data on prevalence estimates in the NMCD survey, obtained by using a different survey 
method and a nearly four times larger sample of respondents in the 15–34 age group are 
lower. The differences in the case of LTP and LYP are statistically significant, while for 
prevalence of current use (LMP) the difference is not statistically significant. The differences 
may be due to methodological differences between the surveys, but also the fact that the 
sample size for LMP is so much smaller.   
As additional information that contribute to our understanding of lifetime prevalence of 
marihuana use could be used the results obtained by the Institute of Information and 
Prognoses of Education29 (hereinafter referred to as “the IIPE”) in its research on “Opinions 
and attitudes of young people to drug consumption in individual regions of Slovakia” 
(repeated surveys from 1998 and 2001). In a representative sample of 1 526 respondents 
aged 15–26, 249 respondents (16.3%) admitted experience of using at least one kind of 
illegal drug, most of whom – 92.6% (230) or 15% of the total sample – had experience with 
marihuana use.   
 
The data given below on the prevalence of other types of drugs is based on the results of the 
survey conducted by the PORI at SO, calculated for the population aged 15–64 as provided 
to the EMCDDA. 
2.1.3 Heroin  
Compared to 2004, when the lifetime prevalence (LTP) of heroin use in the population aged 
15–64 increased to 1.1%, in 2006 it fell to 0.9%. In the 15–34 age group 2.5 times more men 
than women had used heroin. In the last three waves of research (2002–2006), no women 
were found who had used heroin in the last 30 days, in contrast to cocaine use. 
Table 2.5:  Prevalence of heroin use among men and women in 2006 by age group in % (Luha J., ST 01 for 
REITOX 2006, SO SR, 2006) 
Used heroin Adults 15–64 Young adults 15 -34 Youth 15–24 
 Men Women Men Women Men Women 
Some time in life (LTP) 1.3 0.6 2.4 1.1 3.3 1.5 
In the last year (LYP) 0.5 0.2 1.1 0.4 1.3 0.8 
In the last month (LMP)  0.2 0.0 0.4 0.0 0.7 0.0 
 
2.1.4 Cocaine 
Lifetime prevalence for cocaine use in the 15–64 age group increased very slightly in 2006 to 
1.2%. The ratio of men to women in last year prevalence is approximately 3:1, this difference 
balances out in last month prevalence, however, where there are slightly more women than 
men. 
Table 2.6: Prevalence of cocaine use among men and women in 2006 by age group in % (Luha J., ST 01 for 
REITOX 2006, SO SR, 2006) 
Used Cocaine Adults 15–64 Young adults 15–34 Youth 15–24 
 Men Women Men Women Men Women 
Some time in life (LTP) 1.9 0.6 3.5 0.4 4.0 0.8 
In the last year (LYP) 1.0 0.3 2.1 0.4 2.6 0.8 
In the last month (LMP)  0.2 0.3 0.4 0.4 0.7 0.8 
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2.1.5 Amphetamines  
Use of amphetamines has been reported independently in the standard table ST 01 for 
REITOX since 1998. In Slovakia it is characterised by use of methamphetamine in powder 
form – pervitin. (Pervitin is usually cited to respondents as an example of an amphetamine.) 
Lifetime prevalence of amphetamine (pervitin) use in the sample 15–64 age group was 1.2% 
in 2006. Compared to 2004 there was a slight reduction from 1.5%. Last year prevalence in 
2006 was 0.3% and last month prevalence was 0.2%.  
The highest rates of prevalence are found in the 15–24 age group. Lifetime prevalence in this 
age group is estimated at 3.6%, compared to the 2.4% in the 15–34 age group and 1.2% in 
the 15–64 age group. Since 1998 there has been a slight increase in last year prevalence 
from 2.4% to 3.6% with use by men clearly predominating. 
Table 2.7: Prevalence of amphetamine use among men and women in 01 by age group in % (Luha J., ST 2006 
for REITOX 2006, SO SR,) 
Used amphetamines Adults 15–64 Young adults 15–34 Youth 15–24 
 Men Women Men Women Men Women 
Some time in life (LTP) 1.9 0.6 3.5 0.4 5.3 1.5 
In the last year (LYP) 1.0 0.3 2.1 0.4 1.3 0.8 
In the last month (LMP)  0.2 0.3 0.4 0.4 0.7 0.8 
 
2.1.5 Ecstasy  
Ecstasy use also shows a slight rising trend. Since 2002 it has increased from 1.8% through 
4% in 2004 to 4.3% in 2006. Use is slightly more common among men than women. 
Approximately twice as many men as women had used ecstasy in the last year. A 
comparison of results with the previous survey wave reveals stable growth in the prevalence 
of ecstasy use among women. The ratio of men to women in LYP in 2002 was 3:1 and this 
fell to 2:1 in 2006.  
Table 2.8: Prevalence of ecstasy use among men and women in 2006 by age group in % (Luha J., ST 01 for 
REITOX 2006, SO SR, 2006) 
Used ecstasy Adults 15–64   Adults 15–34   Young adults 15–24 
 Men Women Men Women Men Women 
Some time in life (LTP) 6.1 2.7 10.8 5.7 11.8 7.7 
In the last year (LYP) 2.1 1.2 4.2 3.0 5.3 5.4 
In the last month (LMP)  0.5 0.5 1.1 1.1 2.0 1.5 
 
2.1.6 Poly-drug use  
Although the PORI at SO survey does not track poly-drug use, according to Luha (2007) 
combined use of drugs can be at leased partially investigated using contingency tables. Due 
to the low absolute numbers, the prevalence of combined use of two drugs in terms of LTP 
has been studied.  
The most frequent combination found was cannabis and ecstasy (3%) and cannabis + 
medicines at 2.4%. Other pairs are shown in Table 2.10 
Table 2.9.: Overview of combined prevalence of “drug pairs”. Luha J. National Report on GPS in Slovakia, June 
2007 
 cannabis heroin Cocaine
_crack 
amphet. ecstasy LSD_hal
ucinog.. 
Pharma. anabol. Volatile 
subst. 
cannabis ***  9;  0.7% 15; 1.2% 12; 0.9% 39; 3.0%  9;  0.7% 31; 2.4% 12; 0.9% 15; 1.2% 
heroin  ***  4;  0.3%  2;  0.2%  2;  0.2%  2;  0.2%  4;  0.3%  1;  0.1%   0 
Cocaine_crac
k 
  ***  3;  0.2%  8;  0.6%  2;  0.2%  4;  0.3%  1;  0.1%  2; 0.2% 
 27
Amphet.    *** 12; 0.9%  2;  0.2%  3;  0.2%  2;  0.2%  1; 0.1% 
ecstasy     ***  6;  0.5% 11; 0.9%  5;  0.4%  6; 0.5% 
LSD_haluc.      ***  6;  0.5%  3;  0.2%  2; 0.2% 
Pharma.       *** 13; 1.0%  7; 0.5% 
anabol.        ***  3; 0.2% 
Volatile subst.         *** 
Given different numbers of missing data, the total sample size is changed from  n = 1305 to n = approx. 1290  
Data are reported as: number of cases; % 
 
2.2 Drug use in the school population and amongst young people 
2.2.1 School survey Tobacco – alcohol – drugs  
Methodology  
Between 24th and 28th April 2006, the data collection for the national representative school 
survey Tobacco – Alcohol – Drugs (hereinafter referred to as “TAD”) took place, which is 
conducted in Slovakia in four-year cycles. TAD consists of three separate modules: TAD1 for 
students of elementary school aged 10–15, TAD2 for secondary school students aged 16–19 
and TAD3 for teachers in elementary and secondary schools. Data collection is carried out 
by means of anonymous questionnaires administered in classes. Questionnaires were 
placed in empty envelopes on being completed, which are then sent from the class and the 
school for central processing, which ensures that neither individuals, nor classes nor schools 
can be identified. The section of the TAD2 questionnaire on illegal drugs is largely identical 
with the items in the ESPAD questionnaire. The sample size for TAD 1 was 3 603 boys and 3 
263 girls (aged 10–15) while for TAD2 it was 2 629 boys and 3 831 girls aged 16–19. 
 Results 
Schoolchildren aged 10–13 are most likely to have experience of tranquilisers and 
sedatives30. These are followed by inhalants and marihuana. There is a greater prevalence of 
marihuana among 14-year-olds (8.7%) and its frequency increases rapidly as schoolchildren 
and students get older (38.8% for students aged 19). The second most widely tried group of 
psychoactive substances in the 14–19 age group was tranquilisers and sedatives. The third 
most frequently tried drug, which appears at age 17, is ecstasy.  
Girls are more likely than boys to experiment with tranquilisers and sedatives, with a clear 
predominance appearing around the age of 14.  
Table 2.10.: Lifetime prevalence of drug use for schoolchildren and students according to TAD1 and TAD2 for 
2006 in % (Nociar A., ST 02 for REITOX, 2007) 
               Age 
Drug          10     11     12     13      14       15 16        17        18       19 
B 0.9 1.0 2.5 5.1 9.5 16.6 29.2 41.0 45.5 48.6 
Marihuana G 0.8 0.4 1.9 2.1 7.9 13.4 20.0 27.6 29.0 32.9 
Total Σ 0.8 0.7 2.2 3.7 8.7 14.6 25.1 33.4 35.3 38.8 
B 0.9 1.1 2.7 4.5 5.5 5.2 6.1 8.0 8.4 10.0 
Tranquilisers and sedatives G 1.8 1.1 3.1 4.1 8.3 10.5 11.8 15.3 13.8 14.9 
Total Σ 1.3 1.1 2.9 4.3 6.8 7.6 9.4 10.8 11.9 13.1 
B 0.9 0.0 1.3 1.4 2.0 2.5 2.4 7.0 8.8 11.7 
Ecstasy  G 0.9 0.4 0.6 0.9 0.6 1.7 3.7 5.3 6.1 8.7 
Total Σ 0.9 0.2 1.0 1.2 1.4 2.0 3.2 6.0 7.2 9.8 
Amphetamines B 0.0 0.0 0.7 0.7 0.5 1.8 2.4 5.9 6.0 6.9 
                                                 
30 The TAD questionnaires include questions on medicines formulated to suit the age of the respondent; e.g. pain 
killers (without prescription), sleeping pills (without prescription).  
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G 0.0 0.2 0.0 0.5 1.1 1.9 3.1 3.5 4.6 5.8 
Total Σ 0.0 0.1 0.4 0.6 0.8 1.8 2.8 4.5 5.2 6.2 
B 2.6 0.7 2.2 4.3 4.3 5.5 6.4 5.6 5.2 6.5 
Inhalants G 0.0 1.3 2.3 3.8 2.8 2.7 5.5 4.5 3.3 4.1 
Total Σ 1.3 1.0 2.3 4.1 3.6 4.2 5.9 5.0 4.1 5.0 
B 0.9 0.4 0.8 1.1 1.3 1.2 2.4 4.3 3.8 6.1 
LSD, or hallucinogens G 0.0 0.2 0.0 0.3 0.5 1.1 1.6 1.4 1.9 2.4 
Total Σ 0.4 0.3 0.4 0.7 0.9 1.0 2.0 2.6 2.6 3.8 
B 0.9 0.2 0.6 0.6 0.9 0.4 0.3 1.4 1.1 1.0 
Heroin G 0.0 0.2 0.2 0.2 0.2 0.4 0.7 0.7 0.7 0.4 
Total Σ 0.4 0.2 0.4 0.4 0.6 0.4 0.5 1.0 0.9 0.6 
B 0.9 0.2 1.0 1.3 0.4 0.9 0.8 2.1 2.8 2.5 
Cocaine G 0.0 0.6 1.1 0.5 0.3 0.6 1.4 1.5 1.7 1.6 
Total Σ 0.4 0.4 1.0 0.9 0.4 0.7 1.1 1.7 2.1 2.0 
2.2.2 Youth (15–26) surveys   
Methodology 
The IIPE has studied consumption of illegal drugs by young people aged 15–26 as part of its 
research tasks with a much wider scope since 1995. In June 2006 a regular survey was 
conducted focussed on comparing the situation in all regions in Slovakia in the period 1998–
2006.  
The questionnaire is completed by an interviewer during a face-to-face interview with the 
respondent in their home. 1 526 questionnaires were processed in 2006, of which 752 
(49.3%) were for male respondents and 774 (50.7%) were for female respondents. The IIPE 
survey also studies the frequency of drug use in the last month31.    
Results 
16.3% of respondents (249) admitted experience of at least one kind of illegal drug in 2006. 
20.2% of men and 10.7% of women have experience of using illegal drugs. Again in 2006, 
marihuana was the drug tried most frequently – by around 15% of respondents.  
Although prevalence was lower than in 2005 (20.8%), at 16.3%, the long term trend 
observed among young people aged 15–26 is for a slight rise in the numbers who have tried 
illegal drugs at some time in their life. The percentage of those who had used drugs in the 
last month fell. 
Table 2.11.: Comparison of frequency of drug consumption in IIPE surveys in 1998, 2001 and 2006 (Pétiová M. et 
al., 2006) 
Frequency of drug use in the last month (LMP) 
Q.78 how many times have you used an illegal drug (other than 
alcohol and nicotine) in the last month  
1998 
N=232 
2001 
N=271 
2006 
N=249 
Not once 63.9 59.5 68.1 
Less than 5 times 23.9 23.7 21.4 
More than 5 times 8.0 11.7 9.6 
Don’t know 4.2 5.1 0.9 
Total 100% 100% 100% 
The most frequent age when young people start to experiment with drugs is between 14 and 
18. 11.3% of young people tried drugs before 14; 68.1% did so aged 15–17 and 20.9% of 
those asked had their first drug experience aged 18–22.  
                                                 
31 Less than 5x  and more than 5x  
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More than half of respondents obtained their first drug from a friend (53.3%) and a third of 
young people (31.4%) obtained it from a schoolmate. It is interesting that the number who 
was offered drugs by a sibling32 increased compared to 1998 and 2001.  
Comparison of the results of the IIPE for individual Slovak regions 
The results of the survey for 2006 show increased experience of drug use in Košice and 
Trenčín regions. 
Table 2.12. Comparison of results for individual Slovak region in % (Bieliková M., Pétiová M., 2006) 
Experience of 
drugs 
Bratislava Trnava Trenčín 
▲ 
Nitra 
 
Žilina Banská 
Bystrica  
Prešov Košice 
▲ 
2006 18.4 10.7 19.8 16.0 11.8 15.7 11.6 19.9 
2001 24.9 15.7 16.0 16.9 15.3 21.4 15.0 14.3 
1998 21.6 15.1 15.6 15.4 12.5 15.7 10.9 16.9 
 
As in the surveys cited above, respondents in all regions have the most experience of 
marihuana.  In second place, respondents are most likely to experiment with ecstasy in the 
Bratislava, Trnava and Košice regions, with volatile substances in Trenčín, Žilina, Banská 
Bystrica and Prešov regions and with tablets in the Nitra region. The third place in all regions 
was taken by tablets (medicines), in Trenčín and Nitra together with alcohol (Bieliková M, 
Pétiová, and M.  2006). 
2.3 Drug use in specific population groups  
In 2006 there is no information available about surveys conducted in Slovakia on the use of 
illegal drugs in specific33 population groups. Chapter 8 includes some information from the 
Bordernet survey (drug users among sex workers) and a local survey of homeless people. In 
terms of research tasks, Prešov University implemented a biomedical survey of smoking 
among pregnant women including comparison of the majority population and the Roma 
ethnic minority. More information can be found in chapter 12 – Vulnerable groups of young 
people subchapter 12.1.2.8. 
2.4 Drug use in recreational34  settings  
A NMCD survey in 200635 focussed on the use of legal and illegal drugs in discotheques and 
clubs. The interviewers – social workers from the Prima civil association – interviewed 
respondents – patrons of 20 Bratislava clubs and discos – during the months of May and 
June 2006. In total 300 questionnaires were completed and analysed.  233 patrons (77.6%) 
admitted experience of legal and illegal drugs.  
The most common illegal drug of which visitors to clubs and discos had experience was 
marihuana, which 209 respondents admitted to using at some time in their life (the ratio of 
113 men to 96 women is not statistically significant). Only 42 (20.1%) of respondents stated 
that they had used marihuana directly in a bar, club or disco.  
                                                 
32 Siblings as a source of illegal drugs (including paid) appear in information from the PORI SO survey. The 
largest number of those in the 15–34 age group who said that they had tried drugs – 35.2% – some time gave this 
answer to the question “Who did you get drugs from?” Friends came after this. 
33 The EMCDDA definition (children in surrogate institutional and protective care, young offenders, young people 
coming from socially and culturally disadvantaged backgrounds, the homeless, immigrants, ethnic groups...) 
34 Recreational drug use – usually involving illegal drugs – in a social or relaxing context, without consequences, 
i.e. without drug addiction or other problems. The term recreation use (WHO, 1994) is expanded by the EMCDDA 
to cover drug use in nightclubs for entertainment purposes (2002) and UNODC even adds a social motivation to 
the term – drug use amongst friends in a sociable and accepting environment. Source: Young People and Drugs, 
2006 ,252 pp 
35 2006 Report, p. 40.  
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The most likely illegal drug to be taken in a recreational setting according to this survey is 
ecstasy. Of all the types of drug, the largest proportion (50.7%) replied that they used 
ecstasy in clubs and bars.   
 
 
3. Prevention 
 
The main objectives and framework for drug prevention are defined in the 2004–2008 NPFD, 
where prevention is one of the four pillars of the national strategy. Implementation of drug 
prevention is the responsibility of the three key ministries – Education, Health and Labour, 
Social Affairs and Family, with further significant contributions from the Ministry of Interior 
and increasingly also civil society and community structures.  
The institutional and organisational system for implementing prevention for the largest and 
currently most accessible target group, which is children and young people in schools and 
educational facilities at various levels, is described in detail in the 2006 Report. In the area of 
education for children and young people, universal prevention is understood from multiple 
perspectives and the central idea in the prevention of addiction is support/protection of health 
and/or the development and strengthening of life skills.  
In the network of education facilities, every district has a pedagogical and psychological 
counselling centre (hereinafter referred to as “PPCC”) and a centre for educational and 
psychological prevention (hereinafter referred to as “CEPP”), that play the key role in 
preventing anti-social influences. In 2006 there was a change in these institutional framework 
whereby the CEPP were incorporated into the PPCC.  
The function of drug prevention coordinator in schools, which is established in almost every 
school, contributes a further approach to prevention provision. The new concept of 
counselling services in the education sector gives the school drug prevention coordinators 
and school psychologists and educational advisors a new and stronger status. The concept 
was developed in 2006 and approved by the government in 2007. 
 
3.1. Universal prevention 
 
Compared to 2005 there were no significant changes in the concept or content of drug 
prevention from the information given in the 2006 Report. Likewise, a description of the most 
important interventions under individual sectors/ministries carried out by public authorities 
and NGOs is given in Chapter 3 – Prevention and Chapter 11 – Drug use and related 
problems among very young people in the 2006 Report, and in older reports.  
EMCDDA added a structured questionnaire on universal prevention to this year’s report (SQ 
22-25), which is standardised for all countries. Given the extent of the relevant information 
given in the previous reports and the questionnaire, this chapter presents statistical 
information monitored by the IIPE that gives a quantitative illustration of the activities and 
programmes that are provided and available and the size of the target groups. 
 
3.1.1. Prevention in schools and drug education  
 
Prevention in schools is the responsibility of the Ministry of Education and has two levels. 
One is the area of education towards health and health protection, in which the Ministry of 
Education cooperates with the Ministry of Health36.  Drug prevention – as a part of prevention 
of behaviour that represents a risk to health and other health risk factors is addressed 
comprehensively – it focuses on alcohol, smoking and illegal drugs and partially on risk 
behaviour.  For example, between November 2005 and May 2006, there was a contest for 
non-smoking classes, which took place in 285 classes in 109 schools.  More than 9 000 
pupils entered the competition and by the end of the competition 227 classes from 76 
schools had not broken the basic rules. Another example of the prevention of risk behaviour 
                                                 
36 Also with its institutions such as: regional public health authorities, specialised centres for the treatment of drug 
dependencies.  
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is the prevention programme “With game against AIDS” which is implemented in schools 
under the supervision of the Public Health Authority. 
The second level of prevention in schools is the strengthening of social skills and abilities (life 
skills), as a necessary protective factor in the psychological and personality profile of the 
individual in relation to anti-social influences.  
This form of prevention is carried out in close cooperation with the pedagogical and 
psychological counselling centres of the Ministry of Education (PPCC), which can be found in 
every district centre. At this level of prevention, the PPCC (and CEPP) provide professional 
supervision of prevention activities and programmes for the local level, where they cooperate 
with many other organisations. They provide training for education and prevention workers. 
The provision of prompt and necessary diagnosis for specific individuals/groups and 
subsequent interventions in special educational facilities operate at the level of secondary 
(selective) prevention.  
Law enforcement authorities (under the Ministry of the Interior) also play a part in the 
prevention of anti-social influences in schools, in particular the Prevention Department of the 
Office of the President of the Police Force and the Regional Headquarters of the Police 
Force. These authorities also carry out prevention activities and programmes. 
 
The new Concept of counselling services  
 
Government Resolution 283 of 21 March 2007 approved a new concept for counselling 
services in the education sector “The concept of the pedagogical-psychological counselling 
system and its implementation in practice”37 (hereinafter referred to as “the Concept”).  
The Concept tightens the definition of the content and form of education and psychological 
counselling for children and young people, especially in the prevention of development 
problems in the education process in elementary schools, secondary schools, education 
facilities and the family. It is a realistic vision of an efficient and connected system of 
counselling, prevention and interventions in the education system. It provides above all the 
possibility to build a synergistically connected counselling and prevention system in all district 
centres for children and young people from the age of 3 years to the end of vocational 
training. 
The construction of the system requires a strengthening of human resources in all parts of 
the system and at all levels. The Concept also increases the powers of school psychologists, 
educational advisors and drug prevention coordinators in schools.  
 
3.1.1.1 Statistics on prevention activities carried out in schools 
 
The provision of statistics in the education sector is the long-term responsibility of the IIPE, 
which pays particular attention to information on preventative activities carried out in schools.  
The CEPP are of key significance in the area of prevention, both in universal prevention and 
also in selective (secondary) and indicated (tertiary) prevention, in which they also cooperate 
with other organisations (e.g. psychological and consulting services in the Offices of Labour, 
Social Affairs and Family).   
In the 2005–2006 school year, most of the activities of the CEPP and PPCC were one-off or 
short term activities such as lectures, talks and the like, including interactive activities, which 
also received the largest number of attendants.   
3 019 people took part in 201 training activities for prevention workers in the CEPP (mainly 
drug prevention coordinators for schools). There were 586 more activities than in the 
                                                 
37 http://www.rokovania.sk/appl/material.nsf/0/A637C04B755E271EC1257291002F7EDB?OpenDocument 
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previous year with slightly fewer participants. The PPCC prepared 107 activities, which were 
attended by 1 926 participants.  
Table 3.1: Prevention activities carried out in school year 2005–2006 by CEPP and PPCC (Slovíková M., 2007) 
CEPP PPCC 
Activities Participants Activities Participants 
 
No. % No. % No. % No. % 
Group activity with a client 2 869 74.56 56 722 83.46 1 743 75.91 43 453 66.72 
Training groups 1 267 44.16 20 192 35.60 454 26.05 9 216 21.21 Of 
which Lectures, talks 1 602 55.84 36 530 64.40 1 289 73.95 34 237 78.79 
Services for education workers 542 14.09 1 925 2.83 275 11.98 1 330 2.04 
Methodological 
consultation 
486 89.67 1 009 52.42 234 85.09 581 43.68 Of 
which 
Courses, seminars 56 10.33 916 47.58 41 14.91 749 56.32 
Training for prevention workers 201 5.22 3 019 4.44 107 4.66 1 926 2.96 
Other expert activities 236 6.13 6 294 9.26 171 7.45 18 419 28.28 
Publications and public 
education activities 
102 43.22 3 146 49.98 74 43.28 12 031 65.32 
Publications and 
information events 
65 27.54 1 888 30.00 78 45.61 6 031 32.74 
O
f w
hi
ch
 
Residential events 69 29.34 1 260 20.02 19 11.11 357 1.94 
T O T A L  3 848 100.00 67 960 100.00 2 296 100.00 65 128 100.00 
 
In the studied period, CEPP carried out 1 305 long and medium term prevention 
programmes. The activities targeted pupils of elementary schools and nursery schools and 
students in secondary schools through peer programmes (see figure 3.1). More than a half of 
programmes aimed at nursery schools, peer groups and risk groups were long-term 
programmes. 56.4% of programmes had regional and super-regional scope. 
 
Figure 3.1: Prevention activities in 2006 by type (Slovíková M., 2007) 
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The PPCC carried out prevention programmes 943 times in school year 2005–2006. The 
majority were programmes of a regional or super-regional character (54%). Programmes for 
risk groups took place mainly at a local level. The most frequent target group in programmes 
implemented by the PPCC was pupils of elementary school, who were the target of 
prevention programmes in 606 cases. More information is given in Table 3.2  
 
Table 3.2:  Summary of PPCC prevention programmes in school year 2005–2006 (Slovíková M., 2007) 
 
Target group – type of prevention programme  
total 
 
Pre-
school
 Pupils 
of ES 
Peer 
group 
Risk 
group 
 Sec. 
school 
Free 
time 
activity 
Lectures, 
talks 
 
No. prevention programmes 
943 45 348 107 306 92 4 41
% 100.00 4.77 36.90 11.35 32.45 9.76 0.42 4.35
Pre-school 45 43 2 0 0 0 0 0
Pupils of elementary 
school 
606 0 327 50 204 0 2 23
Secondary school 
students 
228 0 1 57 83 87 0 0
Pupils in special 
elementary schools 
7 0 2 0 5 0 0 0
Parents 12 1 1 0 2 0 0 8
Teachers (coordinators., 
educational advisors) 
45 1 15 0 12 5 2 10B
y 
ta
rg
et
 g
ro
up
 
Others 0 0 0 0 0 0 0 0
Short term 405 25 160 9 141 31 2 37
Medium term 227 15 81 17 92 19 2 1
D
ur
a
tio
n 
Long-term 311 5 107 81 73 42 0 3
Evaluation of programmes 93 8 55 6 17 3 2 2
(36.81% assessed)     % 9.86 17.78 15.80 5.61 5.56 3.26 50.00 4.88
 
3.1.1.2 Evaluation of prevention programmes 
 
According to the statistical data from the IIPE, fewer programmes were evaluated in 2005–
2006 than in the preceding period. The CEPP evaluated a fifth of their programmes and the 
PPCC just under 10%. 
In the case of peer programmes, “Minimum standards for peer programmes”38 have been in 
effect for a long time, guaranteeing the standard of these programmes. Other standards have 
been prepared with the same objective of guaranteeing quality in the “Proposal for 
application of minimum rules for prevention programmes in schools and educational 
facilities”. At present, the material has been considered by the Expert Group of the General 
Secretariat for Prevention and will be transferred to the Ministry of Education for further use.  
 
Evaluation of the Programme The Way to Emotional Maturity (Cesta k emocionálnej 
zrelosti) 
 
Information on this universally39 implemented prevention programme40, aimed at developing 
the life skills of pupils in the 12–15 age group is given in Chapter 3 – Prevention of the 2006 
Report. In this section we discuss it in relation to its regular biannual evaluation, to which 
contribute not only the implementers of the programme (specially trained education workers) 
but also participants in the programme (pupils in years 6–9 of elementary school).  
A third of all the schools in Slovakia took part in the “Way to Emotional Maturity” programme 
(hereinafter referred to as “the Way programme”) in school year 2005–2006. 9% of pupils in 
years 6–9 (27 735 children) took part. The PPCC and CEPP that coordinate this prevention 
programme trained 279 new teachers for this programme. The Way programme is taught 
mainly as part of the curriculum (63%) and is used mainly by teachers of ethics and Slovak 
language, class teachers, drug prevention coordinators in schools and educational 
counsellors.  
                                                 
38 Matula,Š.: Minimálne štandardy rovesníckych programov (Minimum standards for peer programmes)  
39 In its seven-year history the “Way” prevention programme has been used in 16 892 classes with 278 846 pupils 
and secondary school students. 
40 See also appendix II. SQ 22-25 for REITOX  MUSTAP 
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Teachers’ experience of implementing the “Way” prevention programme was studied through 
a survey in which 526 teachers took part (478 women and 44 men). The programme is 
generally perceived positively. More than half of respondents considered the programme 
interesting and a quarter of them said that it was effective.  
Teachers see the main benefit of the programme for pupils in the fact that pupils become 
more open and are able to work in a team and find more effective solutions to problems. In 
the teachers’ opinion there is a notable increase in self confidence and psychological 
resistance, a change in behaviour, reflected in appropriate and effective communication and 
creativity. More than 80% of teachers (who took part in the research) were interested in using 
the programme again.  They recommend improving the programme by incorporating it into 
the curriculum and using it in cooperation with parents.41  
In the set of pupils comprising 527 girls (56%) and 415 boys (44%), the Way programme was 
assessed as follows:  Nearly half of the pupils providing feedback stated that the programme 
was interesting and it brought something new to every third participant. Approximately a fifth 
of pupils, mainly boys, stated that only some parts of the programme were interesting while 
girls evaluated the programme as a whole as interesting more frequently than boys. Of the 
themes, preference was given to interpersonal and partnership relations and the solving of 
life problems and conflicts. A positive evaluation was also given to the creation of space for 
communication, the more open approach of the teacher and the possibility to express oneself 
and defend one’s opinions in the group.  
The pupils were also given an open question on the negative aspects of the programme. 
Pupils responded sensitively to discussions of private and family problems. There was 
dissatisfaction with the large number of participants in the group or the composition of the 
group (boy-girl, old-young ratios), the lack of time given to certain interesting themes and the 
timetabling of the programme after regular hours (or in the last hour).  Respondents are more 
likely to ask for changes in the programme the longer they have been following it.  
Evaluation of the programme We know that….! 
Another of the programmes and processes that have undergone evaluation42 is the 
prevention programme “We know that ...” (Vieme, že...)   (2006 Report, chapter 3 – 
Prevention). The participants of this prevention programme which was implemented during 
the 2005–2006 school year in various types of school in the Nitra region completed a 
questionnaire on starting the course in September 2005 and an identical questionnaire on 
completing the course in June 2006. End-of-course data was received from 796 
respondents. Comparison of the information given at the start and the end of the course 
showed an increased awareness at the knowledge level (knowledge of terms, the legal 
context, better self-knowledge and the acquisition of a critical approach to the assessment of 
the respondent’s own conduct) in all43 the studied topics. On the other hand, the final 
information showed that in ten months there was an increase in pupils’ declared interest in 
using marihuana, an increase in the number of pupils who smoked, an increase in the 
number of frequent and occasional consumers of alcoholic drinks and in the number of 
respondents who had frequent or single experiences of illegal drugs. 
The increase in the number of respondents with experience of legal and illegal drugs cannot 
be linked to participation in the prevention programme however, because no control group 
(outside the programme) was studied and especially since we do not know the other 
variables that could affect respondents during this period.   
 
                                                 
41 The programme includes a module for parents   
42 The EMCDDA requires that “best practice” be assess at least one of three levels: description, process 
evaluation, use of control groups without intervention. Process evaluation is the second level. Optimal evaluation 
requires the use of a control group.  (Evaluated Good Practice Example) according to  Report on selective 
prevention in the EU and Norway , EMCDDA 2004  p. 10    
43 The drug problem is one of a number of anti-social problems.  
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3.1.2 Family-based prevention 
This form of prevention is still rarely applied in practice at the level of universal prevention, 
and although specialists in the field are trying to introduce it, they continue to encounter 
rather low levels of interest and information on the side of parents44. According to a more 
widely oriented representative survey carried out by the AKO agency in 2006, drug addiction 
is not a topic that families talk about. Two thirds of respondents talk about it with their 
children and/or partner approximately once every half year, once a year or even less.   
3.1.3 Community prevention – free-time activities (provision of alternatives) 
In Slovakia free-time activities45 are given great emphasis as a positive way of spending free 
time, which is also declared in the drug strategy NPFD 2005-2008. According to Maľová, the 
most effective instrument of primary prevention against anti-social influences is organised 
and long-term activities of interest to pupils. At present not many schools offer appropriate 
conditions for regular organised activity for children and young people, which may affect the 
effectiveness of prevention (Maľová M., 2007).  
Care for the free time activities of children and young people is the focus of the work of free 
time centres and school centres for extra-curricular activities, which provide children and 
young people with a range of opportunities for self-expression through extra-curricular 
activities. In 2006 there were a total of 257 free time centres in operation (in 2005 – 219) with 
a total of 8 915 regular extra-curricular activity groups, attended by 128 915 members, of 
whom 80% were children aged under 15. The largest number of occasional/single events in 
Free Time Centres were related to exercise and sports (4 689). Events attracted more than a 
million participants of whom 830 453 were aged under 15. The culmination of a year’s work 
with children are summer holiday camps (729 summer camps), which were attended by 
20 436 children aged under 15. 
Regular sports activities were provided by 251 sports centres attended by 12 936 pupils, of 
whom more than an third (37%) were girls (Prutkay I., Slovíková M., 2006a). 
Civil associations for children and young people are non-state entities that play an important 
role in developing the personality of children and young people and are supported by the 
Ministry of Education. 60 civil associations applied for financial support for work with children 
and young people in 2006, and 38 received funding, which amounted in total to 
SKK 64 million (Prutkay I., Slovíková M., 2006b). The activities of 30 of these included 
primary prevention through work with children and young people (31 603 members), 20 are 
directly engaged in the prevention of anti-social influences (criminality and drug addiction). 
The Ministry of Culture is also active in the area of primary (universal) prevention in two 
levels: in the non-specific prevention of addiction – by free time activities and saturation of 
cultural needs of inhabitants (including children and youth). A specialized department of the 
National edification Centre - the Cabinet of social prevention carries out a specific prevention 
of addiction through complex of project of pedagogical-educational and advisory character. In 
2006 the national painting competition “Why I am happy in the world” was organized for the 
12th time (see also 2006 Report, p.39).  
An interesting example of commercial activity was a presentation entitled “Why I must never 
take drugs, not even once” for the 9–13 age group during the Children’s University event at 
Comenius University in Bratislava46 The Children’s University in Bratislava and now also in 
other cities is becoming an attractive event for children and prestigious event for their parents 
                                                 
44 The Anti-Drug Fund provided funding for several local activities in 2006 – joint educational activities for parents 
and children in the project “Let’s go the same way” (Vykročme na spoločnú cestu) or joint sports activities in 
Family Olympics etc. 
45 This is also emphasised in the 2005–2008 NPFD 
46 Special educational/free-time activities are organised during the summer vacation for elementary school pupils 
in Slovak universities (e.g. the Technical University in Košice, Žilina University in Žilina). 
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due to the experts47, who present their subject in a manner that is appropriate for the age 
group of this audience.  
 
3. 2 Selective and indicted prevention under the Ministry of Education  
 
3.2.1 Early identification of risk factors   
 
Early diagnosis (identification) of risk factors in the sector of the Ministry of Education is 
performed by the network of PPCC (and CEPP) mentioned above, including selective and 
indicated interventions. In the routine statistical data collection from both facilities the 
reasons why clients attend counselling centres, including the provision of psychological and 
educational services are reported.   
In the studied period, the problems recorded most frequently by the CEPP are behavioural 
problems (development problems), personality and mental problems and anti-social 
phenomena (14.5% from a total of 2 273 cases).  Anti-social phenomena include problems 
related to drugs, asocial and anti-social behaviour, compulsive gambling, and membership of 
a sects or cults and so on. Drug problems make up 6% (136 cases) and include smoking and 
the use of alcohol, medicines and illegal drugs (Table 3.3). The most clients seen in relation 
to drugs in school year 2005–2006 were recorded in Trnava region.  
Table 3.3: Anti-social phenomena as a reason for referral of clients to CEPP in school year 2005–2006 (Slovíková 
M., 2007) 
 Drugs asocial and 
anti-social 
behaviour 
compulsive 
gambling 
membership of 
a cult or sect 
other total 
total 136 107 16 31 1 983 2 279 
 
Clients of the PPCC were less likely to show anti-social phenomena48  and clients were 
referred for drug use in 46 cases. A summary of the reasons for referral of clients to PPCC is 
given in Table 3.4  
 
Table 3.4: Anti-social phenomena as a reason for referral of clients to PPCC in school year 2005–2006 (Slovíková 
M., 2007) 
 drugs asocial and 
anti-social 
behaviour 
compulsive 
gambling 
membership 
of a cult or 
sect 
Other total 
total 46 147 5 4 370 572 
 
For complex solutions to problems that cannot be managed without institutionalisation, 
among other purposes, the education sector has special institutional education facilities, 
whose structure and use in 2005–2006 is shown in the following table:  
  
Table 3.5: Structure, number and use of special educational facilities – situation as at 31 October 2006 (Slovíková 
M., 2007) 
Pre-
school 
age 
Compulsory school 
attendance age (6–16) 
After 
completion of 
compulsory 
school 
attendance 
total  No. 
faciliti
es. 
total total Of 
whom, 
girls 
Under 
16 
total Of 
whom, 
women 
No. 
Re-education homes for 8 - 302 81 207 - -   302 
                                                 
47 The topic “Why I must never take drugs, not even once” was presented by prof. MUDr. Vladimír Novotný, CSc, 
head of the psychiatric clinic of the Teaching Hospital of the Faculty of Medicine of Comenius University, 
Bratislava. 
48 Due to the different areas of activity of PPCC and CEPP 
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children 
Re-education homes for 
young people 
9 - - - - 441 162   441 
Re-education homes for 
mothers and children (incl. 
church) 
2 26 - - - 26   26    52 
Therapeutic-educational 
sanatoria (incl. private) 
7 8 296 37 254 22 -   326 
Diagnostic centres for 
children 
3 27 126 38 104 - -   153 
Diagnostic centres for young 
people 
2 - - - - 61   33     61 
TOTAL 31 
(+1) 
61 724 156 565 550 221 1 335 
(incr. + 
13) 
 
The IIPE also monitors statistics on truancy, which, together with problem behaviour among 
pupils at elementary or secondary school, is one of the risk factors for the development of 
other antisocial behaviours, including delinquency (Slovíková M., Dugovičová, M., 2007). 
During the school year 2005–2006 there was a slight rise in indicators (number of hours 
missed and reduced marks for behaviour) compared to the school year 2004–2005 in all 
levels and types of school except for conservatoires, where there was a fall in truancy and 
fall in the number of pupils with reduced marks for behaviour. The lowest results are for 
gymnasiums’ (high schools). (See also chapter 12 – Vulnerable groups of young people in 
the subchapter 12.1.3.2).  
 
3.2.2 Prevention in recreational and specific environments  
The NMCD does not have any information on new forms of prevention activities other than 
occasional interventions49 by health services and NGOs. The experts in CTDD – IDD 
recommend more intense activity on the part of civil society to reduce the risk not only of 
drug use but also of alcohol consumption. These experts carried out activities relating to 
alcohol consumption at this year’s Pohoda festival. 
In 2006 the Ministry of Defence continued education activities aimed at preventing the 
development of drug addiction through the project “Prevention in the fight against alcohol, 
drugs and drug addiction in the armed forces of the Slovak Republic.”50 It is implemented in 
the form of socio-psychological training (4 tutors of whom 2 are Ministry of Defence 
psychologists, one is Military Police officer and one is a psychiatrist in the field of drug 
addiction).  24 persons were assigned for training in 2006, and have now completed in three 
3-day training sessions (2 in 2006). The training for prevention workers (multipliers) will be 
completed in October 2007. 
Drug addiction is incompatible with the work of a professional soldier and is grounds for the 
discharge of professional soldiers and termination of employment of civilian employees51. No 
professional soldiers or civilian employees were discharged on these grounds in 2006.   
  
3.2.3 Prevention in high-risk groups  
 
Selective prevention aimed at high-risk groups mainly involves services provided in health, 
education sectors and the labour, social affairs and family sector. The activities of the non-
governmental sector should also be noted, both in the area of direct prevention and in 
providing training for qualified experts. In 2006 the Ministry of Education provided financial 
support to 16 civil associations working with high-risk groups of children and young people 
                                                 
49 CTDD Hraničná ul.,Bratislava  
50 Gašparová M.: Report for the NMCD, 2007 
51 Order of the head of the General Staff of the Armed Forces no. 1/2002 on provision for the implementation of 
the NPFD to 2003, with planning to 2008 
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and 4 that directly targeted their activities at young people who were vulnerable to drug 
addiction.  
With regard to coverage of the family environment and the family itself, it is necessary to 
mention the NGO the Virginia Satir Institute (IVS), which has operated in Slovakia since 1996 
and since 1998 has trained a large number of professionals to implement the prevention 
programme “Say it straight” (Povedz to priamo) The programme52 aims to prevent addiction 
and other high-risk behaviour. Another education programme that is offered is the anti-
alcoholism prevention programme “Thirst for freedom” (Smäd po slobode) and training for 
building relations within the family and managing anger. Tutors from the IVS in Slovakia 
teach the Virginia Satir model to experts and the general public in more than 20 workshops 
each year. The IVS in Slovakia is a member of the League for Mental Health and is 
accredited by the Slovak Psychotherapeutic Society and the International Family Therapy 
Association (IFTA).  
Its trained experts are currently applying these programmes in specialised centres – the 
departments for social and legal protection of children and social guardianship of the Offices 
of Labour, Social Affairs and Family, which have taken over the original Centres for 
Counselling and Psychological Services, for individuals, couples and families. Family therapy 
based on Satir model is provided in 10 centres, another 20 centres provide family counselling 
(the total number of psychological departments is 79). Specialised psychological counselling 
for families with drug addiction problems and the implementation of prevention programmes 
for children and young people in children’s homes and other groups in the labour, social 
affairs and family sector are tasks that must be performed by law.  
9 943 persons made use of free psychological and counselling services in 2006, and these 
are the target group for authorities in the area of social and legal protection and social 
guardianship. The basic target groups were identified as clients of the authorities for the 
social and legal protection of children and social guardianship who: are at risk of becoming 
addicts; who experiment with psychoactive substances; or activities that can lead to 
addiction; members of addicts’ families; clients who have undergone treatment and re-
socialisation for addiction and members of their families. Activities are also aimed at 
specialists in facilities for the social and legal protection of children and social guardianship 
who carry out addiction prevention activities in their professional work. 
In 2006, as part of the Twinning Project (Support to the Implementation of the NPFD) 
participants were introduced to the German model of timely intervention for drug users – 
FreD (Frühintervention bei erstauffälligen Drogenkonsumenten), which is mentioned in the 
2006 Report (p. 34). Although the idea of short interventions for users when they come into 
contact with public order and safety authorities for the first time is not new in Slovakia 
(especially as regards marijuana, such intervention was proposed by the chief expert of the 
Ministry of Health for drug dependency Ľ.Okruhlica in 2004)53, it is inspirational above all as a 
model for cooperation between the helping services and the repressive authorities, who have 
managed to find a common platform in Germany. The adopted conclusions of the Twinning 
Project include a recommendation for the implementation of such a selective prevention 
project. At present there is an agreement on the participation of Slovak experts in the project 
“FreD goes net” (EU – public health area), in the implementation of which the main partners 
will be experts and authors of FReD from North Rhine – Westphalia.      
 
3.3 Other forms of selective prevention and measures54 for high-risk groups  
In 2006 the Anti-Drug Fund supported a broad range of projects in schools55 aimed at high 
risk groups, including day residential camps for children with behaviour disorders and 
                                                 
52 The programme is accredited by the Ministry of Education  
53 Online with Ľ.Okruhlica, Pravda daily newspaper 30.09.2004  
54 See also chapter 12 – Vulnerable groups of young people) 
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ADHD56, summer camps for children from socially disadvantaged backgrounds and also 
year-round creative workshops, low threshold clubs such as Klub Maják in Poprad, Klub M in 
Košice, the Mirroring project, focussed on prevention and re-socialisation of emotionally and 
socially disturbed girls in re-education homes, the establishment of peer clubs and so on.   
The Slovak UNICEF committee, the Presidium of the Police Force and the supermarket 
chain TESCO stores launched a national campaign “Hľadané deti” (Looking for Children) in 
2006. Photographs of children and young people who had run away from home for various 
reasons were placed at busy points in 39 stores. The objective of the campaign under the 
slogan, “Lets get children back to safety” was to find them before they could become the 
victims or even criminals also in the areas including drug crime57.   
In its two-year programme, “Relations between the capital city and young people” the 
government of the city of Bratislava has made available financial resources for crime 
prevention, drug prevention and the prevention of other anti-social phenomena, and also for 
the creation of ways for children and young people to spend their free time (in particular 
those with unequal opportunities, i.e. those from socially and economically disadvantaged 
backgrounds). The programme also aims to create conditions for raising the level of the 
qualifications of children leaving children’s homes (by provision of accommodation, schools, 
public education etc.) 
 
3.3.1 New technologies for prevention activities  
 
Use of the Internet or mobile communication equipment in universal and selective/indicative 
prevention is still limited, but there has been a certain observable growth in the number of 
organisations providing advice on the Internet. 
At present, four out of six Centres for the Treatment of Drug Dependencies (CTDD) provide 
professional, anonymous advice via the Internet – CTDD Bratislava, CTDD Nové Zámky 
(also for registered clients of the Alcoholics Anonymous Section), CTDD Predná Hora and 
CTDD Žilina.  
Other possibilities are available on www.infodrogy.sk. Since the establishment of four 
counselling facilities on www.infodrogy.sk – in October 2005 - 300 anonymous interventions 
were provided to June 2007, of which over 75% were provided by medical experts. In 2006 
on of the 8 regional PPCC applied for a grant from the Anti-Drug Fund to build and operate 
an internet counselling facility. 
In 2006 the telephone helpline QUITLINE began to operate, providing interactive advice for 
giving up smoking.  
Part of the campaign in support of vaccination against HCV (advertising in the media, 
information on web sites) includes a free information line that operates on working days and, 
according to oral information obtained directly from the helpline, receives about 20 calls per 
day requesting information on the means of transmission and the possibilities for testing for 
HCV.       
 
 
 
                                                                                                                                                        
55 Projects submitted by schools or educational facilities  
56 Kežmarok - Therapeutic camp for children with ADHD. The project builds upon previous camps for children with 
ADHD and their parents, aimed at developing core educational skills, strengthening concentration and so on. 
57 “Let’s get children back to safety” (Vráťme deti do bezpečia). 
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4 Problem Drug Use 
The definition of problem drug use in Slovakia is based on the definition used by the 
EMCDDA, according to which problem users are injecting drug users or long term or regular 
users of opioids (heroin, buprenorphine (Subutex) and other opioids), cocaine and/or pervitin 
in the 15–64 age group. Cocaine use is rare in Slovakia and is therefore excluded from 
estimates. 
The population of problem drug users in Slovakia is estimated to be in the range 13 800–
34 500 with a central estimate of 19 000 users. Out of this total, it is estimated that there are 
7 500–19 000 users of opioids, 6 000–15 000 users of pervitin and 13 700–34 300 injecting 
users. Around 21% (12%–29%) of problem users are in contact with needle and syringe 
exchange programmes. 
There continues to be a falling trend in the number of drug users in treatment. In 2006 there 
were a total of 1 927. In 2006 records began to be kept of poly-drug use without the 
identification of a primary drug (190 persons in treatment). This resulted in a real but also an 
artificial fall for all main drug types for all treatment and first treatment demand. 
4.1 Prevalence and incidence estimates 
The results of the studies cited in this Report are based on the EMCDDA’s definition of 
problem drug use.  Cocaine is used rarely in Slovakia and so the definition is practically 
limited to intravenous drug users and regular users of opioids and/or pervitin 
(methamphetamine powder). The results are calculated relative to the population aged 15–
64. 
The estimate of problem drug users in 2006 was made by means of the multiplication 
method using information on the number of clients in contact with harm reduction 
organisations and is thus linked to the 2005 estimates made using the same method using 
the same data sources (Mravcík V., Kiššová L, 2006). The calculation was based on 
information on the number of problem users (according to the EMCDDA definition) who were 
clients of harm-reduction organisations in the given year. The estimated proportion of 
problem users in contact with such organisations (the in-treatment rate, hereinafter “ITR”) 
was obtained using a nomination method in a survey carried out in 2005 among clients of 
harm-reduction programmes (further information on the method is given in the 2006 Report, 
Chapter 4 – Problem Drug Use).  
Estimated population of problem drug users in Slovakia in 2006 is around 19 000, with a 95% 
confidence interval of 13 800–34 500 PDU’s58. The estimate was made for Slovakia as a 
whole and Slovakia excluding the capital city, Bratislava (Table 4.1).  
Table 4.1: Estimated number of problem drug users in Slovakia for 2005 and 2006 (NMCD, 2007a) 
 
The method used allows an estimate of sub-populations of PDU within the total estimated 
population of problem drug users. Users of opioids are estimated in the range 7 500–19 000, 
users of pervitin 6 000–15 000 and injecting users 13 700–34 300 (Table 4.2). 
                                                 
58 See also Standard tables 7 and 8 
 
Year 
Estimate of 
PDU – 
median 
Lower limit Upper limit Median rel./1000 
2005 14 800 10 300 28 100 4.18 Total in Slovakia 
excluding BA  2006 15 200 10 500 30 300 4.29 
2005 18 300 13 500 32 200 4.76 
Total in Slovakia 2006 18 900 13 800 34 500 4.89 
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It is not yet possible to see trends in problem use due to the short time for which estimates 
have been made using the same method. It can only be said that in 2006 there has been a 
slight increase in the number of users of pervitin having contact with harm reduction 
organisations compared to users of opioids.  
Table 4.2: Estimates of sub-groups of drug users included in the definition of PDU (NMCD, 2007a) 
 
We can further estimate problem drug use in individual towns in which harm-reduction 
programmes have been introduced and where a questionnaire survey was carried out in 
2005 to identify the ITR. In Košice there was a fall in the number of clients in contact with the 
needle and syringe exchange programme and in Žiar nad Hronom there was also a lower 
number of clients reported maybe due to the fact that the programme functioned for only 8 
months. This could have affected the estimate for PDU, which is lower in these towns than in 
the previous year.   
Table 4.3: PDU estimate in selected Slovak towns in 2006 (NMCD, 2007a) 
Town Estimate of PDU - median Lower limit Upper limit 
Median 
rel./1000 in 
2005 
Median 
rel./1000 in 
2006 
Bratislava 3 600 3 300 4 200 11.21 11.51
Banská Bystrica* 300 162 5 500 3.66 5.09
Žiar nad Hronom 60 40 80 6.61 4.08
Prešov 200 160 300 2.71 3.00
Košice 800 500 1800 6.24 4.77
Nitra 130 100 200 n.a. 2.12
Sereď 150 100 400 n.a. 12.02
*The large confidence interval in Banská Bystrica is probably due to the low number of respondents in the 
nomination survey and the small stated proportion of drug users in contact with the needle and syringe exchange 
programme (low ITR). 
 
Higher results for Bratislava were provided by the prevalence estimates made by the 
Bratislava CTDD for 2005. The same multiplier method was used based on information on 
drug users from Bratislava or the Bratislava region receiving treatment recorded by the 
National Health Information Centre (NHIC, 2006) and the multiplier (ITR) was acquired 
through a nomination technique – a survey of 409 clients of harm-reduction programmes in 
Bratislava. The authors give a central estimate of 5 600 problem users in Bratislava and 
6 600 in the Bratislava region, with 95% confidence intervals of 3 600–12 300 and 4 400–
14 800 (Šteliar I., and Okruhlica Ľ., 2007)59. The fact that this estimate is higher than 
estimates using data from harm-reduction organisations (see above) can be explained by, 
amongst other factors, the effect on the result of information about treated drug users and 
the collection method – e.g. the absence of reports of completion of treatment, which the 
authors discuss, and also the existence of various types of treatment (e.g. out-patient and in-
patient), which complicates the use of one multiplier for the whole group of persons receiving 
treatment.  
                                                 
59 In addition, the authors made an estimate of problem users based on data acquired by the nomination method 
for clients of the needle and syringe exchange programme in the CTDD (central value 1 050, 95% CI 900–1 200), 
but the authors themselves admit an selection biased in the for this estimate (Šteliar I. and Okruhlica Ľ., 2007). 
Opioid users Pervitin users  Injecting users Year 
Median Interval Rate Median Interval Rate Median Interval Rate 
2005 10 200 7 500 - 18 000 2.7 8 100 6 000 - 14 200 2.1 18000 13 300 - 31 600 4.66
2006 10 400 7 500 - 19 000 2.7 8 500 6 000 - 15 500 2.2 18800 13 700 - 34 300 4.86
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4.2  Treatment Demand Indicator 
Methodology - Data collection 
Information on drug users in treatment are obtained from the information system on health 
care and health care statistics, which is managed by the National Health Information Centre 
(hereinafter referred to as “the NHIC”) The NHIC collects data and processes data in 
accordance with the methodology of the EMCDDA indicator Treatment Demand Indicator 
(TDI). All health care organisations and natural persons authorised to provide treatment for 
drug addiction are obliged to report into the indicator60.  
In 2000 treatment facilities under other ministries61 than the Ministry of Health were included 
into the TDI reporting system. Data is not collected from low-threshold services and 
therapeutic communities (re-socialisation centres) despite the fact that they can contribute to 
TDI under EMCDDA guidelines. 328 facilities – reporting units – providing treatment and 
subject to the obligation to provide information for TDI were contacted in 2006. 65 outpatient 
units, 35 inpatient units and 1862 prison treatment facilities under the Ministry of Justice63 
reported a treatment of a drug user. Some additional information from TDI on the structure of 
clients in outpatient and inpatient treatment is reported in Chapter 5 – Drug-Related 
Treatment. 
In 2006 reporting to TDI was changed slightly in the area of defining the primary drug. In 
cases where it is not possible to identify the primary drug – poly-drug use (diagnosis F19) 
was reported (NHIC and NMCD 2007). The change is a reaction to developments and trends 
in drug use. Into the reporting form different drugs that patients had problems with were 
recorded without specifying one main or primary drug. This created an artificial reduction on 
top of the real reduction in treatment according the types of primary drug in 2006. 
Profile of the clients in treatment 
Since 2000 the number of drug users in treatment has fallen from a total of 2 619 in 2000 to 
1 927 in 2006. Compared to the previous year, there has been a 7.3% fall in the number of 
all treatment demands. Of these, 848 (nearly 12% fewer than in the previous year) were the 
first treatment. The largest part of whole treated population comprised users of opioids (816 
persons receiving treatment – 42%), especially heroin (39%). The second most numerous 
group is made up of users of stimulants, especially pervitin (22.6%) Among those receiving 
treatment for the first time the order is reversed, the largest group being users of stimulants 
such as pervitin (29.6%) and the second being users of opioids (25%). The third most 
numerous group for all and first treatment was marijuana (16% and 24%) followed by poly-
drug users (9.8% and 9.3%).  
The proportion of patients treated according to primary drug in 2006 is shown in Fig. 4.1 and 
the development of treatment demand by primary drug is shown in Fig. 4.2.  
                                                 
60 The obligation derives from Act 540/2001 on state statistics and Decree of the Statistical Office 428/2005 of 
31.10.2005 which issued the programme for obtaining state statistics in the 2006–2008 period 
61 The Ministry of Interior, Ministry of Transport, Posts and Telecommunications, Ministry of Justice and Ministry of 
Defence  
62 Out-patient units  of general practitioners in institutes, independent psychiatric out-patient units, psychiatric 
departments of the hospital for prison inmates. 
63 Information in this part of the chapter is based on the standard table EMCDDA 34 – TDI data 
Fig. 4.1: Proportion of patients treated according to primary drug in 2006 (NHIC and NMCD, 2007) 
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Fig. 4.2: Treatment demand by primary drug (NHIC and NMCD, 2007) 
0
500
1 000
1 500
2 000
2 500
3 000
All patients 2 619 2 559 2 111 2 136 2 315 2 078 1 927
Heroin and other opioids 2 029 1 944 1 372 1 107 987 902 816
Pervitin 80 129 186 361 563 489 420
Marihuana 151 184 221 299 398 400 312
Volatile substances 210 175 167 183 194 161 110
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The number of demand for treatment in Bratislava region is much greater than in other 
regions (132 per 100 000 inhabitants compared to 36 per 100 000 inhabitants in Banská 
Bystrica region, which has the second highest prevalence), and the fall in the number of 
patients is the largest in this region too. A gradual but long-term stable fall in the prevalence 
of treatment demand can be observed in Trnava and Žilina regions. The individual regions 
differ not only in the prevalence of treatment demands but also in the proportions of the types 
of drugs – reported as patients’ primary drugs. In Bratislava and Trnava regions, most users 
are opioid users (60% and 52%). Opioid users are also the largest group in Nitra region 
(30%). There is significant use of methamphetamines (pervitin) in Trenčín and Košice 
regions and cannabis in Žilina, Banská Bystrica and Prešov regions (NHIC and NMCD, 007). 
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Map 4.1: Users receiving treatment per 100 000 by permanent address and primary drug in 2006 (HIC and 
NMCD, 2007) 
 
 
Certain basic characteristics of the drug users in treatment also differ according to the type of 
drug used. On average the youngest are users of marijuana (20 years). The average age of 
methamphetamine (pervitín) users is 23 years and the proportion of men in this group is 
77%. There is the same proportion of men among users of opioids, who have the highest 
average age, 28 years. The most numerous age group in the treated population regardless 
the drug used remained the same as in the previous year – the 20–24 age group (29.5%), 
while 26% were in the age group 25–29 years. First time treated were also most numerous in 
the 20–24 age group, which represented a change from the previous year (15–19 years in 
2005). There were approximately 3.6 times more men than women in treatment in the year in 
question (78.3% men and 21.7% women).  
In terms of studied social characteristics, the unemployed make up the most numerous group 
(55.2%). The unemployed are most frequent among users of opioids or polydrug users (both 
64%) and pervitin users (54.5%). Marijuana users are, schoolchildren and students who have 
completed elementary education (45%), which corresponds with their average age. 
Schoolchildren and students are also common amongst users of volatile substances.  
A large proportion of users receiving treatment are single (82%), have stable accommodation 
(89%) and 66% live with their parents. Opioid users are most likely to live alone. These users 
also make up a relatively high proportion of those who declared that they live with a person 
using drugs in 2006, compared to users of other drugs (Table 4.4). 
 
Table 4.4. Selected social characteristics of drug users in % (NHIC, 2007a) 
 
  
Opioid 
users 
Pervitin 
users 
Marijuana 
users 
Volatile 
substance 
users 
Combination of 
substances 
Unstable accommodation 11.4 7.4 4.2 10.9 5.8
Live with a person using drugs 13.7 5.0 5.0 7.0 6.0
Alone  16.2 7.4 8.0 5.0 9.0
With a  partner  10.5 6.2 2.0 1.0 7.0
With a partner and child 8.2 3.3 2.0 3.0 6.0
Alone with a child 1.5 1.0 0.0 1.8 3.7
 
The most frequent way of administration is injecting, 46.2%. The number of injecting users 
(claiming to inject their primary drug) has fallen in absolute numbers over the last 4 years. 
Their proportion in the total number receiving treatment has grown slightly compared to the 
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previous year (Table 4.5). In 2006 the proportion of injecting users was 83% of all users of 
opioids and 43.8% of all users of pervitin. 
Table 4.5.: Injecting use of primary drug – number of users (NHIC and NMCD, 2007) 
Year Number of injecting users Total number receiving treatment Proportion in % 
2003 1 051 2 136 49.2 
2004 1 024 2 315 44.2 
2005   921 2 078 44.3 
2006   890 1 927 46.2 
 
4.3  Problem users from non-health care facilities 
4.3.1 Clients in re-socialisation centres 
In last year’s report, for 2006, we presented an outline of the basic characteristics of clients 
in re-socialisation centres. Re-socialisation centres do not contribute to the health care 
information system on treatment for drug users (TDI), even though they provide one of the 
services (phases) in the treatment of drug users. (See the 2004 Report, p. 85) 
The collection of data for 2006 was carried out through the Ministry of Labour, Social Affairs 
and Family as part of supplementary monitoring as part of one universal questionnaire. The 
questionnaire was developed with the aim of avoiding excessive load and duplicating 
requests for information from the re-socialisation centres by various state institutions. It was 
not possible, however, to assess the collected data statistically. 
 
 4.3.2 Problem drug users - clients of needle and syringe exchange 
programmes 
As in 2005, information on the structure of clients in field programmes is available thanks to 
direct cooperation between all the NGOs and the NMCD. Data was collected using a special 
questionnaire on the structure of clients and the kinds of service provided to the clients. It is 
not possible to exclude duplication in the tables given in this chapter resulting from the 
number of persons attending multiple facilities, especially in Bratislava but in 2006 also in 
Banská Bystrica.  
In 2006 there were 7 organisations providing such services in 10 Slovak towns. The needle 
and syringe exchange programmes in Žiar nad Hronom and Banská Bystrica operated for 
only 8 months, however, and in Púchov the programme ended at the end of the year64. The 
total number of persons making use of harm-reduction programmes was the same as in the 
previous year. A fall in drug users in contact with the programme was observed in Košice.  
Table 4.6 Clients in contact with harm-reduction programs in each town (NMCD, 2007b) 
  2004 2005 2006 
Bratislava 2 639 2 853 2 944 
Banská Bystrica 40 67 91 
Žiar nad Hronom 35 73 47 
Nitra 80 88 105 
Sereď 70 92 84 
Trnava - - 17 
Púchov 80 111 49 
Prešov* 192 225 260 
                                                 
64 A programme operated in Zvolen from September 2006, but did not have any registered clients 
 47
Košice 265 470 360 
Total 3 401 3 979 3 957 
*In Prešov a large proportion of the clients are alcohol users 
 
90% of the clients are drug users, representing mainly injecting users due to the character of 
the programme. A primary drug was identified for around 87% of drug users. Of these, 40% 
used heroin and 39% pervitin. Users of pentazocine (Fortral) in Košice made up 4.5% and 
just as last year 3% of users were taking buprenorphine (Subutex), mainly in Žiar nad 
Hronom and Nitra. The differences between individual towns are described in the previous 
Report, in Chapter 4 – Problem drug use. 
Table 4.7. Problem drug users in contact with harm-reduction programs (NMCD, 2007b) 
  
Number of clients 
classified as PDU 
 - of whom, injecting 
users  
 - of whom opioid 
users 
 - of whom, pervitin 
users 
  2005 2006 2005 2006 2005 2006 2005 2006 
Bratislava 2657 2736 2594 2736 1244 1285 977 1033
Banská Bystrica 64 89 64 88 50 60 14 10
Žiar nad Hronom 76 47 76 47 74 47 2 0
Nitra 105 104 76 28
Sereď 
  
172 
  77
 172
 76
  
145
  66 
  
27
  11
Trnava - 9 - 9 - 9 - 0
Púchov 110 47 110 47 0 0 110 47
Prešov 91 101 90 93 19 19 72 82
Košice 470 360 470 360 254 162 216 192
Note: In 2005 the data for Nitra and Sereď was provided collectively for the organisation and not for the individual 
towns.  
 
The social characteristics of problem users who are clients of harm-reduction programmes 
are similar to those of drug users in treatment. Information on their characteristics was drawn 
from statistics processed from the so-called in-come forms for clients. Such forms are 
completed only in certain organisations and are not completely standardised. Not all forms 
were filled in completely, the clients omitted much information. Out of 275 clients of field 
exchange programmes65, who completed in-come forms in 2006, 54.5% were users of 
opioids and 45.5% were users of pervitin. The average age was 26 years. General 
conclusions cannot be drawn from this information because of the limitations mentioned 
above. Selected characteristics of clients classified as PDU are given here by way of 
illustration.  
 
Table 4.8 a): selected characteristics of clients of NSP – for 148 opioid users and 125 pervitin users (NMCD, 
2007d) 
Employment status Opioid users  In % 
Pervitin users  
In % 
Pupil / student 6.8 9.6
Regular employee 13.5 18.4
Economically inactive 0.7 1.6
Unemployed 31.1 37.6
 
Table 4.8. b) Selected characteristics of clients of NSP - for 150 opioid users and 125 pervitin users (NMCD, 
2007d) 
Education Opioid users  In % 
Pervitin users  
In % 
                                                 
65 Information provided by the civil associations Risen and Storm at UKF Nitra 
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Incomplete elementary 1.3 1.6
Complete elementary 16.7 5.6
Secondary without final maturita 
exam 15.3 33.6
Secondary with final maturita 
exam 18.7 43.2
Higher education 1.3 2.4
Unknown 46.7 13.6
 
Table 4.8 c): Selected characteristics of clients of NSP (NMCD, 2007d) 
This applies to the following 
number of users Accommodation situation Opioid users  
In % 
Pervitin users  
In % opioids pervitin 
Stable accommodation 56.5 48.4 147 91
With parents 37.8 65.8 143 93
Alone  11.2 8.2 143 73
With a partner  7.7 5.5 143 73
Unstable accommodation 2.7 1.1 147 71
Live with a person using drugs 17.3 19.2 150 125
 
 
5 Drug related Treatment 
Treatment is one of the basic pillars of the national drug strategy. The priority area is to 
provide accessible, quality treatment for drug users.  
Treatment for drug users is provided mainly by specialised facilities – centres for the 
treatment of drug dependencies. The provider network is wider though and includes nearly 
all specialised doctors and psychiatrists in state and non-state health care facilities providing 
outpatient or inpatient treatment. 
5.1 Treatment system 
The system for providing health care for drug users has been described in detail in previous 
reports.  
The concept of health care in the field of drug addiction 
With effect from 1 August 2006, the Ministry of Health adopted a new concept of health care 
in the field of drug addiction. The field comprises the provision of treatment to persons who 
are addicted to psychoactive substances and persons who abuse such substances. 
The concept defines three main points: the content of treatment in the field, the development 
of treatment and education for practitioners. 
The first point regulates, amongst other things, the formal categorisation/classification of 
facilities providing treatment to patients in the field of drug addictions, which are: 
- specialised outpatient units for the treatment of drug dependency 
- centres for the treatment of drug dependencies 
- short duration inpatient units (e.g. day centres) 
- specialised psychiatric outpatient units 
- inpatient units providing psychiatric treatment 
In its second point, the concept goes on to outline the direction for drug treatment in the next 
5–10 years. Treatment should focus on current issues such as: polydrug use (a combination 
of multiple psychoactive substances), the increased number of persons with long duration 
dependency and the increased number of injecting users currently suffering the effects of 
infectious diseases such as hepatitis C, HIV and so on. 
Improvements in access to treatment for persons dependent on alcohol and drugs 
An international project to improve access to treatment for people with alcohol and drug 
related problems was started in 2006, IATAPAD (Improvement of Access to Treatment for 
People with Alcohol- and Drug- related problems) (For more information see chapter 13.2 – 
Main recent studies and publications) 
The project is based on the claim that one aspect of the availability of treatment that is rarely 
taken into consideration is the attitude and prejudices of medical personnel to people 
suffering problems related to the use of psychoactive substances66. The aim of the project is 
to carry out a comparative study in various countries to investigate these problems. The 
objective is to identify common factors that could form the basis for various measures that 
EU countries can take to reduce the negative impacts of this aspect of the availability of 
treatment for people with alcohol and drug problems.  
5.2 Drug free treatment  
Drug free treatment is the most widely used form of treatment for patients with drug 
addictions in Slovakia. In response to the changing structure of drug use, the decline in the 
use of opioids in recent years and the increase in the demand for treatment for problems with 
                                                 
66 www.ec.europa.eu 
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stimulants and marijuana where only this form of treatment comes into consideration, it can 
be expected that it will also dominate in the near future (Ministry of Health, 2007) 
5.2.1 Inpatient and outpatient treatment 
5.2.1.1 Information sources – statistical form for patients hospitalised in psychiatric 
facilities 
Some of the information on the number of patients diagnosed as suffering from drug 
addiction in inpatient and outpatient treatment is obtained by processing the statistical forms 
for patients hospitalised in psychiatric facilities67 (hereinafter referred to as “statistics forms”). 
The NHIC is responsible for collecting and processing this information. It is a non-standard 
output of the system because information is not usually processed and published in such a 
form. The method used to process information and criteria for including/excluding the case is 
different from that used in TDI.  The primary purpose of this form is to gain information on the 
population hospitalised in psychiatric facilities and requirements for further treatment after 
release. The information on the number of patients diagnosed as suffering from drug 
addiction is not the same as for TDI. 
In 2006, analyses of statistics forms showed that the total number of patients for all 
diagnoses was 28 919, of whom approximately 28% were diagnosed as being dependent on 
alcohol and 6% were drug users. The average length of hospitalisation for drug users 
receiving treatment in facilities classified as specialised drug addiction units was 42 days (6 
weeks) in 2006. The average number of hospitalisations per patient was 1.3. Out of the total 
number of drug users receiving treatment (1 373), nearly 6% were continuing in drug 
addiction treatment from the previous period. According to the available information, the 
capacity/number of beds in drug treatment facilities was almost unchanged from the previous 
year. 
Table 5.1: Inpatient treatment in Slovakia by basic diagnosis (which need not result automatically in admission of the patient) 
(NHIC, 2007c) 
Alcohol (F10) Drugs (F11 - F16, F18 – 19) 
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Total in the Slovak 
treatment system 73 10702 8195 768 73 1775 1373 82 
- of which, CTDD  10 1481 1350 176 10 468 419 21  
 
Information on patients in outpatients treatment are taken from the reporting form Annual 
Statement A (Ministry of Health) 4 – 10 on the activity of psychiatric outpatient departments 
(NHIC, 2007c). According to this information source, 4 805 patients diagnosed as suffering 
from drug addiction received treatment in outpatient units, which makes up nearly 2% of all 
persons (247 812) receiving outpatient treatment. (20 179 patients received treatment for 
problems with alcohol (8%).  
 
Table 5.2: Outpatient treatment in Slovakia by basic diagnosis (which need not result automatically in admission 
of the patient) (NHIC, 2007c) 
  Alcohol (F10) Drugs (F11-F16 - F18, F19) 
  
No. 
outpatient 
facilities 
Consultatio
ns Patients 
No. 
outpatient 
facilities 
Consultati
ons Patients 
                                                 
67 ZS (Ministry of Health) 1-12 Statistics form for a patient admitted to inpatient care in a psychiatric facility 
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Total for Slovakia  367  176 944  20 179  367  142 996  4 805
Of which, in outpatient 
facilities of CTDD  8  81 561  1 588  8  128 371  1 685
 
5.2.1.2 Information sources – TDI 
Information on the characteristics of drug users receiving individual forms of treatment can 
only be acquired from TDI data. According to TDI68 more drug users received inpatient 
treatment (56%) than outpatient treatment (44%). In total inpatient facilities under the Ministry 
of Health (35 facilities) reported 653 patients, which is 116 patients (15.1%) less than in 
2005. The largest group of these patients (25%) was stimulant users (particularly pervitin), 
followed by opioids users (20%), poly-drug users (19%) and then users of marijuana (18%) 
and volatile substances (12%). The average age of patients receiving inpatient treatment in 
the studied year was 24 years, while those receiving treatment for the first time had an 
average age of 22. The most numerous age group in inpatient treatment were users aged 
20–24 (31%) and users aged 15–19 (26%) (NHIC, 2007b). 
In 2006 TDI reports were submitted by 65 outpatient units. The total number of patients 
covered by such reports was 826 (13% less than in the previous year). The largest group of 
users receiving outpatient treatment was users of opioids (49%), followed by stimulants 
(23%) and marihuana users (19%). Polydrug users made up 4%.The average age of persons 
receiving outpatient treatment was 25 years. For patients receiving treatment for the first time 
it was 22 years. As in the case of inpatient treatment, the largest age group for patients was 
the 20–24 age group (19%) followed by the 15–19 age group (14%) (NHIC, 2007b). 
 
5.2.3 Convalescence and re-socialisation  
 
Patients who have completed withdrawal treatment, who express an interest and show the 
appropriate indications are admitted for convalescence in re-socialisation facilities, which are 
usually within the domain of the Ministry of Labour, Social Affairs and Family, or they can 
continue to receive treatment in outpatient convalescence facilities, in group therapy 
activities and social and therapeutic clubs (Ministry of Health, 2007).  
Further information on re-socialisation and re-socialisation centres is given in chapter 9 – 
Responses to Social correlates and Consequences.   
5.3 Pharmacologically assisted treatment  
5.3.1 Detoxification treatment 
No new information is available compared to the situation described in the previous reports. 
Statistical data on individual forms of treatment such as detoxification, drug free treatment 
and substitution treatment are not available. Data collection from health care units through 
the NHIC still does not permit the processing of information on individual forms of treatment.  
 
5.3.2 Substitution treatment 
 
Two methadone substitution programmes for patients addicted to opioids were run in 
Slovakia through CTDD in 2006 – in Bratislava and Banská Bystrica – and there was a 
substitution programme making use of buprenorphine in Košice. In this case, however, 
substitution treatment involves not only the prescription of medicines but also counselling, 
psychotherapy and didactic therapy services. Buprenorphine is available on prescription in 
                                                 
68 For further information see chapter 4 – Problem drug use. Treatment of a drug user is reported only once for 
TDI purposes, for the first treatment of the user in each year. 
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the Slovak Republic and may be prescribed by psychiatrists with additional attestation in the 
field of drug addiction or psychiatrists working in a CTDD.  
Information on the guidelines/rules governing substitution treatment (methadone) is given in 
the previous reports. 
The results of the follow-up study of patients receiving buprenorphine treatment in Outpatient 
Unit for Addicts in Nitra have been published and show that out of 86 patients studied, 39% 
were still not using drugs one year after completing treatment, somewhat more were 
cooperating in treatment despite lapses and there was less unemployment and criminal 
activity (Višňovský E., 2006). 
 
5.4 Information dissemination  
 
A more comprehensive overview of organisations working on drug issues, including the 
provision of drug services for people seeking assistance is available on the web portal of the 
NMCD www.infodrogy.sk in the section Adresár inštitúcií a organizácií (Directory of 
institutions and organisations). The portal provides basic contact data for the organisations 
and enables visitors to search for them by location/region and type. It includes categories of 
organisations such as: coordination, local government, organisations providing prevention, 
counselling and law enforcement authorities. There is contact information for the following 
types of treatment facility:  
- needle and syringe exchange programmes  
- centres for the treatment of drug dependency, treatment for alcoholics, psychiatric 
facilities 
- abstainers’ clubs 
- re-socialisation centres 
 
In addition, the Akreditácia (Accreditation) section of the MLSAF website 
www.employment.gov.sk provides a list of accredited organisations classified as re-
socialisation centres, crisis centres, children’s home and accredited NGOs. (An organisation 
must be accredited under Act 305/2005 on the social and legal protection of children and 
social guardianship in order to perform or participate in the performance of measures for the 
social and legal protection of children and social guardianship.) 
A comprehensive alphabetical list of health care facilities is maintained on the website of the 
Ministry of Health www.health.gov.sk giving contact information for all health care units in its 
area of responsibility, with no more detailed information on departments/specialisations such 
as drug treatment.  
Organisations providing drug services operate their own websites, where they publish 
information on their activities.  
 
 
6  Health Correlates and Consequences  
Compared to 2005, there has been a slight fall in total reported deaths caused by 
psychoactive substances. Most such deaths are due to pharmaceutical drugs, in particular 
benzodiazepines, and take place in higher age groups (over 35 years). Opiates and volatile 
substances are also frequent among causes of death. In 2006 there was a fall in the number 
of direct deaths related to medicines and the number of such cases was the same as opiates 
overdoses. 
The prevalence of HIV infections for injecting drug users remains below 1%. In 2006 one 
new injecting drug user was found to be HIV positive, having become infected abroad. In 
2006 and at the start of 2007 a number of studies (projects) were in preparation or were 
being implemented to determine the prevalence of HIV and hepatitis infections among 
injecting drug users. 
According to the results of a prenatal study of data for Bratislava region in the 2000–2006 
period, 0.5%–0.8% of the total number of children born in Bratislava are born to drug users. 
6.1 Drug related deaths and mortality of drug users 
Information on drug-related deaths is monitored by means of a special register based on 
data from 11 forensic medicine facilities of the Healthcare Supervision Authority (hereinafter 
referred to as “the HSA”). In all cases an autopsy and chemical toxicological examination69 
was done. Data from 2004 were analysed retrospectively in close cooperation with the 
NMCD and the cases monitored in 2006 were for the first time reported by means of 
electronic forms on the NMCD’s internet portal. Continuous collection of data began in 2007.  
6.1.1 Direct drug related deaths (overdoses, poisoning) 
32 deaths caused by the direct effects of psychoactive substances were reported in 2006. 
The largest proportion of these were caused by opioids (12 cases); in particular their 
combination with various substances – 11 cases, which represents around a third of all direct 
deaths. In two cases, death was caused by methadone in combination with other 
substances. Another 12 deaths were caused by medicines, among which benzodiazepines 
predominated (9 cases). Benzodiazepines were also identified in another five cases in 
combination with opioids, i.e. a total of 14 cases. Other substances excluding opioids were 
identified in 8 cases and one case there was an overdose of heroin alone. Men made up 
nearly 66% of cases. A detailed overview of the identified cases is given in Table 6.1 
 
Table 6.1: Direct death related to psychoactive substances in Slovakia in 2006 (Śidlo,J.: Special deaths register, 
NMCD/HSA, 2007) 
 
Psychoactive substance/ 
age group 
0-
14 
15- 
19 
20- 
24 
25- 
29 
30- 
34 
35- 
39 
40- 
44 
45- 
49 
50- 
54 
55- 
59 
60- 
64 65+ 
Total 
 
Share 
in % 
Opioids alone 
(excluding methadone) 
 
- 
 
- 
 
1/- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
1 3,1 
Methadone alone - - - - - - - - - - - - - - 
Polysubstances including 
opioids - - 1/- 3/- 1/- - 1/- 2/- -/1 - 1/1 - 11 34,4 
Representation of opioids 
– total  - - 2/- 3/- 1/- - 1/- 2/- -/1 - 1/1 - 12 37,5 
Polysubstances excluding 
opioids 
 
- 
 
1/- 
 
-/1 
 
2/- 
 
3/- 
 
- 
 
- 
 
- 
 
1/- 
 
- 
 
- 
 
- 
 
8 25 
Psychoactive medicines - - 2/- - - 1/- -/2 - -/2 -/2 -/2 1/- 12 37,5 
Unspecified substances - - - - - - - - - - - - - - 
                                                 
69 There were a total of 53 301 deaths in 2006 (www.statistics.sk). According to information from the Health Care 
Supervision Authority autopsies were carried out in 9 141 cases, i.e. the autopsy rate for 2006 was 17.1%.  
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Total - 1 5 5 4 1 3 2 4 2 4 1 32   
Note: the first number in the cell identifies men; the number after the slash indicates the number of women (M/W) 
6. 1. 2 Deaths under the influence of psychoactive substances 
This group includes all deaths under the influence of psychoactive substances where the 
cause of death is other than poisoning or overdosing with the given substance, i.e. drugs are 
an indirect cause of death. In 2006 a total of 70 deaths were reported in this category. 
Medicines were identified in 36 cases (51.4%), among which benzodiazepines predominated 
(24 cases). In comparison with the category of direct drug-related death, men made up an 
even greater proportion, nearly 89%. The greatest mortality was in the 20–34 age group, in 
which 31 cases were reported. 
Table 6.2.:  Deaths under the influence of psychoactive substances in 2006 (Śidlo, J.: Special deaths register, 
NMCD/HSA, 2007) 
 Note: AMT – amphetamine, MAMT – methamphetamine. 
 Note: the first number in the cell identifies men; the number after the slash indicates the number of women (M/W) 
Table 6.3.:  Deaths under the influence of psychoactive substances in 2006 by cause of death and age group 
(Śidlo, J.: Special deaths register, NMCD/HSA, 2007) 
Cause of death / 
age group 
under 
14 
15- 
19 
20- 
24 
25- 
29 
30- 
34 
35- 
39 
40- 
44 
45- 
49 
50- 
54 
55- 
59 
60- 
64 
over 
65 Total 
Natural/ 
internal       
 
- 
 
1/- 
 
- 
 
1/- 
 
3/- 
 
- 
 
1/- 
 
4/- 
 
- 
 
1/2 
 
- 
 
2/- 
 
15 
 
Accident         
 
- 
 
2/- 
 
7/- 
 
5/1 
 
2/- 
 
4/- 
 
2/1 
 
- 
 
2/- 
 
1/1 
 
4/- 
 
-/1 
 
33 
 
Suicide  
 
- 
 
- 
 
4/- 
 
3/- 
 
2/- 
 
- 
 
2/- 
 
3/- 
 
1/- 
 
1/- 
 
1/- 
 
1/- 
 
18 
 
Murder          
 
- 
 
1/- 
 
- 
 
- 
 
1/1 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
3 
 
Unidentified      
 
- 
 
- 
 
-/1 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
1  
Total - 4 12 10 9 4 6 7 3 6 5 4 70 
Note: the first number in the cell identifies men; the number after the slash indicates the number of women (M/W) 
6. 1. 3 Comparison with data acquired in the period 2004–2006 
The number of drug-related deaths reported in 2006 was lower than in 2004 and 2005. The 
total number of cases reported in each year were 124 (2004), 123 (2005) and 102 in 2006.  
Direct drug-related deaths were the same in 2004 and 2005 – 46, while in 2006 there were 
32 cases. Poisoning with medicines occurred in 2004 and 2005 mainly in the over-35 age 
group and opioid poisoning was much more common in younger age groups. In 2006 
relations between substances used and age group changed slightly; substances in other 
categories than medicines were found more frequently in the over-35 group.  
The number of direct D-r-deaths in individual substance categories changed only slightly. A 
significant fall in the number of deaths caused by combinations of substances excluding 
opioids was recorded in 2005. In 2006 there was a fall in the number of deaths caused by 
medicines (Fig. 6.1). 
 
Psychoactive 
substance/ cause 
of death 
Natural/ 
internal  Accident Suicide Murder 
Unidentifi
ed Total 
Share 
in % 
Opioids - 4/1 2/- - - 7 10 
AMT/MAMT 2/- 5/1 3/- 1/- -/1 13  18,6 
Cannabinoids - 6/- 3/- 1/- - 10 14,3 
Solvents 2/- 1/- - - - 3 4,3 
Cocaine - - 1/- - - 1 1,4 
benzodiazepines 6/2 7/2 7/- - - 24 34,3 
Other medicines 3/- 6/- 2/- -/1 - 12 17,1 
Total 15  33  18  3  1  70  
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Fig. 6.1: Direct drug-related deaths in the 2004–2006 period (Śidlo, J.: Special deaths register, NMCD/HSA, 
2007) 
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78 cases of indirect drug-related death were recorded in 2004, 77 in 2005 and 70 in 2006. 
The proportions of individual kinds of psychoactive substances in indirect drug-related deaths 
in the individual years of the 2004–2006 period were approximately the same except for 
cannabinoids and amphetamines/methamphetamines. Reports of these substances halved 
in 2005 but increased again in 2006 (Fig. 6.2). The distribution of cases by cause of death70 
changed only slightly in the 2004–2006 period. Mortality was most frequent in various 
accidents. The number of cases with an unidentified cause of death fell sharply in 2005 and 
2006. 
 
                                                 
70 natural cause of death, accident, suicide, murder, unidentified cause of death 
Fig. 6.2: Indirect drug-related deaths in the 2004–2006 period (Śidlo, J.: Special deaths register, NMCD/HSA, 
2007) 
32 36
24
1
15
12
11
11
7
15
7
13
13
6
10
5 1
3
1 1
1
0
10
20
30
40
50
60
70
80
90
2004 2005 2006
N
um
be
r o
f r
ep
or
te
d 
ca
se
s
Benzodiazepines Other medicines Opioids AMT/MAMT Kanabinoids Solvents Cocaine
 
 
The above analysis of reported drug-related deaths by categories of psychoactive 
substances is based on the EMCDDA categorisation, i.e. deaths in which a combination of 
methamphetamine and opioid substances was detected were categorised as 
“polysubstances including opioids” or in Fig. 6.1 “combination with opioids”.  
In 2007 a secondary analysis of data for the 2004–2006 period was conducted focussing on 
the prevalence of specific kinds of psychoactive substance in death reports. The results of 
the analysis are given below71.  
 
6.1.4 Comparison of data for individual kinds of psychoactive substance in the 
2004–2006 period 
 
Heroin-related deaths 
Between 2004 and 2006 there were 23 recorded heroin-related deaths. There were 11 cases 
in 2004, 9 cases in 2005 and 3 cases in 2006. Nearly all deaths (21) were reported from 
Bratislava. In 2006 cases were also reported from Banská Bystrica and Martin (1 case each). 
Out of the stated total number, 12 deaths were caused by a direct overdose of heroin alone 
(5 cases) or in combination with other substances (7 cases). 11 deaths took place under the 
influence of heroin.  
 
Table 6.4: Cases of heroin overdose 2004–2006 (Śidlo, J.: Special deaths register, NMCD/HSA, 2007) 
Year Gender Age (years) 
Cause of death 
(heroin/combined overdose) ST code 
2004 male 18 heroin (18) 
 male 18 combination of substances (20) 
 male 25 combination of substances (20) 
 male 26 heroin (18) 
 male 26 combination of substances (20) 
 male 30 combination of substances (20) 
                                                 
71 Data is processed by a method different to the EMCDDA methodology. For this reason there is a slight 
discrepancy between the results given in 6.1.1–6.1.3 and 6.1.4. 
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2005 female 21 combination of substances (20) 
 male 23 combination of substances (20) 
 female 23 heroin (18) 
 male 32 combination of substances (20) 
 female 41 heroin (18) 
2006 male 23 heroin (18) 
Total 12 Average: 25.5 5 / 7   
Note: ST code – code for the cause of death used in EMCDDA standard tables 
 
Table 6.5: Deaths under the influence of heroin 2004–2006 (Śidlo, J.: Special deaths register, NMCD/HSA, 2007) 
Year Gender Age (years) Cause of death ST code 
2004 female 21 road accident                         (25) 
 male 22 gunshot wounds – unidentified        (28) 
 male 25 suffocation by hanging                   (26) 
 male 27 road accident                        (25) 
 male 43 suffocation by hanging                  (26) 
2005 female 19 suffocation by strangulation             (27) 
 female 29 exposure                               (24) 
 female 30 disease                        (24) 
 male 54 gunshot wounds – suicide  (26) 
2006 male 24 suffocation by contents of stomach           (25) 
 male 28 road accident                       (25) 
Total 11 Average: 29.3   
Note: ST code - code for the cause of death used in EMCDDA standard tables 
 
Methadone-related deaths 
In the studied three-year period 6 methadone-related deaths were recorded.  There were 3 
cases in 2004, 1 case in 2005 and 2 cases in 2006. One death was the result of a 
methadone overdose alone and in 5 cases methadone was identified in combination with 
other substances. 
 
Indirect marijuana-related deaths 
In the 2004–2006 period a total of 29 deaths under the influence of cannabinoids were 
recorded. 13 such deaths were recorded in 2004, 6 in 2005 and 10 in 2006.  
 
Amphetamine and methamphetamine related deaths 
10 deaths were reported that were directly caused by this category of substances: 7 cases in 
2004, 2 cases in 2005 and 1 case in 2006. 4 deaths resulted from the use amphetamines 
and methamphetamines alone and 6 resulted from their combination with other substances. 
 
Table 6.6: Deaths caused by overdoses involving amphetamines and methamphetamines in the 2004–2006 
period, by gender and age (Śidlo, J.: Special deaths register, NMCD/HSA, 2007) 
 
Year Gender Age (years) 
Cause of death 
(AMT/MAMT/combined overdose) ST code 
2004 male 18 combination of substances (20) 
 male 21 AMT (21) 
 male 21 combination of substances (20) 
 female 22 combination of substances (20) 
 male 25 AMT/MAMT (21) 
 male 31 MAMT (21) 
 male 74 AMT (21) 
2005 male 20 combination of substances (20) 
 male 30 combination of substances (20) 
2006 male 22 combination of substances (20) 
Total 10 (9/1) Average: 28.4 4  / 6  
Note: ST code - code for the cause of death used in EMCDDA standard tables 
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Cocaine-related deaths  
Since 2003 no deaths have been reported in which cocaine was a direct cause of death 
either alone or in combination with other substances. 1 indirect cocaine-related death, i.e. a 
death that took place under the influence of cocaine, was reported each year in the 2004–
2006 period.   
 
Solvent-related deaths  
A total of 17 such cases were reported. Their numbers in individual years were as follows: 6 
cases in 2004, 3 cases in 2005 and 8 cases in 2006. In 13 cases the overdose was caused 
by toluene alone, in 2 cases it was caused by toluene in combination with other substances. 
1 death was found to be the result of a combination of toluene and acetone and 1 death was 
caused by a combination of acetone and other substances. 
 
Table 6.7: Deaths caused by solvent overdose in the 2004–2006 period in Slovakia (Śidlo, J.: Special deaths 
register, NMCD/HSA, 2007) 
 
Year Gender Age (years) 
Cause of death 
(toluene/combined overdose) ST code 
2004 male 21 toluene (21) 
 male 22 toluene (21) 
 male 23 toluene (21) 
 male 29 toluene (21) 
 male 29 toluene (21) 
 male 31 toluene (21) 
2005 male 23 toluene (21) 
 male 28 toluene (21) 
 male 34 toluene (21) 
2006 male 18 toluene (21) 
 male 26 combination of substances (21) 
 male 29 combination of substances (21) 
 male 31 combination of substances (20) 
 male 31 toluene (21) 
 male 31 toluene (21) 
 male 32 toluene (21) 
 male 53 combination of substances (21) 
Total 17 (17/-) Average: 28.9 13 / 4  
Note: ST code - code for the cause of death used in EMCDDA standard tables 
                                                                                                            
6.2 Drug related infectious diseases  
6.2.1. HIV/AIDS among injecting drug users 
Slovakia has one of the lowest prevalence of HIV infection in the European Union and also 
the lowest prevalence in central Europe. Data on recorded cases of HIV/AIDS are provided 
by the National Reference Centre for HIV/AIDS. 27 new cases of HIV infection were reported 
in 2006 (an incidence of 5.0/1 million inhabitants). The most frequent transmission routs are 
homosexual and heterosexual intercourse (table 6.8).  
Infections were registered in all eight regions in Slovakia in 2006. Cases of infection were 
first recorded from all regions the year before.  
A total of 197 368 tests for anti-HIV antibodies were carried out in 2006. Drug taking was 
given as a reason for testing in 194 cases. One case of infection resulting from injecting drug 
use was detected in 2006 but this took place outside the territory of Slovakia – in Portugal 
(NRC HIV/AIDS, 2007). This is the third case in history, after two cases recorded in 1985 and 
1986.  
Table 6.8: Incidence of HIV in Slovakia in the last 5 years, by means of infection (NRC HIV/AIDS, 2007) 
Means of infection before 2002 2002 2003 2004 2005 2006
Homo/bisexual intercourse 61 6 10 12  9   13
Heterosexual intercourse 26 3 3 2  11   11
IDU 2 0 0 0  0   1
Haemophiliac 0 0 0 0  0   0
Blood recipient 1 0 0 0  0   0
Homosexual intercourse and 
IDU 0 0 0 0  0   0
Mother to child 0 0 0 0  0   0
Unidentified 8 2 0 1  1   3
Total 98  11  13  15  21  27
 
According to expert opinion there may be a number of reasons for the low prevalence of HIV 
in Slovakia: for example, the long isolation of Slovakia from the western countries the same 
as in the case of most countries in the former Soviet bloc. After the opening of the borders 
prevalence increased gradually but not as rapidly as in other countries. Immediately after the 
first HIV infection in 1986 compulsory testing for blood donors was introduced, this was later 
extended to sperm, tissue, organ and milk donors. At the same time the first specialised 
facility dedicated to HIV/AIDS diagnosis was created in the Virology Institute of the Slovak 
Academy of Science and the first National Programme for the Prevention of HIV/AIDS in 
Slovakia was established. The Ministry of Health established the National Reference Centre 
for the Prevention of HIV/AIDS in the Institute of Preventative and Clinical Medicine72 in 1994 
(Staneková D., 2007).  
Relatively soon non-governmental organisations began to work on HIV/AIDS prevention, 
especially those working in harm-reduction, particularly in Bratislava, which was the area with 
the highest risk due to its status as the capital city and the high prevalence of drug use. 
When they were established, low threshold organisations had already had a chance to learn 
from their more experienced western partners and make immediate use of more effective 
prevention mechanisms developed in other countries (Staneková D., 2007). 
On the other hand, the extremely low prevalence may also be due to a very low rate of 
testing in the population (around 100 000 tests for anti-HIV antibodies annually) and general 
underestimation of the problem. The majority of people are unaware of the risk of infection. 
They do not protect themselves or go for tests. This suggests that the currently know number 
of persons infected with HIV may be just the tip of the iceberg (Staneková D., 2007). 
 
6.2.2 Viral hepatitis among injecting drug users  
 
6.2.2.1 Information from the national register of infectious diseases 
Data on the number of cases of infectious disease in Slovakia are collected by the Regional 
Public Health Authority in Banská Bystrica (hereinafter referred to as “the RPHA”) which 
processes information acquired at the regional level and stores it in the national register of 
reported infectious diseases. 
In comparison with the previous year there was an increase in reports of chronic hepatitis C 
in particular. 239 cases were reported in total in 2006 (in 2005 – 110 cases)73. One of the 
possible explanations for this increase is that it is being more actively sought74, together with 
the introduction of a more modern diagnostic technique and improvement in the system of 
                                                 
72 It is now the Slovak Medical University – Scientific research establishment, see also chapter 13.1.3 – Principal 
national research institutions 
73 Data are also reported in the Standard Table 9 for the EMCDDA  
74 based on the national programme coordinated by the National Centre for the Management and Treatment of 
Chronic Hepatitis based in Bratislava 
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reporting incidents of hepatitis in the EPIS system75. This change has revealed deficits and 
areas requiring improvement in the reporting of hepatitis and confirms the theory that the 
numbers of cases of chronic hepatitis C are higher than originally thought. It is not thought, 
however, that the increase in the number of reported cases of hepatitis indicates the onset of 
an epidemic (Lokša, P., 2007, Holomáň, J., 2007)  
A similar increase in the number of reported infectious diseases resulting from the changes 
listed above took place in cases where there was a history of injecting drug use. 13 cases of 
acute hepatitis C were detected among injecting drug users in 2006. 108 drug users had 
chronic hepatitis; in 2005 only 27 such cases were reported. Among persons with a medical 
history of injecting drug use, 1 case of acute hepatitis A was recorded in 2006 and 7 cases of 
acute hepatitis B.  
From a long term point of view, there is a clear reduction in the incidence of transmissible 
infectious diseases as a result of preventative vaccination, i.e. hepatitis A and B. 
 
Table 6.9: Incidence of hepatitis virus infections by region and number of injecting drug users (RPHA, 2007) 
HAV HBV acute HCV chronic HCV  Region 
Total IDU Total IDU Total IDU Total IDU 
Bratislava 6  1 24 5 3 0 32 23
Trnava 5  0 6 1 9 1 55  22
Nitra 4  0 12 1 7 5 41  19
Trenčín 2  0 11 0 4 2 12  1
Žilina 43 0 8 0 1 1 5  0
Banská Bystrica 13  0 9 0 1 0 48  27
Prešov 138  0 18 0 3 1 13  0
Košice 251 0 25 0 3 3 33  16
Total 462  1 123 7 31 13 239  108
 
The proportion of men and women in cases reported to the RPHA fluctuates. It ranges from 
2:1 to 5:1 except for 2004 when it was 10:1.  
 
6.2.2.2 Infectious diseases among drug users receiving treatment  
 
Results of tests in the CTDD – IDD in Bratislava 
The CTDD – IDD in Bratislava has been carrying out sentinel monitoring of trends in the 
incidence of infectious diseases that are transmitted via blood (HIV, HCV, HBV) among drug 
users who request treatment for the first time in the relevant calendar year. The results 
reported to the EMCDDA76 show an incidence of hepatitis C antibodies of 44.6% in the given 
facility in 2003, 45.8% in 2004 and 53% in 2005. Data for 2006 were not available at the time 
of writing. The number of patients tested was something over 100. AntiHCV serological 
markers were used. Positive responses to antiHBc markers (hepatitis B) made up 11.5% in 
2003, 4.4% in 2004 and 10.1% in 2005.  (EMCDDA – ST09, 2005)  
Hepatitis C in injecting drug users in the Banská Bystrica region  
In 2006 the team of Lovrantová, Skladaný, Bachová began a research programme to map 
the prevalence/incidence of hepatitis C among intravenous drug users in this region. The 
study is divided into two stages: retrospective analysis of selected data for the 2000–2006 
and subsequently a prospective study for the 2007–2009 period.  
The population studied are the patients  of the centre for the treatment of chronic hepatitis in 
the F. D. Roosevelt Teaching Hospital in Banská Bystrica, patients of the centre for the 
                                                 
75 Epidemiological information system 
76 In Standard Table 9 
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treatment of drug dependencies and clients of re-socialisation centres in the region. The 
family and persons close to drug users with HCV are also involved in the study. 
The aim of the retrospective stage was to map the population of intravenous drug users in 
the Banská Bystrica region and the sub-population of carriers of the HCV virus among IDU. 
Information was acquired through a review of medical records, questionnaires and personal 
interviews. 73 patients (58 men and 25 women) took part in the retrospective stage. The 
average age of first contact with drugs among the patients studied was 15.6 years and the 
length of intravenous drug use was 4.8 years on average, ranging from 1 month to 11 years. 
Hepatitis C infection was diagnosed at most 5 years from the start of drug use and the 
average age at the time of diagnosis was 20.5 years (15–29 years). In addition to 
intravenous drug use, the HCV risk factor tattoos/piercing (50.1%) and sexual transmission 
(3.1%) dominated the aetiology of HCV among the studied patients.  
3.8 times more men than women were diagnosed with HCV. Medical records for the studied 
population showed that genotype 3 was dominant among them at 54.7% while 13.7% had 
genotype 1 and 1.2% had genotype 2. No genotype was given for 30.7% of patients. 
The aim of the stated work is to find and exploit spare capacity in the process of identifying, 
recording, assignment to a clinic and treatment of HCV virus. The authors expect that the 
information acquired through this project will be used to increase the success of HCV 
treatment, to support work to prevent the spread of infection and to spot predictive 
parameters for the success of hepatitis C treatment for injecting drug users (Lovrantová et 
al., 2007). 
 
6.2.2.3 Incidence of infectious diseases among drug users entering prison 
 
In prisons (including remand prisons) and in the hospital for prison inmates in Trenčín, 
screening takes place continuously for the timely diagnosis of infectious diseases in persons 
with high risk behaviour. This takes the form of blood tests for HIV and the hepatitis B and C 
viruses. Previous statistical measures did not permit the extraction of data relating 
specifically to drug users, however. Since 1 January 2007 the General Directorate of the 
Prison and Court Guard Corps (hereinafter referred to as “PCGC”) has changed the system 
for recording test results. This change is intended to ensure the immediate availability of real-
time information on the prevalence of infectious diseases among drug users entering prison 
in the structure required by the EMCDDA. 
Project:  Risk of the incidence of blood-borne infectious diseases among prison 
inmates in the Slovak Republic 
During 2006 and 2007 this project was prepared under the supervision of the General 
Directorate of the PCGC and the National Centre for the Management and Treatment of 
Chronic Hepatitis (NCMCH). It will be implemented in the course of 2007.  
The primary objective of the project is to determine if the imprisonment is the risk factor of 
infection (if any) with the blood-borne infectious diseases HCV, HBV and HIV. The study will 
also examine the risk factors, including combinations of factors that most strongly influence 
the incidence of HCV, HBV and HIV before imprisonment and the factors that influence 
infection while in prison. The output of the project will include findings on the prevalence and 
incidence of infection during imprisonment (Holomáň J., 2007). 
 
6.2.2.4 Incidence of infectious diseases among clients of outreach programmes 
 
The civil association Risen in Prešov offered its clients tests for syphilis and HIV in 2006. No 
positive result was found in 60 tests for HIV and 40 tests for syphilis.  
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ERATO Project 
In 2006 the civil association Odyseus carried out tests for syphilis antibodies, HIV antibodies, 
hepatitis B antibodies (HBsAg) and hepatitis C antibodies (anti-HCV and HCV RNA PCR) for 
clients of outreach programmes in Bratislava as part of the international ERATO project. 
Further information on the project is given in chapter 7 – Responses to health correlates and 
consequences. The results relating to the prevalence of infectious diseases were not 
published yet by the time this report went to press.  
Project: Testing of the hidden population of active drug users 
A project for the testing of the hidden population of active drug users was also prepared in 
200677. The project is being carried out by the following harm-reduction organisations: the 
civil associations Prima (Bratislava), Heuréka (Banská Bystrica, Žiar nad Hronom, Zvolen), 
Risen (Prešov) a Storm at UKF (Nitra, Sereď, Trnava). The aim of the project is to determine 
the prevalence of the following infectious diseases: hepatitis B and C, HIV and syphilis 
among active drug users and also to direct/motivate clients with suspected infections to 
health care units and medical professionals. 
Testing began in 2007 and it is expected to be completed in autumn 2007. Testing is being 
conducted in eight towns in Slovakia in the form of fast screening tests. Tests are conducted 
on drops of capillary blood from the pad of the finger. Preliminary results from tests carried 
out to the end of May 2007 show relatively high prevalence of hepatitis B (13.3%) and 
syphilis (26.3%) among intravenous drug users, with a high rate of infection in Prešov. The 
prevalence of hepatitis C antibodies in preliminary results is 47.3% of 91 persons tested.  
The test results must be interpreted carefully. Firstly, they are tests for antibodies, which 
need to be confirmed and furthermore the testing project is incomplete and therefore the 
results are only preliminary. The results may also be affected by the environment in which 
the harm-reduction organisations work. For example, weather the environment is a stable 
environment with a stable clientele or have the organisations broadened their activities to 
include a new target group. For example, the relatively high percentage of prevalence for 
hepatitis B and syphilis infections in Prešov was caused when services began to be provided 
to a new group of drug users in the Roma community, where the users were infected by their 
partners working in the sex-business (Risen civil association, 2007). The effect of opening a 
new programme in this community can also be seen in comparisons with the results obtained 
by the Risen civil association in syphilis tests conducted in 2006 and 2007. While none of 40 
tests for syphilis antibodies were positive in 2006, 20 out 37 tests were positive in 2007 when 
the organisation began to provide services in the new client community.  
Table 6.10. Results of the project Testing of the hidden population of active drug users – results to May 2007 
(Prima - civil association, 2007a) 
Infectious diseases HIV HCV HBV SYPH. 
Number of tests performed 98 91 90 95 
Number of positive tests 1* 43 12 25 
Percentage of positive tests 1% 47,3% 13,3% 26,3% 
* After only one test, confirmation tests not carried out  
 
                                                 
77 The project received financial support under the small grant scheme of the project for the support of the 
implementation of the 20042008 NPFD declared and implemented by the General Secretariat of the Government 
Office. 
6.3 Psychiatric co-morbidity (dual diagnosis) 
 
Some information on psychiatric co-morbidity for patients with drug addictions was published 
in the 2006 Report.  
Turček (2007) has studied the excessive use of psychoactive substances in 55 hospitalised 
patients with eating disorders. His research found that 43.5% of patients were dependent on 
or abused at least one psychoactive substance. The most frequent substances were 
tobacco, alcohol and caffeine (Turček M., 2007). 
 
6.4 Other drug related health correlates and consequences  
 
6.4.1 Pregnancy and children born to drug users  
In 2006, 68 pregnant women with drug dependencies were reported, giving birth to 52 babies 
(5 more than in 2005). At the end of the 1990es such births were recorded almost only in 
Bratislava but now children of mothers with drug addictions are appearing in other towns. 
Although health workers are better able to diagnose neonatal abstinence syndrome, it is 
thought that there are still some cases where it goes undiagnosed. Patients with such a 
diagnosis are sent for intensive care (Type III neonatal facilities) or to specialised perinatal 
centres because they require long term specialised care78. 
A perinatal analysis of results for the Bratislava region in the 2000–2006 period (Korbeľ 
2001, 2002) shows that children born to mothers with drug dependency make up 0.5%–0.8% 
of all children born. In the last two years (2005 and 2006) the number of children born to 
mothers with drug addictions in Bratislava has been the same (39 babies). 
Children born to drug users in the Cyril and Methodius hospital in Bratislava  
In 2006 the perinatal care centre at the Cyril and Methodius hospital in Bratislava diagnosed 
neonatal abstinence syndrome in 15 of 2 194 hospitalised children (0.68% of cases).  
The main drug used during pregnancy by the mothers of these patients was heroin or 
combinations including heroin, which was usually injected: in 4 cases heroin was used alone, 
in 4 cases heroin was used with methadone, in 2 cases heroin was used with pervitin 
(methamphetamine) and in one case heroin was combined with Diolan. 3 babies and their 
mothers were addicted to pervitin.  Polydrug use was diagnosed in 1 case (a combination of 
heroin, methamphetamines and amphetamines). All the drugs were diagnosed by means of 
toxicological analysis of the babies’ urine. In 6 cases babies had low birth weight and two 
children died as a result of complications (with weights of 760g and 1450g). Only 4 mothers 
in the population did not carry the hepatitis C virus, 5 children required treatment with 
penicillin because their mothers did not complete treatment for syphilis during pregnancy.   
 
 
                                                 
78 Children born to mothers with addictions receive long term treatment in clinics for children with perinatal 
pathology. Their psychomotor development and later behaviour and education must be monitored. In addition 
they are often placed in institutions for young children.  
 
7. Responses to health correlates and consequences 
Measures aimed at reducing health risks associated with drug use are carried out not only by 
health care units but also notably through the activity of non-governmental organisations that 
provide low threshold social services (harm reduction organisations).  
Since 1994, when the first programme to distribute needles and syringes began at the 
Bratislava CTDD, 7 organisations have been established to operate needle and syringe 
exchange programmes. Odyseus, Prima, Storm at UKF, Risen, Heuréka, Pomocná ruka 
and Centrum dobrovoľníctva – project V.I.S. Services were provided during the year in ten 
towns, though not all functioned for the whole year. The needle and syringe exchange 
programme in Púchov closed down at the end of 2006. New needle and syringe exchange 
outreach programmes were established in Trnava, Banská Bystrica, and Košice and, after a 
two year break, in Zvolen. In this year preparations also began for the opening of a new 
contact centre in Nitra.  
In 2006, work began on preparation of minimum standards for low threshold services for drug 
users in accordance with the principle of harm reduction. These standards will be used as an 
instrument to ensure the quality of low threshold services provided to drug users. 
The importance of harm reduction organisations derives mainly from their efforts to reduce 
the incidence of infectious diseases such as hepatitis, HIV and syphilis among drug users, to 
educate users on safe use, to provide counselling and so on. Despite the importance of the 
low threshold services provided by harm-reduction organisations there are relatively few of 
them. It is estimated that 21% of problem drug users are in contact with low threshold 
services79.   
 
Map 7.1: Availability of NSP’s 
 
Note: The NSP in Žiar nad Hronom and Banská Bystrica operated for only 8 months (from May 2006) and in 
Zvolen from September 2006. In Košice there is one organisation providing both fixed and outreach exchange 
programmes. 
7.1 Prevention of drug-related deaths 
Measures to prevent drug-related death or unintentional overdosing include: substitution 
programmes, where addicts are transferred from uncontrolled drug use to controlled use; 
education and training for drug users on safer ways to take drugs and measures to avoid 
fatal overdoses or to provide first aid to other drug users. Education is provided by harm 
reduction organisations and health care facilities through direct communication with drug 
users or through brochures and information leaflets.  
                                                 
79 See the estimates for problem drug use in chapter 4 – Problem drug use  
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Apart from the above there are currently no activities available in Slovakia that could be 
considered as measures to reduce overdoses, such as consumption rooms for safe drug use 
or the direct distribution of antagonists to drug users. 
7.2. Prevention and treatment of drug-related infectious diseases 
In the prevention of infectious diseases priority is also given to suitable education for drug 
users, provided through harm reduction organisations and health care facilities in direct 
communication with users or through brochures and information leaflets. The availability of 
needle and syringe exchange programmes also contributes to such prevention. 
Organisations taking part in harm reduction programmes provide information on infectious 
diseases, train and motivate users to practise safer consumption methods and safer sex, 
distribute condoms, operate needle and syringe exchanges, distribute material on safer 
methods for taking drugs and facilitate the safe disposal of waste materials.  
Vaccination is an important method to prevent hepatitis B infections. The centres for the 
treatment of drug dependency continued to provide vaccination free of charge to injecting 
drug users coming into contact with the centres for the first time in 2006. (Ministry of Health 
2007) 
7.2.1 Services provided by outreach programmes – needle and syringe 
exchange programmes 
In 2006 work began on a document on minimal standards for low threshold services for drug 
users in accordance with the principle of harm reduction80 in response to long standing 
requests from existing harm reduction organisations. Its purpose is to standardise 
terminology, set rules for the functioning of services and the methodology for work in the 
area of harm reduction in Slovakia. It is expected that these standards will serve as an 
instrument to ensure the quality of low threshold services provided to drug users.  
In 2006 there were 7 organisations running needle and syringe exchange outreach 
programmes. In 3 towns – Bratislava, Banská Bystrica and Košice – there were both 
outreach and fixed needle and syringe exchange programmes. In 2006 new outreach 
programmes opened in Banská Bystrica (the civil association Centrum dobrovoľníctva – 
projekt V.I.S.), in Trnava (the civil association Storm at UKF Nitra) and in Košice (the 
Pomocná ruka civil association).  
Services were provided in 10 towns in total, though not all functioned all year round. The 
needle and syringe exchange programme in Púchov (Odyseus civil association) closed down 
in October 2006 and the programmes in Žiar nad Hronom and Banská Bystrica were in 
operation only for 8 months81. An outreach programme was reopened in Zvolen in 
September 2006 but it did not have a stable clientele. According to the organisations, the 
problem of sustainability in these programmes is largely due to uncertain long-term funding82 
but there are also problems with staffing.  
Data was again collected on the clientele structure of harm reduction organisations and their 
services in 2006 (see chapter 4.3 – Problem drug users from non healthcare sources), using 
a questionnaire completed by all organisations performing such activities in 2006.  It is not 
yet possible to present information on the number of actions carried out by harm reduction 
organisations or the number of persons served (Table 7.1) because not all organisations 
keep such records. The total number of contacts with users and non-users for all harm 
                                                 
80 The preparation of the document is supported in part by the Open Society Foundation –Bratislava as a project 
of the civil association Storm at UKF. 
81 In Banská Bystrica two exchange programmes operated in parallel, established by the civil associations 
Heureka and Centrum dobrovoľníctva – projekt V.I.S, both of which began in May 2006. 
82 Odyseus civil association 2007b 
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reduction organisations in 2006 was 30 142, of which 602 cases were first contacts. In 2005 
the numbers were 29 657 contacts, of whom 627 were first contacts. 
Table 7.1: Number of actions carried out and number of persons making use of selected services of harm 
reduction programmes (NMCD, 2007b) 
 Service provided 
Number 
of 
persons 
Number of 
organisations 
providing 
information 
Number of 
actions 
Number of 
organisations 
providing 
information 
Exchanges in exchange programme 1965 5 9784 7
Catering 442 4 6372 5
Medical treatment 316 4 806 6
Individual counselling  218 4 1446 6
Crisis intervention 33 2 105 2
Referrals to K-centre and other 
programmes* 1273 3 4359 3
Referrals for treatment* 101 3 300 5
* Approximate information only. It is not possible to give precise information because referrals and contacts are 
also provided by means of leaflets during counselling. 
The Pomocná Ruka civil association in Košice provided group counselling for 132 persons 
(27 sessions) in 2006. The counselling sessions took place in the premises of the CTDD but 
drug users who were not in treatment were able to attend anonymously.  
The numbers of needles and syringes issued and collected are given in the following table.  
Table  0.1: Needle and syringe exchanges in outreach programmes (NMCD, 2007b) 
Year 
Number of 
needles/syringes 
collected 
Number of 
needles/syringes 
issued 
Number of needle/syringe 
exchange programmes* 
providing information 
2004 249 322 297 935 8 
2005 254 730 362 055 10 
2006 327 665 384 293 13 
* Programmes are understood here to cover independent exchange programmes provided by field services, 
institutions and the K-centre.  
7.2.2 Counselling and testing 
The centres for the treatment of drug dependency carried out tests on drug users in 
treatment to detect HIV or hepatitis B or C infections in 2006 (Ministry of Health 2007).  
Testing for infectious diseases of drug users who are not in contact with health care units (in 
treatment) is not a regularly available service and most harm reduction organisations provide 
it only occasionally. 
In 2006 the Odyseus civil association in Bratislava provided testing for infectious diseases 
and hepatitis for the clients of its outreach programmes. It was possible to carry out low 
threshold testing for antibodies for syphilis, HIV and hepatitis B (HBsAg) and hepatitis C 
(anti-HCV and HCV RNA PCR) thanks to the ERATO international research project. The 
project was financed by the Greek ministry of foreign affairs (HELLENIC AID) and operated 
in 3 countries: in Slovakia, by the civil association Odyseus, ACT UP HELLAS in Greece and 
SALUS in Ukraine.  
The testing service was provided as part of the Chráň sa sám (Protect yourself) project83 and 
was offered to injecting drug users, sex workers and their partners and customers. The 
service included pre-test and post-test counselling. For taking part in the research, 
participants received condoms and a brochure published specially for the purposes of the 
                                                 
83 Project for field social work related to the exchange of syringes, the distribution of health material and condoms for 
injecting drug users and sex workers. 
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project. Blood samples were taken in a specially adapted mobile unit by qualified medical 
personnel (who also provided counselling). A total of 62 persons made use of the testing 
service in 2006, of whom 35 were men. In addition to the quick tests, the Odyseus civil 
association carried out 104 tests for syphilis antibodies, 68 tests for HIV antibodies, 66 tests 
for hepatitis B and 66 tests for hepatitis C (including confirmation if necessary) (Odyseus, 
2007a).  
 
In 2006 the Risen civil association also carried out tests for syphilis and HIV antibodies for 
drug users. 
During 2006 a project was prepared to test the clients of harm reduction programmes for 
antibodies for hepatitis B and C, syphilis and HIV. The project is implemented by four civil 
associations (Prima, Storm at UKF, Risen and Heuréka) in eight Slovak towns (Bratislava, 
Nitra, Sereď, Trnava, Banská Bystrica, Žiar nad Hronom, Zvolen and Prešov). Testing began 
in 2007 (for further information see chapter 6 – Health Correlates and Consequences). 
7.2.3 Infectious diseases treatment 
The treatment of injecting drug users for infectious diseases is described in the 2006 Report, 
chapter 7 – Responses to health Correlates and Consequences). 
7.3  Interventions related to psychiatric comorbidity  
The treatment of patients with a dual diagnosis, with psychiatric comorbidity, takes place in 
the Slovak healthcare system; patients are admitted for treatment in hospital psychiatric units 
(2004 Report).  
8. Social correlates and consequences 
 
Drug use can be understood as a consequence or cause of social exclusion – because 
social marginalisation can be on the one hand a reason to start using drugs or can lead to 
problem use, and on the other hand (problem) drug use may lead to a deterioration in living 
conditions (income, employment, housing and so on). The most serious social problems 
facing drug users include unemployment, low education, family and employment problems, a 
worsening of their housing situation.  
In addition to drug users, groups vulnerable to social exclusion include the unemployed, 
migrants, marginalised Roma communities, the homeless, persons released from prison and 
the disabled.  
Crime is one of the social consequences of drug use. The rising trend in the number of 
offences committed continued in 2006 (84 cases more than in the previous year); there was 
a slight fall in the number of arrests. During the year it became compulsory for the Police 
Force to record drug-related offences and offenders by type of drug. In addition to the broad 
category of synthetic substances, most drug-related offences were committed in relation to 
marijuana, pervitin (methamphetamine) and heroin. In 2006 the new penal code came into 
effect and the new provision disturbed the continuity in the monitoring of the number of 
persons convicted under individual sections and thereby limits the interpretation of data for 
2006. A total of 722 persons were convicted of drug-related offences (an increase of 132).  
8.1  Social exclusion and inclusion  
The 2004–2006 National Action Plan on Social Inclusion defines the main population groups 
at risk of poverty and social exclusion as follows: The unemployed, families with children 
(with an increased risk in incomplete families and families with a large number of children), 
Roma communities, people with disabilities, migrants, the homeless and other vulnerable 
population groups such as drug addicts, gamblers, abused children, victims of domestic 
violence, prison inmates and former inmates, young people who have been brought up in 
care.  
Information on social exclusion among drug users or on drug use in marginalised groups is 
not extensive. The relationship between on the one hand social exclusion and its 
consequences such as unemployment, homelessness, financial problems etc. and drug use 
on the other is not a specific area that is monitored or studied, nor is there information on 
specific studies being performed in this area. 
8.1.1 Homelessness and drug use 
It likewise applies that there is little information on drug use among the homeless. A survey 
of current and potential clients of social service was conducted84 in the Bratislava region in 
November 2006, focussing on the following groups: people with disabilities; seniors, families 
and individuals in crisis (female victims of domestic violence, homeless people etc.) and 
users of psychoactive substances (Kusá Z., 2007). The survey was aimed at possibilities and 
barriers for the use of social services among the individual categories of clients and the area 
of psychoactive substances was not a part of the survey. 
A survey of the case-history (anamnesis) of addictive behaviour of 369 homeless people 
living in a shelter in Nitra was conducted. The published results found that 37.9% of 
homeless people had alcoholic parents and 25.7% had relatives involved in crime. It was 
also found that 66.4% of the homeless respondents were addicted to alcohol, 92.9% smoked 
tobacco, 7.9% used other psychoactive substances and 6.5% gambled. 1.9% had undergone 
protective treatment (Kasanová A., 2007). In the article the author states that the numbers 
                                                 
84 Carried out by the Institute of Social Sciences of the Slovak Academy of Sciences 
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given could be higher for homeless people who do not live in a shelter but other forms of 
temporary accommodation. The low prevalence of other psychoactive substances and 
gambling may be a result of the homeless spending their money on cheap alcoholic drinks 
and tobacco products. Drug use and gambling are behaviours/commodities that they cannot 
afford to finance.  
Information on certain measures aimed generally at the homeless has been included in 
previous reports in chapter 8 – Social correlates and consequences. 
8.1.2 Drug use in Roma communities 
Information of a mainly qualitative nature is provided by the studies of Roma pupils in 3rd 
school year in 2003–04 and 2004–05 (Liba, 2006) and Roma children aged 5–10 (Farkašová 
et.al. 2005), which are discussed in the 2006 Report in chapter 2 – Drug use in the 
population and chapter 11 – Drug use and related problems among very young people 
(under 15 years).  Chapter 12 gives the basic results of biomedical research into smoking 
among pregnant women in the majority and minority (Roma) population, which show both the 
known negative effects of nicotine on unborn children but also significant differences 
between women who smoke in the majority population and women who smoke in the socially 
and culturally marginalised group.    
In the course of the project Concept for using regional resource in the creation, 
implementation and evaluation of drug policy in the Prešov region85, a survey of 70 Roma 
communities in the Prešov region was planned for 2007. The research took the form of semi-
guided interviews with two categories of respondents: important community figures (mayors, 
teachers, religious leaders, local activists and the like) and inhabitants of the Roma 
communities and drug users. 
8.1.3 Drug users working in the sex business 
The BORDERNET project ran in Slovakia and five other European countries with the support 
of the European Commission86. The project was aimed at people working in sex-business in 
order to improve prevention and diagnosis of HIV/AIDS and other sexually transmitted 
diseases in a number of European border regions. It also includes monitoring of the risks that 
various groups are exposed to. The project inquired into personal mobility, HIV/AIDS and 
other STDs and awareness of them and sexual behaviour.  
The hidden population of drug users currently also active in the sex-business in the city of 
Bratislava also took part in the project. The Prima civil association collected the data and 
identified certain characteristics of the target group of the survey, which are almost identical 
with selected characteristics of the target group of clients of harm reduction programmes.  
The survey population consisted of 98 respondents, 76 women and 22 men. The main 
primary drug used was pervitin (methamphetamine powder) (62); 36 used heroin. The 
average age of persons was 27 years and the most numerous age group was 20–25 (36% of 
respondents). The largest group of respondents (35%) was persons who had achieved 
secondary education; this was followed by 30% who had qualifications from vocational 
schools. 
The survey also inquired about employment; 61% of respondents were unemployed 
and 14% worked part time. Only 8 respondents worked full time or were self employed.  
46% of respondents lived without a partner at the time of the survey and 29% had a partner. 
45% of respondents had children. The youngest child of clients of the outreach social 
                                                 
85 In 2006 it was supported from the small grant scheme of the project Support for the Implementation of the 
2004–2008 NPFD 
86This study was carried out in Slovakia under the supervision of the Slovak Medical University in Bratislava under 
the leadership of RNDr. D. Staneková, CSc.  
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programme of the Prima civil association was 1 year old and the oldest was 30. Respondents 
had 64 children in total with an average age of 11 years; 78% of children were minors. 
Table 8.1: Number of children of respondents in the BORDERNET survey, clients of the outreach programme for 
drug users (Prima civil association, 2007b) 
Number of children Number of respondents 
1 child 26 
2 children  16 
3 children 2 
 
Table 8.2: Age structure of children of respondents in the BORDERNET survey, clients of the outreach 
programme for drug users (Prima civil association, 2007b) 
Age group Number of respondents 
  1- 5 18 
  6-10 23 
11-15 9 
15-20 4 
21-25 6 
26-30 4 
 
The full results of the complete BORDERNET survey for all 6 countries were not yet 
available when the report was written.  
8.1.4 Social characteristics of drug users in treatment 
Some indicators of the worsened conditions in which drug users live can be found in the 
socio-demographic data from the TDI (Chapter 4 – Problem drug use). The social 
characteristics of drug users in treatment do not vary significantly; a large proportion are 
unemployed and have completed only elementary education, more than 8% had no stable 
accommodation in 2006 and over 1% had been in some form of state custody (prison, 
diagnostic institution and the like). Chapter 4.2 – Treatment Demand Indicator has already 
presented some of the basic social characteristics of drug users in treatment and the clients 
of low threshold organisations.  
Table 8.3: Selected social characteristics of drug users in treatment from the TDI – all treatment, in % (NHIC, 
2007b) 
  2003 2004 2005 2006 
Unstable accommodation 6,6 7,6 8,9 8,6
Prison/institution inmate 1,9 1,6 1,6 1,03
Unemployed 55,2 54,2 54 55,2
No education 5,8 4,4 5,3 4,1
Elementary education 40,3 43 39,1 38,5
 
Table 8.4: Selected social characteristics of clients first treated from TDI, in % (NHIC, 2007b)   
  2003 2004 2005 2006 
Unstable accommodation   6,3 7,4 7,1
Prison/institution inmate   0,9 1,4 1,1
Unemployed 33,1 49,7 44,4 46,9
No education 7,1 5,4 5,5 4,2
Elementary education 40,1 43,3 39 38,4
 
8.2 Drug-related crime 
 
The term “drug-related crime” as defined by the EMCDDA means: Psychopharmacological 
crimes (crimes committed under the influence of a psychoactive substance, as a result of its 
acute or chronic use), economic-compulsive crimes (crimes committed in order to finance 
drug use); systemic crimes (mainly violent crimes committed within the functioning of illicit 
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drug markets, as part of the business of drug supply, distribution and use) and finally crimes 
committed in violation of drug legislations (EMCDDA, 2007).  
This chapter presents mainly data for the last category – crimes committed in relation to 
violation of applicable drug legislation. Drug-related crime and drug-related criminal acts are 
offences committed under section 171 – illegal possession of drugs87 for personal use, 
section 172 – illegal production, distribution and possession of drugs, section 173 – illegal 
production and possession of items intended for the production of drugs and section 174 – 
promoting drug addiction of the New Penal Code (and the equivalent sections of the Penal 
Code, Act 140/1961 hereinafter referred to as “the Old Penal Code”)88.  
At a national level, records and statistics on offences and offenders are provided by the law 
enforcement and judicial authorities, in particular: The Ministry of Interior (MI), the Office of 
the Prosecutor General (OPG) and the Ministry of Justice (MoJ). There are discrepancies in 
the data that these institutions provide on the numbers of arrests, prosecutions and 
convictions. One of the reasons may be the lack of mutual connections between statistical 
systems. The MI and the Presidium of the Police Force began to monitor drug-related 
offences and offenders by drug type on 1st June 2006. The OGP and the MoJ introduced this 
system on 1st January 2007.  
This report uses information on the number of offences and arrests drawn from the police 
system for recording crime. This statistical information covers the total number of offences 
and arrests in the given year, including drug-related offences. Information on the number of 
persons convicted of drug-related offences is taken from MoJ statistics.  
 
8.2.1 Number of offences and arrests according to police data 
The rising trend in recorded drug-related crime that we have seen in the last 7 years 
continued in 2006 (see the 2006 Report, chapter 8.2 – Drug-related crime). According to 
information from the Presidium (central headquarters) of the Police Force (hereinafter 
referred to as “the PPF”), 1 722 offences relating to the production, distribution and 
consumption of drugs were recorded (84 more cases than in 2005), although the number of 
arrests fell to 1 256 persons in 2006 (53 fewer).   
Out of the total number of persons prosecuted (as in the previous year) the majority belong 
to the 18–30 age group. The proportion of women prosecuted rose from 8.6% (2005) to a 
round 10% in 2006. (In 2004 their share was 10.2%). In terms of level of education, the 
distribution of offenders was not significantly different from that in previous years – 50% of 
offenders had completed elementary education, 19% had secondary education and only 1% 
was persons with a university education.       
On 1st June 2006 the Police Force introduced compulsory reporting of drug-related offences 
and perpetrators by drugs. For its purposes it has included monitoring of abuse of medicines 
and precursors in addition to “traditional drugs”89.  
467 offenders are recorded for the period 1st June–31st December 2006. The police recorded 
the largest number of offenders as committing offences related to so-called “other 
substances” (38%). This group includes, amongst the chemical substances (ephedrine and 
pseudoephedrine) also equipment for drug production. This was followed by offenders who 
committed offences related to marijuana (34%), pervitin (12%) and heroin (9.6%). Most 
offenders committed offences related to one type of drug (457 arrests) and only 10 cases 
involved combinations of 2 or 3 types of drugs.  
                                                 
87 Under the penal code, Act 300/2005, a drug is any narcotic, psychotropic substance, poison or precursor 
88 Section 186 – illegal possession of drugs for personal use, section 187 – illegal production and possession of 
narcotic and psychotropic substances, section 188 – illegal production and possession of an item intended for the 
production of narcotic and psychotropic substances and section 188a – promotion of drug addiction 
89 marijuana, hashish, heroin, pervitin, other amphetamines, cocaine, LSD, ecstasy 
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The same ranking was found in offences. In the period 1st July–31st December 2006, 1 032 
offences were reported in the system. 493 offences related to “other substances”, 303 
related to marijuana, 103 to pervitin, 100 to heroin and 11 to cocaine.  
Fig. 8.1 Number of perpetrators of offences under section 171–174 by type of drug for the period 1.6. 2006–
31.12. 2006, Ministry of Interior 2007b) 
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Medicines abused: rohypnol, modafen, nurofen, clarinese and other medicines 
Other substances: ephedrine, pseudoephedrine, anabolic steroids, equipment for drug production (driers, 
pressure vessels) and other poisons and precursors. 
 
8.2.1.1 Drug-related crime in regions, according to police data 
 
Bratislava has for a long time had the largest proportion of national drug-related crime 
reported in terms of the number of drug-related offences, arrests and convictions and the 
other regions follow behind. (Office of the Prosecutor General, 2007; Ministry of Justice, 
2007a). Once again in 2006 the fewest offences were committed in the Prešov region (see 
Table 8.5). 
In 2006 the largest rise in the number of offences was recorded in Trnava region (an 
increase of 55 compared to year 2005) and Nitra region had the highest growth in arrests. 
On the other hand, the sharpest fall in crime was reported in Trenčín region. (for long term 
trends in drug-related crime in the regions over the last 8 years, see the 2006 Report, 
chapter 8.2 – Drug-related crime) 
 
Table 8.5: Comparison of crime trends in individual regions of Slovakia (in terms of offences and arrests), Ministry 
of Interior, 2007a) 
Number of offences Number of arrests 
Region 2006 2005 
Difference 
2006 2005 
Difference 
Bratislava 1055 1024 31 750 802 -52
Trnava 195 140 55 107 97 10
Trenčín 64 83 -19 44 69 -25
Nitra 131 119 12 116 80 36
Žilina 57 65 -8 34 70 -36
Banská Bystrica 131 111 20 111 96 15
Prešov 35 34 1 30 32 -2
Košice 54 62 -8 64 62 2
Total 1722 1638    –– 1256 1308     –– 
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8.2.2 Number of convictions according to the Ministry of Justice 
 
The statistics of the Ministry of Justice (MoJ) record the number of persons convicted of 
offences under individual sections of the penal code in each year. Due to the long time it 
takes to complete some cases, which can take several years, it is not possible to consider 
these data an accurate up-to-date reflection of trends in crime in the year under analysis and 
the data is not compatible with the police statistics for the given year.  
The New Penal Code entered into effect in 2006. This legislative change means that great 
care must be taken in interpreting the data. The overall picture of convictions in 2006 covers 
total convictions under sections 171–174 of the New Penal Code and total convictions under 
section 186, 187, 188 and 188a) of the Old Penal Code.90 
A total of 722 persons were convicted of drug-related offences in 2006, 132 more than in 
2005 (see Table 8.2). 442 persons were convicted under the Old Penal Code – majority of 
them (158) was convicted for illegal production and possession of drugs. 280 persons were 
convicted under the New Penal Code, majority was convicted for possession of drugs for 
personal use – 248 persons. (See Table 8.6).  
In comparison with previous years, the statistical data reported by the Ministry of Justice 
shows an increase in the number of persons convicted of possession of drugs for personal 
use. (See fig. 8.2) This increase may relate to the wording of the New Penal Code, under 
which the offenders previously prosecuted under section 187 of the Old Penal Code can be 
prosecuted under section 171 of the New Penal Code. The New Penal Code allows clearer 
distinctions between persons who possess drugs for personal use and drug dealers and the 
statistical data should give a better reflection of reality. 
 
Table 8.6: Number of persons convicted under individual sections of the New and Old Penal Code by region in 
2006 (Ministry of Justice, 2007a) 
Penal code, Act 140/1961 Penal code, Act 300/2005 
Region §186 §187 §188 §188a §171 §172 §173 §174 Total 
Bratislava 123 114 2 0 154 4 1 0 398 
Trnava 9 34 3 0 22 6 0 0 74 
Trenčín 1 25 1 0 9 5 0 1 42 
Nitra 7 38 0 0 28 8 0 0 81 
Žilina 9 15 0 1 6 1 0 0 32 
Banská Bystrica 5 14 5 0 21 4 0 0 49 
Prešov 1 12 0 0 2 0 0 0 15 
Košice 3 18 1 1 6 2 0 0 31 
Total 158 270 12 2 248 30 1 1 722 
 
                                                 
90 The trials of persons prosecuted while the old penal code was in effect were conducted under the old 
provisions. 
Fig. 8.2: Comparison of the number of persons convicted under each section by year (Ministry of Justice, 2007a) 
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8.2.3 Young offenders  
 
According to the statistics issued by the PPF, the OPG and the MoJ, the number of young 
persons arrested, prosecuted and convicted for drug-related offences fell in 2006.  
According to police data, 67 fewer children and young people were arrested than in 2005 
(total 103). The OPG recorded 39 fewer prosecutions of young people and the MoJ recorded 
5 fewer than in 2005 convicted of drugs offences (50 young people altogether), including one 
14-year-old convicted of illegal production of narcotic and psychotropic substances.  
 
8.2.4 Other drug-related crime  
 
There is no relevant data available on so-called economic-compulsive crimes committed to 
obtain money or drugs to support drug use. This type of crime is not monitored in central 
statistics and no study has yet been carried out in this area. The only available information 
on this type of crime is the experience of law enforcement and judicial authorities. According 
to the OPG drug addicts must frequently commit property crime – pick pocketing, thefts from 
cars, shoplifting and so on (Office of the Prosecutor General 2007).  
 
Crimes committed under the influence of drugs 
In its statistical yearbooks the MoJ also presents information on crimes committed under the 
influence of addictive substances other than alcohol (drugs)91. According to available 
information, year 2006 represented a change in long term trends. In contrast to the situation 
described in the 2006 Report (Chapter 8.2.4 – Crimes committed under the influence of 
drugs) this was the first year in five years when there was an increase in the number of 
convictions for offences committed under the influence of drugs (321 persons – 81 cases 
more than in 2005). On the other hand there has been a fall in the number of convictions for 
offences committed under the influence of alcohol. This fall may relate to increased use of 
                                                 
91 Section 201 of the old penal code and section 289 of the new penal code. 
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institutes of non-judicial proceedings, especially for road traffic offences which include 
offences committed under the influence of alcohol (Office of the Prosecutor General, 2007) 
 
8.3 Drugs in prison 
 
In 2006, 646 persons declared the use of drugs during medical examination on starting a 
prison sentence or entering custody. This represents 12% of the total number of persons 
committed to prison in 2006. As at 31st December 2006 there were a total of 954 convicts 
and persons in custody addicted to drugs, which represents 11.56% of all prison inmates at 
that date. This proportion has grown very gradually since 2003 (when it was 6.7%) and it is 
currently the same as in 2005 (11.6%). The majority of recorded users are injecting users of 
heroin and pervitin.  
In 2006 as part of the project Reduction of the risk of the penetration of drugs into prisons92, 
1 627 screen tests were carried out for the presence of drugs in urine. Positive results for the 
presence of drugs were found in 147 cases. The most frequently abused substances were 
benzodiazepines (84) followed by opioids (21), cannabinoids (20), and amphetamines (14) 
and barbiturates (7). 
 
8.4. Social costs associated with drug use  
  
The latest available information on social costs associated with drug use are contained in the 
study Social and economic costs of illicit drugs used in the Slovak Republic, which was 
carried out in 2005 (Fazey C., 2006). 
  
                                                 
92 to support the National Programme for the Fight against Drugs 
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9  Responses to Social correlates and Consequences  
 
The situation with regard to drug addiction can be explained by reference to, amongst other 
things, the overall social situation, in particular that of threatened and vulnerable groups of 
population. The first comprehensive measure to address their situation was the National 
Action Plan on Social Inclusion (2004–2006), which operated on two levels: Preventing the 
risk of exclusion (by facilitating participation in employment and access to resources, rights, 
goods and services) and providing assistance to the most vulnerable sections of society. The 
MLSAF has an important role in implementing measures for vulnerable and marginalised 
groups93 and aims to solve the problem by introducing specific measures that address the 
situation of people who are vulnerable to drug addiction either directly or through an 
intermediary (through elimination and/or reduction of primary risk factors). 
It can also be said that some measures, in particular measures carried out for children and 
young adults at risk of drug addiction, which became more visible in 2006, are focussing 
more on this group.  
Weaknesses and areas for improvement in re-socialisation are being sought in a joint 
Slovak-French-Finnish project, Improving and broadening the care for the re-socialisation 
and rehabilitation of persons addicted to psychoactive substances. The project includes also 
a development of a proposal of conditions for the provision of professional assistance to 
addicts (so-called quality standards) (for further information see Chapter 1.3 – 
Implementation of policies and strategies) 
  
9.1 Institutional and legal framework for measures directed towards the social 
consequences of drug use 
2006 was the first complete year following the entry into force of the Act on Social and Legal 
Protection of Children and on Social guardianship94 (see also the 2006 Report, Chapter 9 – 
Responses to Social Correlates and Consequences). This law created a framework for 
various forms of field work (e.g. mobile and stationary street work); for new types of 
educational measures (e.g. orders for residence in a re-socialisation centre for minors 
addicted to drugs, to impose a childe to undergo treatment in specialised outpatient care, to 
impose a childe to take part in an educational or social programme); the possibility to 
establish specialised independent groups for children with drug and other dependency in 
children’s homes; the introduction of accreditation and so on.  
In March 2006 the Central Office of Labour, Social Affairs and Family prepared a Concept for 
the Provision of Institutional Care95 focussing on the period 2006–2007 with forecasts for the 
years 2008–2010. The main aims of the concept include the creation of specialised 
independent groups for children with drug and other dependencies96. The planning objectives 
of the Central Office of Labour, Social Affairs and Family propose the establishment of such 
a specialised group for children in every self-governing region by 31st December 2008. The 
concept also includes a timetable for the establishment of such groups so to make it possible 
to address/solve the problem of children with drug and other dependency who have not yet 
reached school-leaving age. It is due to the restriction that having left school is a requirement 
for admission to a re-socialisation centre97.  
 
                                                 
93 Including drug users  
94 September 2005 
95 See Chapter12  Alternative institutional care  
96 The act allows for the creation of six types of specialised independent groups for children including  groups for 
children with drug and other addictions 
97 It must be stated that a children’s home is not just a facility in which institutional care is provided, but other court 
judgements are also executed here – educational measures and interim measures.  
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9.1.1 Social guardianship measures  
 
Basic information on social guardianship (in Slovak, sociálna kuratela) measures are given in 
the 2006 Report, Chapter 9 – Responses to Social Correlates and Consequences.  
In 2006 an analysis was carried out of the activities of the specialised centres of the former 
PPCC98 in preventing drug addiction and facilitating re-socialisation. At present, all Centres 
for Psychological Counselling Services carry out tasks for the social and legal protection of 
children and social guardianship, and the main focus of work in the area of psychological 
counselling services for drug addiction has moved from the area of primary prevention to the 
area of secondary prevention.  
In 2006, 308 children were subject to social guardianship due to drug or other addictions, or 
experimentation with drugs (1.4% of a total of 21 896 children). In comparison with 2005, 
when 363 children were subject to social guardianship for the given reasons (1.71% of the 
total number) there are 55 fewer cases.  
In the studied period, there was only a slight increase in social guardianship related to drug 
addiction or experimentation for people who have already reached the age of maturity  
compared to 2005 (115 out of a total number of 8 559 – 1.34%). In 2006, this measure was 
applied to a 124 persons out of a total of 8 878 (1.39%). Of these, 20 clients had been 
released from health care units after treatment for drug dependency and 27 had completed a 
stay in a re-socialisation centre. The indicator once again takes into account on the primary 
reason for the application of the measures, and therefore does not take into consideration 
the fact that 197 clients (of whom 34 were women) were motivated to treatment for drug or 
another dependency. 
Current legislation allows the active participation of accredited organisations in cooperation 
to implement the educational measures (in Slovak, výchovné opatrenia). There remains a 
problem of a lack of interest among non-state organisations in obtaining accreditation for 
cooperation in the implementation of educational measures, in particular non-residential 
educational measures involved in social guardianship. The relevant authorities ordered 
treatment in specialised outpatient care in 7 cases (pure outpatient care). 38 places in re-
socialisation centres were booked to implement court orders for treatment in such centres in 
2006 (Table 9.1.).  
 
Table 9.1: Provision for the enforcement of court orders in re-socialisation centres in the territory covered by the 
stated office (MLSAF, 2007) 
LSAF Office Provision for the enforcement of court orders in re-socialisation centres 
Bratislava 13 
Trnava 0 
Nitra 2 
Trenčín 10 
Banská Bystrica 3 
Žilina 8 
Košice 2 
Prešov 0 
                                                 
98 The Centre for Psychological Counselling Services for Individuals, Couples and Families. Since the Act 
305/2005 on social and legal protection of children and social guardianship came into force, this centre has been 
incorporated into the Central Office for Labour, Social Affairs and Family as an integral part of the authorities for 
social and legal protection of children and social guardianship. 
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Total 38 
 
Child welfare and social guardianship authorities gave a largely positive appraisal of the 
effectiveness of the new types of measures for children and young people. The programmes 
have been effective, especially where they have been intensive and long term in their 
character (MLSAF, 2007)  
 
9.1.2 Re-socialisation centres 
 
The information given in this section of the chapter is based on the 2006 Annual Report on 
the Implementation of Selected Measures of Social and Legal Child Protection and Social 
guardianship99 and supplementary monitoring by the MLSAF. As at 31st December 2006, 
these measures were implemented in 18 re-socialisation centres for drug users.  
These facilities had an overall capacity of 242 places at the end of the year. 509 clients 
received professional treatment in the facilities in 2006, of whom 338 began the re-
socialisation process in the studied period. (Around 40% of the total number of clients left the 
re-socialisation centre in the course of the year). Out of the total number of clients who 
began re-socialisation programmes in 2006 4.5% were minors (5 girls and 18 boys) and 
women made up 15.6% of the 486 adult clients. Average monthly expenditure per client was 
EUR 448 (SKK 16,679)100. The self-governing regions contributed on average EUR 3,979 
(SKK 148,200) per client per year. 
The average length of the re-socialisation process was 9 months; the first phase of the re-
socialisation process – lasting 7 months – is considered to be disproportionately long 
(MLSAF, 2007).  
On average, 164 clients of re-socialisation centres received a protective allowance each 
month. The protective allowance forms a part of the financial assistance provided to people 
in material need101, who in this case are not able to actively seek work due to their stay in the 
re-socialisation centre. 
According to information obtained in supplementary monitoring by the MLSAF, cooperation 
with the social guardians (in Slovak, sociálni kurátori) is problematic. Of 14 re-socialisation 
centres that responded to the open questionnaire used for supplementary monitoring, 5 
reported that they do not cooperate with social guardians, around a quarter described 
cooperation as being conducted by telephone or else from the text it is clear that cooperation 
is limited to the provision of information for the purposes of receiving material need 
assistance and supplementary allowances to material need assistance.  
 
                                                 
99 In (MLSAF)13-01 
100 Amounts are calculated at the average exchange rate for 2006 according to the National Bank of Slovakia 
(SKK 37.248/EUR),  http://www.nbs.sk/ 
101 Act 599/2003 on material need assistance and the amendment and supplementing of certain acts 
 79
Table 9.2: Selected professional activities provided by re-socialisation centres, MLSAF 2007 
 
A large part of the activity in re-socialisation centres is dedicated to occupational training, 
assistance in finding employment and assistance in acquiring occupational skills. (Table 9.2). 
Occupational therapy, in which the client prepares food under the supervision of the staff, 
makes up a significant part of activities. This method of food preparation is used in 90% of 
facilities. Re-socialisation centres state that cooperation with the client’s family is an 
important part of re-socialisation (through parents’ groups, family therapy in the field and the 
like). 
Monitoring the effectiveness of a re-socialisation programme varies between re-socialisation 
centres, as it did in previous years, particularly in terms of the variety of methods of 
monitoring abstinence after the end of the re-socialisation programme. The re-socialisation 
centres assess the end of the re-socialisation process as successful for around 48% of 
clients out of a total of 337 who completed their stay in a re-socialisation centre in 2006. This 
is usually a re-socialisation programme that is not shorter than 12 months. Information on the 
monitoring of the efficiency of re-socialisation and catamnesis cannot at present be accepted 
as proven given the absence of unified and generally accepted criteria.  
 
9.2 Prevention of drug crime 
9.2.1 Treatment for drug users in prisons 
The Prison and Judicial Guard Corps (hereinafter referred to as “the Corps”) carried out the 
following project in 2006: Reduction of the risk of the penetration of drugs into prisons. 
Activities focussed on the prevention and treatment of drug-related infectious diseases 
included, inter alia, the provision of anonymous means for prisoners on remand and 
convicted prisoners to obtain condoms from dispensing machines in institutions managed by 
the Corps. Sports equipment was purchased for drug-free zones and drug treatment 
departments. Particular attention was given to testing groups of prisoners on remand and 
convicted prisoners for infectious diseases. The Anti-drug Fund allocated financial resources 
for this project amounting to EUR 16,054 (SKK 598,000) for the implementation of selected 
activities within the project. 
464 persons (12.3% more than in 2005) underwent treatment (for alcoholism or drug 
dependency) by court order in facilities managed by the Corps in 2006 and 54 convicted 
prisoners underwent treatment for drug addiction voluntarily (10% more clients than in 2005).  
 
Breakdown by addiction 
Professional activity Number of acts/sessions alcohol 
Heroin and 
other 
opiates 
Other 
types of 
drug 
Non-material 
addiction  
Professional counselling 645 199 190 204 52 
Individual social work 2 381 1 158 433 496 294 
Group social work 3 371 1 130 376 931 270 
Field social work 110 21 31 57 1 
Social work with families 559 150 135 235 39 
Provision of psychotherapy 1 284 595 224 346 119 
Provision of occupational training 99 20 17 60 3 
Assistance in finding employment 336 137 57 111 31 
Assistance in acquiring and increasing 
occupational skills 600 278 89 179 54 
Arrangement of after-treatment for re-
socialisation 444 13 114 262 55 
Monitoring of the effectiveness of re-
socialisation after its completion 611 87 168 301 55 
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9.2.2 Penitentiary and Post-penitentiary treatment 
 
Activities in institutes are followed by activities aimed at ensuring continuity between 
penitentiary and post-penitentiary treatment. Reports giving notice of the forthcoming release 
of a convict from prison are prepared, in which social workers cooperate with Corps trainers 
to specify the results that have been achieved in re-socialisation and to propose 
recommendations for social guardians or probation and mediation officers. 
In addressing social problems, Corps social workers assist convicts in cooperation with 
social guardians, municipal (local) offices, children’s homes, asylum centres and re-
socialisation centres. Social assistance for convicts focuses on their re-socialisation, placing 
great emphasis on developing social skills, forming pro-social behaviour and changing 
attitudes in order to build up elements of independence and responsibility. (See Table 9.3). 
Table 9.3: Overview of numbers of cases in 2006 in which social workers in Corps institutes provided services to 
drug users - convicts (Director General of the PCGC, 2007b)  
Type of preventative activity Number of interventions 
Individual counselling 202 
Group counselling 106 
Arrangement of assistance in resolving a 
convict’s social problem 99 
Providing for post-penitentiary treatment 65 
Preparing a convict for release 123 
Arranging post-prison accommodation 15 
Arranging placement in a re-socialisation 
centre 3 
Other forms of care in cooperation with 
spiritual and pastoral services 21 
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10  Drug Markets 
There were no major changes in the Slovak drug market between 2005 and 2006. All types 
of drugs are usually available. Marijuana continues to be the most widely available. It is used 
mainly by young people aged 15–25. There is increasing interest in stimulants such as 
pervitin (methamphetamine powder) and ecstasy. Increased distribution, consumption and 
production of pervitin were recorded in every region of Slovakia. Trafficking of heroin and 
cocaine remains under the control of the Albanian community and Bratislava remains as ever 
the main source of heroin for users in West and Central Slovakia.  
Drugs seizures increased again, growing by 9.8% compared to 2005, i.e. from 1 702 to 1 868 
seizures. Out of a total of 1 868 seizures, 1 099 were seizures of marijuana, which makes up 
nearly 59% of the total. Drug prices: The prices of marijuana, hashish, cocaine, heroin and 
LSD remained relatively stable in 2006 though there were regional differences. 
Tablets sold as ecstasy were increasingly likely to contain 1-(meta-chlorophenyl)piperazine 
(mCPP) as the main active substance. 10 368 tablets were seized, being sold at a relatively 
low price of EUR 2.7 – 5.4 per tablet (SKK 100-200). 
10.1 Availability and supply  
10.1.1 Perceived availability in the general population  
The general population’s subjective perception of the availability of drugs is indirectly 
mapped in the PORI at SO population survey by the question “Has anyone offered the 
respondent (in the last month, year or previously) for free or for sale” various kinds of drugs. 
This survey showed that the most widely available drug in the studied period was 
marijuana/hashish, which the latest findings suggest has been offered to around 6% of the 
population in the last year. Ecstasy has regularly been in second place since 1998 – the 
proportion of citizens who have been offered this drug is rising gradually, with strongest 
growth being seen amongst young people (15–29). Amphetamines follow marijuana and 
ecstasy in frequency of offers (PORI at SO, 2006). 
The information contained in police reports also confirms the easy availability of marihuana 
and pervitin and the increasing availability of ecstasy, particularly amongst young people 
(Ministry of Interior, 2007a). 
10.1.2 Sources of supply – production and trafficking 
The information given here is drawn from the report of the National Anti-Drug Unit of the 
Organised Crime Office in the Presidium (central headquarters) of the Police Force 
(hereinafter referred to as NADU OCO PPF).  
According to information provided by the NADU OCO PPF, there are several organised 
groups that manage the import, transit and distribution of drugs or precursors. The heads of 
these groups tend to be foreigners. Groups often make use of the illegal drug trade as their 
sole source of income. The funds thereby obtained are invested in the purchase of real 
estate in Slovakia or abroad. The perpetrators of drug crime can be divided into five groups 
according to the subject of their activities: groups engaged in trafficking and distribution of 
heroin; cocaine; production and distribution of pervitin (methamphetamine); trafficking and 
distribution of ecstasy and groups involved in hydroponics grown production of marijuana 
and its distribution.    
Marijuana, whose consumption is increasing in all regions of Slovakia, comes mainly from 
domestic growers. There has been a fall in the amount of cannabis grown in the open; the 
proportion grown using hydroponics continues to rise as this method permits shorter growing 
periods and higher THC levels. Growers operate in organised groups and purchase high 
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quality seeds from abroad. Laboratories are usually built in cellars, warehouses or remote 
locations102. They have the latest equipment and technology for growing plants, e.g. 
humidifiers, lighting equipment, transformers, backup power supplies and the like 
In 2006 a laboratory for hydroponics marijuana cultivation was found, containing 
approximately 460 kg of marijuana at various stages of growth and processing.  It is one of 
the largest seizures in the last 10 years. The laboratory had the same level of furniture and 
equipment as other European laboratories and drugs were to be distributed not only in 
Slovakia but also in neighbouring countries. 
Hashish appears in Slovakia sporadically. The greatest interest in its consumption is 
amongst persons of Arab origin. Compared to 2005 trafficking in this drug remained 
unchanged. 
Most pervitin (methamphetamine powder) was produced locally in 2006. Production is 
increasing and more numbers of people are becoming involved in its production and dealers 
activities. Pervitin is produced mainly in small laboratories so called “kitchen laboratories”103.  
According to the NADU OCO PPF interest in pervitin consumption is rising particularly 
among young people and the lower age limit is falling. Non-invasive methods of consumption 
such as snorting and inhaling are popular. Increased distribution, consumption and 
production are concentrated particularly in East Slovakia. While pervitin was previously 
imported to this region from other areas, even from abroad, production began also in East 
Slovakia (Košice, Rožňava) in 2006. Pervitin is produced from ephedrine or 
pseudoephedrine. Pseudoephedrine is found in medicines registered and sold in Slovakia 
either without prescription (containing 30 mg of pseudoephedrine per tablet) or purchased 
using false prescriptions (containing 120 mg of pseudoephedrine per tablet). In October 2006 
Disophrol repetabs, which contain 120 mg of pseudoephedrine per tablet, became available 
without prescription. Ephedrine for the production of pervitin in Slovakia is trafficked from 
Turkey via Hungary by various organised groups. In 2006 there were also increased seizures 
of Turkish ephedrine (158 992 tablets of the medicine Efedrin Arsan). 
According to information from NADU OCO PPF, heroin consumption has not increased. 
Heroin is imported to/ or transported through Slovakia from Afghanistan and imports and 
distribution are organised by the Albanian community. On the Western and Northern part of 
Slovakia mainly small groups of Wallachian Roma are involved in distribution of heroin; while 
in the Middle part of Slovakia it is the activity of non-Roma organized groups - of Slovak 
citizens. Heroin is mainly sold by dealers operating from their own flats. Heroin is transported 
from Bratislava, where consumption is highest, to other towns in West Slovakia (Sereď, 
Trnava) and Central Slovakia (Banská Bystrica, Žilina). In the Eastern part of Slovakia heroin 
is distributed in a great lower quantities than in other regions.  
Cocaine trafficking, like heroin trafficking, is mainly in the hands of Albanian criminal 
organisations. The price of cocaine is relatively high (the price per gram is approximately 1/3 
of the subsistence minimum) and it is consumed by persons with high incomes. It is 
distributed mainly in larger towns (Bratislava and the surrounding area, also Banská Bystrica 
and Košice), i.e. towns with a wealthier population. Taking into account the growing 
production of pervitin, easier availability of pervitin and its lower price per dose, the decrease 
in the price of cocaine was observed. 
                                                 
102 The laboratories for growing marijuana are changed regularly. They have the latest equipment and technology 
for growing plants, e.g. humidifiers, lighting equipment, transformers, backup power supplies and the like 
103 According to information provided by the NADU OCO PPF, the number of laboratories continues to rise and 
they are hard to detect, despite increased activity on the part of law enforcement authorities. Facilities for the 
production of pervitin, “kitchens” move continuously from place to place, mainly in areas that are seldom 
frequented by people such as allotments and colonies of holiday cottages. Opportunities for pervitin distribution 
are increasing and pressure is growing to increase its quality and reduce prices, thus making it more accessible 
for consumers. 
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Ecstasy consumption has not reached the level found in other countries. It is a popular drug 
at various techno parties, discos and similar forms of entertainment. Ecstasy for Slovak 
consumers is imported mainly from the Netherlands and Hungary104. It is sold in the form of 
tablets but also as powders.   
In street sales a new type of synthetic substance, mCPP, began to appear. It produces 
similar effects to ecstasy, i.e. it is a stimulant. It was sold in the form of tablets with various 
logos. 
10.2 Seizures 
This section of the chapter is based on the data given in standard table 13 for the EMCDDA 
on drug seizures. The information relate to selected types of drug (they do not include 
medicines containing substances listed as banned narcotic and psychotropic substances, or 
cases in which equipment for the production and use of drugs was seized).    
Total seizures increased again in 2006, to 1 868 cases, which represents an increase of 184 
cases compared to 2005. The largest proportion of seizures was of marijuana (58.8%) and 
pervitin (24.6%), seizures of which have been rising since 2002. In terms of quantities 
seized, there was a fall compared to the previous year in all three of the main types of drug: 
marijuana, pervitin and heroin. The number of seizures of cocaine and the quantity of 
cocaine seized were both slightly higher than in the previous year (See Table 10.1).  
13 884 tablets offered as ecstasy were seized in 2006, whereas in 2005 only 2 267 tablets 
were seized. Tablets containing mCPP made up the majority of the amount in 2006 (10 368 
tablets).  
 
Table 10.1: Number of seizures and quantity of drugs seized in Slovakia (ST 13, FEI PF (A. Bolf), 2007) 
2003 2004 2005 2006 
Drug 
Unit of 
quantity No. Quantity No. Quantity No. Quantity No. Quantity 
Marihuana kg 991 619.23 817 1545.47 1039 1172.74 1 099 696.34 
Hashish kg 23 0.11 29 0.96 29 0.27 30 0.54 
Heroin kg 217 7.1 167 2.34 235 3.71 214 2.43 
Cocaine kg 15 0.9 12 1.98 18 0.36 25 0.96 
Pervitin (meth-
ampheamines) kg 157 0.09 280 1.46 326 1.99 459 1.3 
Amphetamines kg 1 0.001 1 0.009 9 0.014 6 6.96 
Ecstasy tablets 20 1 893 37 2387 26 1698 34 13 403 
LSD tablets 7 217 6 207 2 11 1 100 
 
 
                                                 
104 No laboratory for its production has yet been found in our country. The reason for this may be the complicated 
technological process involved in production and the high cost of equipment (driers, tablet makers and the like) for 
such a production facility. 
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Fig. 10.1: Number of seizures of individual types of drug in 2006 in Slovakia (ST 13 FEI PF (A. Bolf), 2007) 
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10.3 Price and purity of drugs  
 
10.3.1 Price  
Information on drug prices are not monitored statistically or recorded in Slovakia. The 
following information is based on information acquired by officers of the NADU OCO PPF on 
active duty. In general it can be said that there has not been a significant change in drug 
prices compared to 2005 (see Table 10.2). 
In 2006 the price of ecstasy fell to a level of EUR 5.4 – 13.4 per tablet (SKK 200–500) from 
EUR 10.7 – 16.1 per tablet (SKK 400–600) in 2005. It would appear that the price of ecstasy 
has been strongly influenced by the decline in purity (the average concentration of MDMA in 
ecstasy has fallen by 28% compared to 2005) and the appearance of a new competitor 
substance mCPP. Tablets containing mCPP were sold mainly for a dumping price of around 
EUR 2.7 (SKK 100) mainly amongst students (with low incomes) for whom mCPP 
represented a financially accessible drug, with a similar stimulating effect to ecstasy. A 
significant “benefit” in sales of this drug was the fact that the active ingredient mCPP was not 
listed as a prohibited substance and therefore its production was not a crime under Slovak 
law.  
Downward pressure on prices was also seen in the case of methamphetamine (pervitín). 
According to information from the NADU OCO PPF, users could buy a dose of pervitin for 
EUR 5.4 – 13.4 (SKK 200–500) in 2006, with the lowest price having dropped by a round 
EUR 2.7 (SKK 100) since 2005 (EUR 8 – 13.4 per dose; SKK 300–500). The reason was 
simple availability; pervitin production is relatively simple and does not require any expensive 
equipment. It is also relatively easy to obtain the ephedrine precursor necessary for its 
preparation (See also chapter 10.1.2 – Sources of supply). 
Table 10.2: Drug prices in 2006 (NADU OCO PPF, 2007) 
Type of drug “Wholesale” price (kg, 1 000 tablets) 
“Retail” price (kg, 1 
tablet) Quantity seized in 2006 
Cannabis resin (hashish) 100 000-150 000/kg  0.536 kg 
Marijuana – plants  50 000 - 100 000/kg 200 - 400 614.48 kg – wet 81.63 kg – dry  
Cocaine 1 000 000 - 2 000 000 / kg 2.000 – 3.000 0.96183 kg 
Brown heroin 400 000–600 000/kg 800 – 1.200 2.43417 kg 
Amphetamines   5 tablets + 0.77 g + 6.95951 kg paste 
Methamphetamines 750 000 - 2 000 000 / kg  1.30378 kg + 4.86 ml 
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solution 
 1 000 doses 1 dose  
Methamphetamines  300 - 500  
MDMA (ecstasy)  400 - 600 8 477 tablets + 1.3 g 
LSD trip  200 - 500 100 
 kg or 1 000 doses gram or 1 dose  
Psilocin   117.15 g 
m-CPP  100 - 300  
Ephedrine   159 357 tablets 
 
10.3.2  Purity  
Drugs seized in Slovakia are analysed by the Forensic Expertise Institute (FEI) of the Police 
Force Presidium in Bratislava and its laboratories in Banská Bystrica and Košice. The central 
register is kept by the FEI in Bratislava. In 2006 the FEI carried out 2 592 quantitative 
analyses of drugs, which was 11.6% more than in 2005 (2 323 analyses) and 34.6% more 
than in 2004 (1 925 analyses).  
A seizure of tablets containing mCPP and a small amount of MDMA caused a fall in the 
average (weighted average) amount of MDMA per tablet in 2006. Since this was the result of 
a single case, the median content of MDMA per tablet remained basically the same as in 
2005.  
The concentration of active substances in heroin has returned to its pre-2004 level (Fig. 10.2) 
According to experts, this may relate to the blockage of distribution channels by means of 
which the drug is imported to Slovakia. On the other hand, there has been a long-term rise in 
the concentration of active substances (median value) in marijuana (7.4% in 2006) and 
pervitin (67.8%), which is even more pronounced in the weighted average – marijuana up 
from 2.6% in 2004 to 6.4% in 2006 and pervitin up from 42.9% to 61.7%. 
In the samples of hashish analysed, there was a fall in the concentration of active 
substances, but an increase in the case of cocaine, although the relatively small number of 
cases means that it is not possible to establish a clear trend.  
Fig. 10.2: Development in median concentration of selected drug types (ST 14 (2002–2006) FEI PF (A. Bolf), 
2007) 
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Table 10.3 Weighted average and median concentration of active substances in selected drugs (ST 14, FEI PF 
(A. Bolf), 2007) 
2004 2005 2006 
Drug 
Concentration of active 
substances in  
Weighted 
average Median 
Weighted 
average Median 
Weighted 
average Median 
Marihuana % THC 2.6 6.2 6.1 7.8 6.4 7.4 
Hashish % THC 15.5 13.1 13.2 12.8 9.8 10.2 
Heroin % 14.4 12.6 12 12.5 8 9.7 
Cocaine % 28.8 32.6 34.8 37.1 45.8 35.3 
Pervitin (meth-
amphetamines
) % 42.9 55.5 46.7 58.3 61.7 67.8 
Ecstasy mg MDMA  per tablet 70.6 72.5 52.7 54.6 14.8 53.9 
 
Fig. 10.3: Number of samples analysed of the stated drug intended for end consumer (ST 14, FEI PF (A. Bolf), 
2007)  
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Part B: Selected Issues  
 
11. Public expenditure  
The objective of the chapter on drug related public expenditure was to provide up-to-date 
information on expenditure attributable to the drug problem in the European Union in a 
unified form and to obtain an estimate of drug-related public expenditure at a national level in 
individual member states.  
The EMCDDA has proposed possible sources and methods for determining drug-related 
expenditure but these cannot be applied in the current conditions in Slovakia in such a way 
as to provide relevant data. An independent study had to be carried out to determine the 
level of drug-related public expenditure, which found that public spending related to drugs 
was approximately EUR 21,316,600 in 2006 (SKK 794,000,000).  
 
11.1  Labelled drug-related expenditures 
One of the possible sources of information for determining the level of financial resources 
spent in response to drug problems are financial year-end reports, budgets and other 
financial documents of government, central governmental organisations etc. for the relevant 
financial year. Such sources can be used only where expenditures are directly labelled in the 
documents, i.e. it is clear from their description that the expenditures related to drugs.  
In Slovakia such sources of information are not available because expenditures are not 
labelled in this way in such documents. Various budgetary and financial documents were 
studied – financial statements submitted to the government, budgets and year-end reports of 
central state administrative bodies, annual reports of various institutions working in the field 
of drugs and so on. Documents at the central level do give values for financial movements in 
the budgetary year but expenditures are usually reported in total without more detailed 
specification e.g. whether they were drug-related. Consultation with experts and the Ministry 
of Finance confirmed that such information cannot be obtained. 
The Ministry of Finance provided us two materials intended for consideration by the National 
Council of the Slovak Republic: Proposed expenditures of budgetary chapters for the years 
2005 to 2007 implemented in the form of programme budgeting105 and the second under the 
same title for the years 2006 to 2008. These documents presented several items of 
expenditure where the description clearly indicated that they related to drugs. They were 
planned expenditures and there is no guarantee that the stated amounts were really spent. 
 
                                                 
105Material for discussion by the National Council of the Slovak Republic, Proposed expenditures of budget 
chapters for the years 2005 to 2007 implemented in the form of programme budgeting, government of the Slovak 
Republic, Bratislava, October 2004, pp. 258 
Material for discussion by the National Council of the Slovak Republic, Proposed expenditures of budget chapters 
for the years 2006 to 2008 implemented in the form of programme budgeting, government of the Slovak Republic, 
Bratislava, October 2005, pp. 335 
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Table 11.1 Planned level of labelled drug related expenditures for programmes in 2005 in thousand EUR – central 
level of government      
Classification Name of programme Amount106 COFOG classification Reuters division 
03. Government Office Coordination (administration) 
Creation and 
implementation of policy NMCD 124 01.3  
 Anti-Drug Fund 1,342 01.1  
Programme-allocated 
expenditures 
Support to the Implementation 
of the 2004–2008 NPFD 322 01.2 
 
21. Ministry of Finance 
9 Treatment
A.079 Prevention and 
health protection 
Health for intravenous drug 
users 22 07.6 
 
B. 07A Health care 
Epidemiological survey and 
evaluation of the effect of 
treatment for drug addicts 14 07.5 
 
 Methadone maintenance 
programmes 14 07.2 
 
C. 07B Creation and 
implementation of policy 
Special programme of 
education and training in the 
field of drug addiction 76 07.6 
 
Total   1,914   
 
It is clear that the stated information and amount EUR 1,914,196 (SKK 71,300,000) is far 
from a reflection of the actual situation. 
 
11.2 Non-labelled drug-related expenditures   
 
It is widely known that drug-related spending is highly concentrated in the sectors of health 
and public order and safety. Such expenditures are not always directly labelled as drug-
related within their sector. The EMCDDA therefore proposed estimating their value using a 
top-down method, i.e. by multiplying total expenditures by the estimated proportion of 
expenditures that are probably attributable to drugs.   
In this method, the calculation of total expenditures on health or public order and safety 
should be based on the international COFOG classification (international classification of the 
functions of government), which is managed for Slovakia by the Statistical Office. The Slovak 
Statistical Office does not publish COFOG data however, and did not provide it even when 
officially requested to do so for the purposes of this Report107.  
 
11.3 Studies carried out at a national level 
 
11.3.1 Study carried out in 2005 
The first comprehensive study of the social and economic costs of drug use in Slovakia was 
carried out in 2005 by prof. Cindy Fazey (as part of the Phare project, 2003). The study’s 
preliminary results were included in the 2005 Report in Chapter 1.3 – Budget and public 
expenditures. This chapter uses the corrected data from the final version published in 
January 2006108. The study was based on the acquisition of data using a combination of 
bottom-up and top-down methods. Ministries, state institutions, foundations and funds active 
in the field of drugs were contacted and asked to calculate their drug-related expenditures. 
The collected data related to 2004 and where this was not available data for 2003 or 2002 
                                                 
106 Amounts are calculated at the average exchange rate for 2006 according to the National Bank of Slovakia 
(SKK 37.248/EUR),  http://www.nbs.sk/ 
107 in a personal conversation, it was suggested that the data was not provided because the collected data was 
unreliable   
108 The 2005 Report contained preliminary results of the study as at September 2005. They do not correspond to 
the data given in this chapter, which are drawn from Prof. Cindy Fazey’s final report of January 2006. 
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was used (Fazey C., 2006). Ratio of expenditures: supply reduction vs. demand reduction 
was approximately 57%: 43% in 2004. 
 
Table 11.2: Annual drug related expenditure by area in 2004 (Fazey C., 2006) 
Sector SKK EUR 
Administration 12,878,500 327,906 
Health 84,242,932 2,144,951 
*Education - prevention 158,204,513 4,028,123 
*Re-socialisation 26,923,748 685,519 
Public order and safety - police 144,483,700 3,678,770 
Public order and safety - prisons 94,663,010 2,410,261 
Public order and safety - customs 121,068,572 3,082,586 
Total 644,691,575 16,358,116 
* Double reporting in the areas of education and re-socialisation is possible. Around 40% of funding for prevention 
programmes was spent on sports activities for school-age children (Fazey C, 2006).  
 
Table 11.3.: Current annual drug related expenditures in Slovakia in 2004 (Fazey C., 2006) 
Organisation SKK EUR 
General Secretariat and NMCD 12,878,500 327,906 
Anti-drug fund 50,852,208 1,294,773 
Ministry of Health 77,762,335 1,979,945 
Ministry of Labour, Social Affairs and Family 19,528,640 497,228 
Ministry of Education 120,837,010 3,076,690 
Ministry of Culture 355,000 9,039 
Ministry of Interior  137,082,653 3,490,329 
Ministry of Transport, Posts and Telecommunications 1,337,887 34,065 
Ministry of Defence 6,063,160 154,377 
Ministry of Finance (customs directorate) 121,068,572 3,082,586 
Ministry of Justice 96,889,610 2,466,954 
Other sources of funding (including NGOs and the EU) 55,723,456 1,419,402 
Total 700,379,031 17,832,693 
 
The difference between the two total EUR 17,832,693 and EUR 16,358,116 may be due to 
double counting in relation to the financing of NGOs (Fazey C., 2006).  
 
11.3.2  Study carried out in 2007 
There was a new data collection in 2007 to map the situation in financing drug-related issues 
in Slovakia and to seek ways and means of estimating the level of drug-related expenditures. 
Again, all central institutions were contacted with the aim of obtaining up-to-date information. 
Data on treatment expenditures were obtained from health insurance companies. In addition 
to providing information for EMCDDA – for the purposes of this chapter, it is also planned to 
use the collected data as a basis for the creation of Rules for the financing of drug policy in 
Slovakia (see Chapter 1.2.2.1 – National drug strategy). 
The tables below update the information from Professor Fazey’s earlier study. The obtained 
information represents only a gross and limited estimate of drug-related expenditures in 
2006.  
Comparability of the information is complicated by a number of factors:  
- information was also provided by ministries that were unable to provide estimates three 
years ago (e.g. the Office of the Prosecutor General) while on the other hand some 
ministries no longer reported a drug-related expenditures  
- data were provided in another item structure (e.g. concerning the Ministry of Education 
there was a large difference (“fall”) in declared drug-related expenditures. This was 
caused by the exclusion of expenditures on such items as: free time centres, sports 
activities for children and young people and similar activities that cannot be directly 
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classified as drug-related expenditures. The Ministry of Justice included a share of 
expenditure on prisons for staff, dogs and so on that had not been taken into 
consideration in the previous study. The MLSAF included items that could not be valued 
previously such as the proportion of payroll expenses attributable to drugs in relation to 
social guardianship activities, counselling and psychological services, protective 
allowances provided during re-socialisation etc.  
- due to the great complexity of estimating drug-related expenditures, individual ministries 
took various approaches in calculating this expenditures, and so on. 
Moreover some large movements in expenditure upwards or downwards in individual 
ministries compared to the previous study are due to the implementation or completion of 
larger European projects (e.g. in the Ministry of Finance, Support for the Implementation of 
the NPFD, project Equal, etc.) 
Future calculations of drug-related expenditures will require the development of a clear 
methodology and procedure for calculations in order to ensure standardised and reliable 
data.  
 
Table 11.4.: Drug-related expenditure in 2006 by sector (NMCD, 2007e) 
Organisation SKK EUR 
General Secretariat and NMCD 12,057,993 323,722 
Anti-drug fund 4,900,000 1,315,507 
Ministry of Health 91,356,120 2,452,645 
Ministry of Labour, Social Affairs and Family 36,319,498 975,072 
Ministry of Education 8,619,600 231,411 
Ministry of Culture 1,088,133 29,213 
Ministry of Interior  188,548,000 5,061,963 
Ministry of Transport, Posts and Telecommunications - - 
Ministry of Agriculture 661,771 17,767 
Ministry of Defence 10,314,680 276,919 
Ministry of Finance (customs directorate) 20,925,954 561,801 
Ministry of Justice 267,921,154 7,192,900 
Prosecutor General  25,230,834 677,374 
Statistical Office 743,485 19,960 
Other* 81,945,600 2,200,000 
Total 794,998,288 21,343,382 
*includes expenditures in the project Support to the Implementation of the NPFD, which could not be assigned to 
individual categories. 
 
Table 11.5.: Drug-related expenditures by area in 2006 (NMCD, 2007e) 
Sector SKK EUR 
Coordination (administration) 13,956,871 374,701
Prevention  60,620,387 1,627,480
Treatment  117,629,244 3,158,002
Harm-reduction 6,904,827 185,374
Education (science, research) 9,924,202 266,436
Public order and safety 502,631,942 13,494,199
Other* 81,945,600 2,200,000
Total 793,613,073 21,306,193
*includes expenditures in the project Support to the Implementation of the NPFD, which could not be assigned to 
individual categories. 
Note: the item Education (science, research) includes mainly educational expenditures 
 
Once again there is a small difference between the two totals EUR 21,300,000 and 
EUR 21,340,000. This may be caused by double counting of projects supported by the Anti-
drug fund in some ministries.  
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The ratio of expenditures on supply reduction (public order and safety) to expenditures on 
demand reduction (prevention, treatment, and harm-reduction) is approximately 70: 30%. 
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12 Vulnerable groups of young people   
The objective of this chapter is to present information on the extent of drug use and the 
related problems in vulnerable groups, on profiles and risk factors for the vulnerability of such 
groups, to present socio-demographic characteristics and to map existing and new measures 
relating to vulnerable groups.  
Vulnerable groups are understood as individuals linked by one dominant risk factor: e.g. an 
internal risk factor (ADHD, personality disorders, behavioural disorders) or external factor 
related to the environmental context (socially, economically and culturally disadvantaged 
environments, environments with high drug availability) or a lack of close emotional and 
social relations (family) or their broader social surroundings (peers). This categorisation into 
groups according to one dominant risk factor is more a tool for orientation purposes than an 
accurate reflection of the real situation and in this context expresses more the current 
situation of the individual rather than a causal relationship with drug use. 
The chapter presents descriptive information on drug use in certain groups (minors in 
children’s homes, in special care institutions and for visitors to various music and dance 
events – IIPE surveys) and information from three cycles of the ESPAD survey in Slovakia, 
showing the level of affinity to experimentation with drugs in the studied groups.  
For other vulnerable groups there is little or no information available on the prevalence of use 
from surveys or studies. The same situation exists with regard to specific selective 
prevention programmes. Despite this fact, such groups are not ignored and measures are 
targeted at such groups to reduce, eliminate or teach better coping strategies for the primary 
risk factors. From this point of view, the most comprehensive interventions are aimed at 
children and minors and the Roma national minority, towards whom the state, local 
government and non-governmental organisations direct most of their systematic measures.    
12.1 Epidemiology related to vulnerable groups (prevalence, patterns of use; 
risks, correlates and consequences) 
 
12.1.1 Definitions and profile of vulnerable groups 
 
In Slovakia there are no standard definitions for individual vulnerable groups. The National 
Plan for Social Inclusion defines vulnerable (marginalised, disadvantaged) groups as people 
who are threatened by poverty or social exclusion.  
 
12.1.2 Drug use and problem drug use in vulnerable groups 
 
12.1.2.1 Children and young people living in surrogate institutional care – children’s 
homes  
In the event of a breakdown of family care for whatever reason, the state shall take over 
responsibility for care. Surrogate institutional care establishments – children’s homes and 
homes for young people are a social service and fall within the competence of the Ministry of 
Labour, Social Affairs and Family.   
 
The IIPE carried out a survey of this group in 2000 which covered the use of legal and illegal 
drugs (Pétiová M. et al., 2000). The survey studied the opinions and attitudes of young 
people (aged 15–19) to drug use in 36 selected children’s homes. The results were 
compared with data acquired in a relevant age sub-group from a regularly repeated youth 
survey among 15–26 years old (see for example Chapter 2.2.2 – Youth (15-26) surveys). 
The sample group in the children’s home consisted of 425 children in care of whom 54.8% 
were boys and 45.2% were girls. 80.2% of respondents were aged 15–17; the others were 
aged 18–19 years. 60.9% of respondents lived in institution-type children’s homes, the 
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remainder grew up in family-type children’s homes. The control group (250 respondents) in 
the 15–17 age group was a sub-group of respondents of the regular IIPE youth survey of 15–
26 age group.  
Table 12.1: Data for selected questions from the survey in children’s homes in the 15–17 age group in % (Pétiová 
M. et al., 2000)  
 Children’s homes 
N=425 
Control group 
N=250 
Occasional smoking 11.8 18.8 
Daily smoking  44.6 17.6 
Occasional consumption of alcohol 65.3 57.2 
Daily consumption of alcohol 0.7 0.8 
Gambling  –  only tried playing slot machines 36.9 30.1 
Gambling – gamble frequently  1.2 0.4 
Respondents whose friends have tried drugs 57.9 54.8 
Personal experience of drug use  30.8 17.2 
Age at first use of drug 13-16 15-16 
Number of kinds of drugs tried 10 4 
Order of drugs most frequently tried 1.marijuana 
2.volatile substances 
3.tablets  
4.hashish 
1.marijuana  
2.tablets 
3.hashish 
4.volatile substances  
 
For children in children’s homes, there is greater prevalence of regular smoking, 
experimentation with drugs, a lower age at first use and a broader range of drugs tried. 
Another interesting finding is the information on the evaluation of positive relations with 
siblings. 49.8% of respondents assessed their relationship with their siblings as being very 
good, whereas in the control group only 14.9% declared such a quality of relations.  
 
12.1.2.2 Children and young people in protective educational institutions – re-
education homes 
Re-education homes and diagnostic centres are among the special educational facilities 
under the Ministry of Education, which play a role in protecting children against anti-social 
influences and in the prevention of developmental problems in children, in the prevention of 
delinquency in children and play role implementing provisions of institutional and protective 
education.   
 
The study “Opinions and attitudes of young people living in diagnostic centres and in re-
education homes for youth concerning drug consumption” (IIPE, 2005) studied not only the 
current situation but compared the development of opinions, attitudes and personal 
experience of drug use over a period of 7 years in the institutional education environment109. 
In 1998, the study had a sample of 469 young people aged 16–18. The sample in 2005 was 
smaller (304) and the age range was broader (15–19 years). A comparison of the data 
shows a slight increase in experimentation with drugs among young people in re-education 
homes over seven years and a reduction in the lower limit for the age of first contact with 
drugs. 
                                                 
109 The 2006 Report ( pp. 29-31) presents the results of a survey carried out in re-education homes in 1998 and 
2005 with a “control” group from the regular IIPE youth survey  
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Table 12.2: Comparison of results for selected survey questions in re-education homes in % (Pétiová M. et al., 
2005) 
 1998 
8 establishments 
N=469  (16–18 years) 
2005 
10 establishments 
N=304 (15-19 years) 
Occasional smoking 8.7 10.2 
Daily smoking   82.7 72.7 
Occasional consumption of alcohol 60.1 60.2 
Daily consumption of alcohol  11.3 8.9 
Gambling - only tried playing slot machines 43.1 30.3 
Gambling - gamble frequently  10.9 7.6 
Experience of use of illegal drugs  66.2 72.0 
Experience of use of at least one drug   31.9 31.9 
Experience of the use of 4 or more drugs 15.2 45.7 
Age of first experimentation with drugs 12-14 9-14 
 
The information acquired in the 6 IIPE surveys, despite a degree of simplification and limits 
relating to the differences in age groups and years of survey, show differences between 
groups in different educational environments in terms of their experience with illegal drugs. 
 
Fig. 12.1: Comparison of lifetime prevalence of drug use according to youth survey (15–17), children in children’s 
homes (15–17), and in re-education homes (15–18 and 16–18) 
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12.1.2.3 Incomplete elementary education – school drop out 
There is no information available on studies carried out on the epidemiology of drug use in 
this group. This group is not monitored in educational statistics.  
     
12.1.2.4 Young people in families where alcohol or drugs are used 
There is no information available on studies carried out on the epidemiology of drug use in 
this group.  
 
12.1.2.5 Young homeless people 
Homelessness is one of the indicators of poverty110. An individual suffering from 
homelessness suffers from the loss of a home, which is not the same as the loss of 
accommodation. A homeless person may have shelter (a hostel, a night shelter, an 
                                                 
110 http://www.socionet.sk/index.php?kat=013&opn=opn – accessed 12 July 2007  
 95
abandoned house, a shed or the like) but this does not create a suitable environment for 
establishing social relations that are formed in a home environment. In this definition of 
home, basic social relations are formed within the family, the workplace or with likeminded 
groups. A home is necessary for the establishment and maintenance of such relationships. 
In Slovakia young homeless people are a community on whom the amount of research or 
statistical information available is minimal. It is generally thought that the homeless consume 
mainly legally available cigarettes and alcohol. In a local study in Nitra, 66.4% of homeless 
people were dependent on alcohol, 92.9% smoked tobacco and 7.9% used other 
psychoactive substances (Kasanová A., 2007). For further information see chapter 8.1.1 – 
Homelessness and drug use. It is further thought that homeless young people are most often 
former residents of children’s homes who are required to leave these establishments when 
they cease to be minors111.  
 
12.1.2.6 Young offenders 
The term delinquent (in Slovak terminology the perpetrator of a crime) is used at various 
levels of public order and safety processes – arrest, prosecution, and sentencing. 
 
Epidemiological or qualitative information on young offenders is minimal. The group of young 
offenders (aged 14–18) is heterogeneous in the different phases of the repressive process 
(arrest, prosecution and sentencing). The social characteristics of the arrested and 
sentenced groups of young people are not available from the statistics published by law 
enforcement institutions.    
Convictions of young offenders made up 6.15% (1584) of all convictions in 2006. The largest 
numbers of convictions of young people were in the two eastern Slovak regions Prešov 
and Košice112, and were mostly for property crime (theft) (Ministry of Justice, 2006). It can be 
presumed that many property crimes are motivated by the desire to obtain resources for 
drugs but this cannot be confirmed at present because such information is not yet reported in 
Slovakia113.  
There is one foreign study114, which gathered data on drug use, treatment and the availability 
of drugs in prison by means of the RAR or focus group method. It does not however give 
information on the characteristics of this group. General information on drug related crime 
(see chapter 8.2 – Drug related crime, and chapter 10 – Drug market).  
 
12.1.2.7 Young people in socially disadvantaged environments with high availability of 
drugs 
Specific studies are not available. It is possible to observe the dissatisfaction of citizens in 
certain urban areas about the availability of drugs and the concentration of persons with 
high-risk behaviour (drug users, dealers, sex workers, thieves) in their vicinity. This applies 
particularly in Bratislava115 in parts of the Petržalka and Vrakuňa districts. These two districts 
of Bratislava permanently have the highest number of persons in treatment per 100 000 
inhabitants (196.2 per 100 000 inhabitants in Petržalka and 206.6 per 100 000 in Bratislava 
                                                 
111 www.socionet.sk  
112 Both regions are amongst the most populous (14.3% and 14.6% of the total population), with the highest 
natural growth rate ( 3.73 and 2.21 compared to the average for Slovakia as a whole of 0.18) and currently they 
have the highest rate of unemployment (Košice region 20.3% and Prešov region 18.1% compared to the average 
for Slovakia as a whole 13.3%) (www.statistics.sk)  
113 The first extensive survey of drug-related property crime is in preparation. 
114 MacDonald et al: Juveniles in Secure Settings: Services for problematic drug and alcohol users, November 
2006  
115 The PORI SO population survey particularly studies the prevalence of drug use amongst young people in 
Bratislava aged 15–29. In 2006 the proportion of young people in Bratislava with experience of illegal drugs was 
36%, which is the highest rate ever in any cycle of the survey and any sub-group. ( SR 18+ = 13%, young people 
in Slovakia aged 15–29 = 29%) (SO, 2006) 
 96
II). The average for Slovakia as a whole in 2006 was 35.5 in treatment per 100 000 
inhabitants; the average for the Bratislava region is 132.2 (NHIC and NMCD, 2007). 
       
12.1.2.8 Ethnic minorities  
The ethnic factor alone is not an indicator of vulnerability. The socio-cultural norms of a 
particular ethnic group or its living conditions may combine with other factors to produce 
higher vulnerability as a synergistic effect. A large part of the Roma population in Slovakia 
live in the eastern Slovak regions of Prešov and Košice in segregated osadas (rural 
settlements) with a low standard of accommodation and an ecologically hazardous 
environment. The low level of education, a lack of standards for personal and communal 
hygiene, unhealthy eating habits, higher consumption of alcohol and tobacco products (also 
during pregnancy) together with increasing rates of drug addiction and a higher risk of HIV 
infection and type B and C hepatitis are the main determinants of the poor health condition of 
the Roma population (Pavúk A., 2007). 
Biomedical research in eastern Slovakia has focussed on the prevalence of smoking among 
pregnant women in the majority population and among Roma women and its influence on the 
course of pregnancy, birth and the condition of the child at birth. For the purposes of this part 
of the report we present information on smoking – addiction to tobacco amongst young 
people belonging to the national minority. 
The survey population comprised 1 992 women, of whom 616 came from the Roma minority 
and 1 376 from the majority population. The women came from six districts in eastern 
Slovakia (Bardejov, Humenné, Prešov, Rožňava, Trebišov and Vranov nad Topľou).  
The Roma mothers were significantly younger (40% of the Roma women were in the 15–20 
age group compared to 13% of the majority population in the same age group); most of the 
women had elementary or incomplete education (57.4%). 60% of the Roma women smoked 
during pregnancy and a quarter of the women from the majority population. With increasing 
age the prevalence of smoking among the Roma mothers also increased: 55.2% in the 
youngest age group (15–20 years); 73.1% for those aged over 31. Roma women who 
smoked did not significantly reduce their smoking during pregnancy and smoked just as 
intensively as before they became pregnant. Only a third of Roma mothers stated that they 
intended to give up smoking after giving birth, in contrast to the majority, where nearly three 
quarters declared such an intention. The largest number of premature births was recorded 
for Roma smokers, and the least among non-smokers in the majority population116. The 
greatest occurrence of children with a low birth weight (lower than 2 500g) was among Roma 
women who smoked, who had nearly twice as many children with delayed prenatal physical 
development as smokers in the majority population (Pavúk A., 2007). 
 
12.1.2.9   Party goers 
An IIPE (2003) survey on use of synthetic drugs among young people in secondary schools 
(720 respondents aged 15–18 years) found that 27.2% of young people in this age group 
(196) had experience of at least one type of drug, usually marijuana.  
80% of those who have tried drugs visit various kinds of music “party”. Most of them like 
music in the styles of techno, house or hip-hop while respondents without any experience of 
drug use prefer to listen to popular music. Compared to groups with no drug experience, 
those who experiment with drugs were more likely to come into contact with persons who 
use synthetic drugs and were more likely to be offered drugs at such events.  Many 
respondents expressed the opinion that it was part of the atmosphere of such events (clubs, 
discos etc.) to consume synthetic drugs.  
                                                 
116 The differences are statistically significant 
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34 respondents (4.4%) had tried synthetic drugs (ecstasy, LSD, pervitin (methamphetamine 
powder)). These respondents were frequent party goers, had significantly more information 
about synthetic drugs than other respondents and nearly half of them knew someone who 
also used synthetic drugs (IIPE 2003). 
As in the NMCD survey (2006), where socially integrated (the economically active and 
students of universities and secondary schools) club and disco goers made up 90% of the 
clientele, the IIPE survey found that most secondary school students who were party goers 
did not belong to marginalised groups. 
 
12.1.3 Drug use in relation to other risk factors    
 
12.1.3.1 Family   
The healthy and functioning family is the primary protective factor in the emotional 
development of the individual. The family can, however, also function as a risk environment 
at a number of levels: A family with an addicted sibling will function differently from one 
where one or both parents are addicted to psychoactive substances; development of a child 
may be affected by the divorce of the parents, change in the economic status of the family 
resulting from unemployment, parents lacking time, excessively liberal upbringing and a lack 
of interest in how children spend their free time etc. In most of the population, school and 
youth surveys study family background by asking about relations with parents. In the vast 
majority of surveys these are assessed as good or very good.  
Incomplete families and changed families in relation to experimentation with drugs  
According to Nociar (2004) it is a psychologically important factor whether a family is 
complete or incomplete. All three previous waves of ESPAD in Slovakia have studied the 
relationship between family completeness and the use of psychoactive substances. Over 8 
years the numbers of complete and changed families have been relatively stable but the 
number of incomplete families, i.e. single-parent families has nearly doubled. 
Table 12.3: Number of complete, changed and incomplete families according to ESPAD research for the 15–19 
age group (Nociar A., 2004) 
 Size of full 
population 
Complete 
families 
Changed 
families 
Incomplete 
family – single 
parent 
Other type / no 
data 
ESPAD 1995 8 179 83.1 È 4.3 È 6.1 n/a 
ESPAD 1999 7 975 82.6 4.0 9.9 n/a 
ESPAD 2003 11 287 80.2 4.0 11.6 Ç 4.2 
 
The relation between the lifetime prevalence of the use of any drug117 and family 
completeness is shown by the following figure 12.2. The greatest risk is associated with 
changed families, i.e. families with one real parent and one stepparent and then single-
parent families. 
 
                                                 
117 The following drugs are covered: marijuana, amphetamines, LSD and hallucinogens, crack, cocaine, heroin, 
ecstasy.  
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Fig.12.2 Lifetime prevalence of illegal drugs in individual waves of the ESPAD survey in 1995, 1999 a 2003 
(Nociar A., 2004) 
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Table12.4 Summary of the results of the ESPAD 2003 with regard to the consumption of legal and illegal drugs in 
% (Nociar A., 2004) 
ESPAD 2003 Composition of household* 
 N = 11 287  Boys Girls All students 
  Complete Changed 
Incompl
ete 
Comp
lete Changed
Incompl
ete 
Comple
te Changed
Incompl
ete 
Other drugs, lifetime prevalence 
Any illegal drug 42.5 61.5 50 27.6 39.7 36.6 34.2 46.8 42
Any illegal drug other 
than marihuana 9.5 17.9 10.7 6.2 9.6 10.9 7.7 12.7 10.8
Marijuana or hashish 42.1 61.5 49.6 27.2 35.8 35.1 33.8 45.5 41
Amphetamines 3.9 12.7 4.8 2.5 4.7 4.6 3.1 7.7 4.7
Ecstasy 6.4 13.1 8 4.1 5 6.8 5.1 8 7.3
Alcohol and tablets 16.5 25.9 18 20 26.2 25.3 18.5 26.1 22.4
Inhalants 10.5 14.8 14.1 6.6 8.5 8.4 8.3 10.9 10.7
 
The results of the ESPAD survey confirmed the risk effect of an incomplete or changed 
family. Over eight years, however, the prevalence of drug use has also increased among 
children from complete families although the situation is relatively less disturbed in relation to 
legal and illegal drugs (Nociar A., 2004). 
Absence of parental supervision  
The information in Table 12.5 shows that the risk of experimentation with legal or illegal 
drugs associated with the absence of parental supervision is increasing in real terms. Two 
cycles of the ESPAD survey have studied this risk through questions on whether parents 
know where their son/daughter spends his/her Saturday evenings. The values for the 
prevalence of legal/illegal drug use are higher where parents know only occasionally or 
usually do not know where there child spends Saturday evenings. 
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Table 12.5: Use of psychoactive substances in relation to the absence of parental supervision for the 15–16 age 
group (Nociar A, 2004) 
 ESPAD 1999 ESPAD 2003 
 
Drug 
  
Always 
know 
Usually 
know 
Some-
times 
know 
Usually 
don’t 
know 
  
Always 
know 
Usually 
know 
Some-
times 
know 
Usually 
don’t 
know 
Cigarettes: 30 days 22.6* 47.1 63.4 67.2 25.4* 42.5 62 66.7 
Use of alcohol 
Last 30 days 48.8* 70.6 76.6 80 51.9* 73.9 75.6 77.6 
5 or more times in the last 30 
days 20.1* 37.9 55.3 53.8 28.5* 50.1 61.6 65.5 
Drunk in the last 30 days 15.9* 31.4 45 61.4 21.0* 38.1 49 52.8 
Drunk in the last 12 months 35.9* 62.2 75.3 80.3 41.7* 72.3 80.1 81.9 
Other kinds of drugs         
Cannabis in the last 12 months 6.6* 19.5 29.6 38.9 11.4* 23.4 37.3 37 
LSD, hallucinogens – LTP  1.1* 3.1 6.3 9.9 1.0* 2.1 5 2 
Ecstasy – LTP  0.7* 1.6 3.7 4.6 1.4* 2.8 8.3 6.8 
Amphetamines – LTP   0.3* 1 3.3 1.5 1.2* 2.2 4.3 2 
* On analysis of variance, the difference of 4 averages (Scheffé test) significant at p>0 001 
Table 12.6: Use of psychoactive substances in relation to the absence of parental supervision for the 17–18 age 
group (Nociar A, 2004) 
ESPAD 1999 ESPAD 2003 Drug 
  
Always 
know 
Usually 
know 
Some-
times 
know 
Usually 
don’t 
know 
  
Always 
know 
Usually 
know 
Some-
times 
know 
Usually 
don’t 
know 
Cigarettes: 30 days 31.3* 47.1 63.9 70.5 31.3* 47.4 63.9 49.7 
Use of alcohol  
Last 30 days 61.2* 78.7 81.6 81 61.2* 69.8 82.6 74 
5 or more times in the last 30 
days 26.0* 42.7 61.2 59.3 47.1* 49.1 64 52.6 
Drunk in the last 0 days 20.8* 39.3 52.6 55.3 38.5* 39.7 54.6 44.4 
Drunk in the last 12 months 46.3* 70.2 83.7 84.3 67.3* 69.1 83.4 71.9 
Other kinds of drugs 
Cannabis in the last 12 months 11.1* 22.5 32 45.4 24.6* 25.8 37.1 27.3 
LSD, hallucinogens - LTP  2.0* 4.4 4.5 15.1 3.2* 4.5 5.5 3.6 
Ecstasy - LTP  1.1* 1.5 1.9 9.7 6.0* 6.7 10.7 7.2 
Amphetamines - LTP   1.1* 2.4 2.3 10.2 3.3* 3.7 6 4.1 
* On analysis of variance, the difference of 4 averages (Scheffé test) significant at p>0 001 
Drug use by older siblings and friends 
Long-term monitoring in three waves of the ESPAD survey show that the close social 
surroundings of students in the 15–16 age group (and the 17–18 age group) represents a 
risk factor given the constant increase in the use of legal and illegal drugs among their older 
siblings and particularly among their peers.  
A question on drug use by older siblings of respondents aged 15–16 was included in the 
1999 and 2003 surveys. The results of the survey show a slight increase in the number of 
older siblings using marijuana. Use of tranquilisers and sedatives by siblings had increased 
four-fold (from 1.4% to 5.9%). The increase in ecstasy use was greater – nine-fold (from 
0.7% to 6.5%).  
The ESPAD data shows a greater increase in the use of legal and illegal drugs among the 
friends of respondents in the 1995–2003 period. From 1995 to 2003 the proportion of the 
friends of respondents in the 15–16 age group who had used marijuana/hashish rose from 
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2.8% to 20%, i.e. nearly seven-fold. Use of ecstasy among friends grew to thirteen times the 
initial rate in eight years (from 0.3% to 3.9%); among girls the increase was six times the 
initial rate.   
 
12.1.3.2 Truancy  
According to Nociar (2004), truancy is sometimes interpreted as one of the signs of problem 
behaviour in students, experimentation with drugs or their frequent use. Each of the cycles of 
ESPAD has included questions on unexcused absence from school in the last 30 days. 
Between 1995 and 2003 there was a rise in the number of students who missed 1–2 days 
and 3 or more days without a real reason. The results confirmed the correlation between 
declared use of psychoactive substances and truancy. There was a statistically significant 
difference (p >0.001) between them and those who attend school regularly. There were also 
significant differences between groups of students who missed 1–2 days and those who 
missed 3 or more days. 
 
Table 12.7: Use of psychoactive substances in the 15–16 age group in relation to truancy.  (Nociar A., 2004) 
ESPAD 1995 ESPAD 1999 ESPAD 2003 
Drug Regular 
attendance Truants 
Regular 
attendance Truants 
Regular 
attendance Truants 
Cigarettes: 30 days 30.6* 47.3 39.9* 60.7 34.9* 62.3 
Use of alcohol 
Last 30 days 53.1* 67.5 63.2* 76.1 61.2* 79.3 
5 or more times in the last 30 days 31.8* 47.3 31.9* 49.5 38.7* 59.6 
Drunk in the last 30 days 21.0* 34.2 28.1* 45.3 28.6* 52.8 
Drunk in the last 12 months 43.2* 62.6 52.9* 73 55.1* 79.2 
Other kinds of drugs 
Cannabis in the last 12 months 6.6* 14.5 16.2* 25.4 18.2* 36.2 
LSD, hallucinogens - LTP 0.6 1.1 2.7* 6.2 1.5* 4.7  
Ecstasy - LTP  0.5 0.4 1.5* 3.4 2.6 7.9 
Amphetamines - LTP  0.7* 1.3 0.7* 2.2 1.8 4.7 
 
The IIPE collects and processes statistical data on truancy in terms of the number of 
unexcused hours missed and problem behaviour of pupils as represented by reduced marks 
for behaviour118. Information provided for the previous NMCD report shows a slight rise in the 
number of unexcused hours of absence per pupil. To be precise, in the second stage of 
elementary school (children aged 10–15) the average number of hours increased from 2.9 
hours per pupil in 1998 to 5.4 hours in 2005–2006. Truancy in secondary vocational schools 
(15–19 years) has been monitored since 2002. In that year the average was 8.2 hours per 
student, rising to 12.2 hours in 2005–2006. In selective secondary schools trend is stable, 
according to the data provided by statistical registers. 
Truancy may be a part of problem behaviour which is recorded in terms of reduced marks for 
behaviour. Reduced marks for behaviour are recorded most frequently in the second stage of 
elementary school and in secondary vocational schools. Since 2002, the proportion of pupils 
in the second stage of elementary school with reduced mark for behaviour has increased 
from 3.9% to 4.4% in the 2005–2006 school year (in absolute terms, 13 553 children aged 
10–15 years). The same trend is observed in secondary vocational schools where the 
proportion has increased from 11.7% to 16.5% (9 784 students aged 15–19). 
In 2005, a survey studied the truancy in special educational institutions – re-education homes 
(Pétiová M. et al. 2005). In a sample of 304 young people aged 15–19, nearly half (49%) 
admitted to frequently playing truant from school. The reason given was a lack of interest in 
their studies and an attempt to be the same as peers. Girls were more worried than boys 
                                                 
118 Slovíková,M., Dugovičová,M. (2007) 
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about punishment for failing to attend school as required. Some characteristics of this 
population have been given in Table 12.2 – it is a group where on average 72% of 
respondents admitted personal experience of illegal drugs.   
 
12.1.4 Vulnerable groups amongst drug users in treatment   
Information on the population of drug users receiving treatment does not track membership 
to an ethnic minority or other national, linguistic or cultural minority. The reporting form on the 
treatment of drug users processed by the NHIC monitor certain socio-demographic and 
economic characteristics of persons treated: Age, gender, family status, character of 
contacts with treatment units (under this heading come items like: social services or law 
enforcement agencies as the initiators of contact), education, economic activity, 
accommodation situation (stable accommodation) and also information on who the client 
lives with (alone, with a drug user etc.) This information precisely copies the EMCDDA TDI 
(treatment demand indicator) methodology. Information on drug users receiving treatment 
and their characteristics are given in Chapter 4.2 – Treatment Demand Indicator. In this part 
we present information only with relevance to certain risk factors. 
Out of a total of 1 927 users receiving treatment, 89% were aged 34 or under (young adults). 
In 13% of all treated users law enforcement and judicial authorities (a court, prosecutors, the 
police) were the initiators of a contact of health care unit and social services created contact 
in 18 cases, where it is likely that minors were involved119. 1.7% of persons receiving 
treatment in 2006 lived in households only with a child – which represents two risk factors at 
once for the child – a parent addicted to psychoactive substances and an incomplete family. 
170 patients (8.8%) admitted living with a person who used drugs; no answer was given in 
138 cases. 4.2% had not completed elementary education. Among those receiving treatment 
aged under 35, men clearly predominated in a ratio of 4:1 (Table12.8)  
 
Table 12.8: Ratio of men and women in treatment by age group in 2006 (NHIC and NMCD, 2007) 
Age 0-14 15 - 19 20-24 25-29  30-34 Under 35 total  
Men  27 292 448 413 189 1369 
Women  10   89 120   86   39   344 
Total 37 381 568 499 228 1713 
Ratio M:F 1: 2.7 1: 3.3 1.3.8 1:4.8 1:5 1:3.9 
 
In all age sub-groups other than the youngest (children aged under 15), there was a fall in 
the number of persons receiving treatment. Out of 37 children who were treated, 15 (40%) 
were from Košice region and received treatment most frequently for problems with volatile 
substances (10 cases).   
 
12.2 Responses to drug problems among vulnerable groups  
 
The legislative and institution conditions for implementing measures to reduce primary risk 
for to children and young people are of a more complex and systematic nature, especially in 
the education and social services systems. 
The following table shows the areas of responsibility of individual ministries and the activities 
of non-governmental organisations in relation to vulnerable groups.  
 
                                                 
119 According to the MLSAF, the authorities for the social and legal protection of children and social guardianship 
referred 7 cases for special outpatient care 
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Table 12.9: Areas of responsibility of individual ministries and the activities of non-governmental organisations in 
relation to vulnerable groups 
  Vulnerable groups  H
ea
lth
 s
er
vi
ce
s 
S
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ia
l s
er
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ce
s 
Ed
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at
io
n 
se
rv
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1. Children and young people living in surrogate family care 
and protective education 
x   x x   x  x   
2. Incomplete elementary education/ academic failure    x      x   
3. Young people in families where alcohol or drugs are used    x     x    
4. Young homeless people     x    x  x   
5. Young offenders   x  x      x  x 
6 Ethnic minorities   x  x  x  x  x   
7 Party goers  x     x  
8 Young people in high-risk families (alcohol, drugs, 
deprivation) 
   x  x       
 
12.2.1  Measures aimed at children in institutional care  
The trend in the provision of surrogate care is to reduce its institutional120 forms and promote 
forms of surrogate  family upbringing, which has better prospects for repairing emotional 
deficits. The number of children in surrogate institutional121 continues to fall and 
correspondingly, the number of children in foster families is rising. (National Report on Social 
Inclusion, 2006) An NGO operating in this area is the Navrat civil association 122, which 
provides a range of services relating to the provision of foster care and the rehabilitation of 
the family environment.  
Other interventions are aimed at children and young people in children’s homes and 
especially re-education homes with aim of increasing the social and communication skills of 
children and young people and their self-esteem.    
 
12.2.2 Measures aimed at early school leavers  
From 1st January 2006, the Ministry of Education began an implementation of a pilot project 
“Finishing elementary school” in cooperation with the Ministry of Labour, Social Affairs and 
Family, which is aimed at long-term unemployed jobseekers, aged 26 or under who have not 
completed basic education. After attending a course and completing elementary education, 
participants can continue in vocational training for employment. The project involves 11 
elementary schools in the Košice, Prešov and Banská Bystrica regions. The programme is 
part of the 2004–2006 National Action Plan for Social Inclusion. 
 
12.2.3  Measures aimed at young people in high-risk families   
See chapter 3.2.3 Selective prevention – for activities of psychological and counselling 
services for the rehabilitation of the family environment. 
 
                                                 
120 The aim is to reduce the number of children in institutional care by 6% by 2008. (2006–2008 National strategy 
on social care and social inclusion) 
121 In 2006 there were 98 children homes out of which 81 were state institutions, 17 belonging to church 
community and other non state 
122 Návrat Centre in Bratislava, www.navrat.sk, www.adopcia.sk  
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12.2.4 Measures aimed at the prison population 
According to the available information, interventions in the penitentiary and post-penitentiary 
environment are aimed at reducing the risk of subsequent social exclusion of offenders. The 
aim of the measures, especially for young offenders, is to re-educate them, including the 
development of moral values and the acquisition of necessary working skills and habits for 
their better integration into majority society.  
In 2006 an average of 94 young people (aged 14–18) served prison sentences in a 
specialised detention centre for young people at Sučany near Martin (hereinafter referred to 
as “the Institute”). 60% of the young people had not completed elementary education and 
40% had elementary education. None of the young people had a qualification for 
employment before entering prison. As part of interventions aimed at increasing their 
qualifications, 6 illiterate young people took a course to acquire basic education, 33 
completed compulsory schooling and 27 were placed on a retraining course,  73 young 
people took part in other courses and the 27 oldest received an education certificate.  
On average, 65% of the young people worked (Ministry of Justice, 2007b).  Vocational 
education and training is the objective of the 14-month project Way of Hope (Cesta nádeje), 
which has been awarded an EU grant123.  
The Institute has one of 6 drug free zones currently in operation to hold offenders who want 
to receive voluntary drug treatment.  Drug free therapy is used with the support of various 
therapeutic approaches, in particular a regime system, but also a system of rewards. A focus 
group of young offenders in the drug free zone at Sučany appreciated the difference between 
conditions in “normal” prison environment and the drug free zone (Mc Donald et al., 2006).  
In 2005 a comparative survey was conducted among staff on how the young offenders are 
treated. The survey was carried out in the above mentioned Institute for young people in 
Sučany (Slovakia) and a similar institute at Opava in the Czech Republic. The aim was to get 
an overview of opinions on the effect of the prison environment on young people. It is 
planned that the results of the comparative study will be used in modifications of the system 
and the philosophy for working with young people in the application of the new prisons act124. 
The information obtained from the two institutions emphasised the need to: improve the 
education system for young offenders and for better cooperation with schools; a broader 
range of education options (e.g. computer courses); a better level and greater continuity in 
after-prison care, including cooperation with non-governmental and community organisations 
(Jánoš J., 2006).  
 
12.2.5 Responses to public nuisance  
Local responses to public nuisance are carried out mainly by the police in cooperation with 
local government. A special project, “Drugs out”, was carried out in the Bratislava district of 
Vrakuňa. (See 12.1.2.7)  
In parallel with law enforcement activities, young people were offered a safe way to spend 
free time in a low-threshold club (MiXklub). The Intenda Foundation contributes to the 
establishment of low threshold facilities for young people through its programme “Lowering 
the Thresholds” (Znížme prahy)125. The foundation has already supported the establishment 
and operation of 19 low threshold facilities (of which 3 are in Bratislava). In 2006 the 
foundation’s support was concentrated on education for volunteers and the professional 
employees of these facilities. Low threshold facilities offer children and young people not only 
free time activities but also remedial and education activities. 
                                                 
123 Under the grant scheme of the project Support for the implementation of the 2004–2008 National Programme 
for the Fight against Drugs. 
124 See chapter 1.1 – Legal framework 
125 Intenda Foundation’s “Lowering the Threshold” prevention programme  won the ECPA (European Crime 
Prevention Award) in 2004 
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12.2.6 Measures aimed at homeless people 
The civil association Proti Prúdu provides a broad range of low threshold health and social 
services for young homeless people in Bratislava and also enables them to participate in the 
association’s main project – the sale of the monthly street magazine NotaBene126. The civil 
association Proti prúdu was established in 2001 as a non-governmental organisation whose 
aim is to help homeless people integrate into society, to assist in the prevention of 
homelessness for socially disadvantaged persons and promote a positive public attitude to 
homeless people.  
Sale of the street magazine NotaBene is now in its sixth year (since 2001) and provides the 
sellers with an income, self esteem and resources for further development. It is a form of 
social service that combines a training instrument for client development with the acquisition 
of resources for survival. In 2006 the magazine NotaBene was distributed in twelve towns in 
Slovakia. (A similar project - selling the street magazine “Cesta” is operated by the Greek 
Catholic diocesan charity in Prešov.) 
At the end of 2005 work on a project called Krištof began in the Proti Prúdu civil association. 
It is an extension programme for NotaBene vendors aimed at increasing the chances of 
finding work for homeless people. The project is part of the EQUAL initiative and is financed 
with European Union funds. 
In December 2006 the first low threshold reception centre to offer services all year round 
opened in Bratislava. During its first winter in operation it provided homeless people with 
8 552 lodgings. Accommodation is provided without any conditions including the possibility 
that a person can be under the influence of alcohol, which other facilities do not allow. The 
total number of clients since the start of the project has been 457, of whom 42 were in the 
18–25 age. The reception centre was established by the city of Bratislava in cooperation with 
the Catholic charity DePaul Slovensko. 
 
12.2.7 Measures aimed at the Roma community 
In terms of the range of measures and services provided by the state, local and regional 
government and non-governmental organisations, the Roma national minority receives the 
second largest amount of attention (after children and young people). The majority of 
programmes are currently financed from the European social fund and other EU sources.  A 
programme supporting the development of community social work in villages in the years 
2004–2007 targets the primary risk factor of social exclusion of persons from a socially 
disadvantaged environment127.  
Continuing education for Roma women who did not finish school is offered by the 
project/department Practical Woman (Praktická žena) provided by certain secondary 
vocational schools in eastern Slovakia128.  
Special interventions are aimed at minors who make up the majority of the Roma population 
– 40% are children under 15. Various instruments are used to help the integration of the 
children of this marginalised group into a standard school environment such as: a pre-school 
year; transitive classes; teaching assistants (who speak the Roma language); extra-curricular 
education; programmes working with parents in schools or community centres and so on.    
12.2.8 Measures aimed at party goers 
No further information on specific interventions aimed at party goers is available except that 
given in chapter 3.2.3 – Prevention in high-risk groups.   
 
                                                 
126 http://www.notabene.sk 
127 These are communities with Roma populations    
128 2006–2008 National strategy on social care and social inclusion, appendix I.  
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13. Drug research in Europe 
 
For the purposes of this chapter according to the EMCDDA the topic of drug research 
includes both basic and applied research into the use of drugs; drug addiction and its 
consequences; and measures aimed at reducing the consequences of drug use and that 
from a medical and social point of view, and prevention point of view. The overview reported 
in this chapter covers studies implemented in the period since 2000 to 2006 and/or the 
currently ongoing or that are definitely going to be undertaken in the near future.  
The information given in this chapter is the result of a survey of drug research in institutions 
that define themselves as research institutions by means of both a direct questionnaire 
survey and subsequent indirect inquiries in institutions that provide funding for science, 
research, development and other resources. The research has contributed to the mapping 
and better knowledge of the situation in drug research. 
The information produced a database on 58 research projects. This chapter presents 
information on the most important of these.    
 
13.1 Research structures 
 
13.1.1 Drug-related research in national policy 
The role of research and the use of research results and best practices in the formulation 
and creation of intervention are formally defined in the national drug strategy (NPFD 2004–
2008). This document declares that one of the principles of the strategy is that “implemented 
activities must be based on up-to-date data and information that has been scientifically and 
practically verified. The area of research and support for it, the collection, analysis and 
dissemination of reliable and objective information must be one of the conditions for 
implementing and applying approved strategies and interventions”. Further, in the strategy, in 
the area of international cooperation, it states an interest in supporting “the evaluation of drug 
policy based on scientific based and verified evidence, to support a multidisciplinary 
approach in research and the adoption of measures and to support common standard of 
good practice including ethical standards”. 
Further objectives of the national strategy in the area of information and evaluation are to 
increase the availability and quality of data and information on the drug situation according to 
EU key epidemiological indicators, to create an effective system for monitoring and 
evaluating activities129. 
Other documents – action plans, which are a more detailed development of the NPFD at the 
level of ministries and regions – also include the task of monitoring drug situation. The action 
plans define measures for the analysis and evaluation of the situation relating to prevention, 
treatment, re-socialisation, public order and safety, and knowledge of the drug situation in the 
Slovak regions130.  
 
13.1.2 Relationship research – policy 
For the purposes of this chapter, the NMCD and the General Secretariat carried out a survey 
of drug research activities undertaken in Slovakia in the 2000–2006 period. The survey, 
which was of an informational character only, did not study mutual relations between 
institutions carrying out drug research or the connection between the results of research and 
policy application. It is not possible to assess the extent to which research results do or do 
                                                 
129 2004–2008 National Programme for the Fight against Drugs  
130 Action plan for the implementation of the objectives of the National Programme for the Fight against Drugs in 
the 2005–2008 period  
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not influence the policy decision makers or how they are used in practice. It can be said, 
though, that conditions exist for science to influence policy, especially in the state 
administration.  
Certain ministries, such health and education, have their own science and research 
institutions whose role is to carry out research tasks and the results serve as the basis for the 
creation of political interventions and strategies (this applies generally, not only to anti-drug 
measures).  
The statute of the Ministerial Board, the coordinating advisory body of the Slovak 
government on drug issues, defines the principles of its activity, one of which is to use the 
expert knowledge and experience of the central state administrative bodies and the opinions 
of scientific research centres and the universities. Likewise, the activity of the General 
Secretariat, which is the executive body of the Ministerial Committee with responsibility for 
the coordination and implementation of the national drug strategy, is supported by an expert 
commissions made up of representatives of various institutions and which provides a 
platform for the exchange of information, including possible information on research activities 
in the area of drug issues. 
Non-state institutions mainly apply the results of their research in their own performance. 
Such non-state institutions include universities, which apply the results of their research in 
their own technical, scientific and educational activities. 
 
13.1.3 Main national structures for drug-related research 
 
In order to acquire a more comprehensive overview of implemented and planned research 
activities in the area of drug addiction, it was necessary to contact and work with of several 
data sources:  
• A survey among potential institutions (total 97) thought to be involved in drug research 
was conducted using a brief questionnaire. 
• Ministry of Education sources were used: Projects supported by the Slovak Research 
and Development Agency (hereinafter referred to as the “APVV”) in the Ministry of 
Education, VEGA (science grants agency) – the joint grant organisation of the MoE and 
the Slovak Academy of Sciences – and KEGA (culture and education grants agency),  
• projects in international programmes of the Slovak Academy of Sciences 
• The register of projects supported by the Anti-Drug Fund, which can provide financial 
support to projects for scientific research into the prevention of drug use under the Act on 
the Anti-drug Fund (Section7) 
• Projects carried out under the Grant Scheme of the project Support to the Implementation 
of the NPFD 2004–2008. 
• Material on drug research prepared by the General Secretariat for the purposes of the 
Council of Europe’s Pompidou Group  
• The information map of data sources and experts prepared in the Open Society 
Foundation’s project, “Evaluation of the implementation of selected sections relating to 
drugs in the Slovak Penal Code131” 
• Internet sources 
 
Of the total 97 subjects contacted, 58 (60%) responded, of whom 28 subjects operated at the 
national level and 30 at the regional level. 11 subjects (8 national and 3 regional) replied that 
                                                 
131 Džambazovič R., Fedačko R, Kiššová L. Klubocký R., Nociar. A.: Preliminary report on the project to evaluate 
the application of sections 171 and 172 (1)  of Act 300/2005 (the penal code), sub-study S3 
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they do not do drug research. The 47 institutions that have carried out or plan to carry out 
research related to some aspect of drug prevention, treatment or re-socialisation include 27 
regional public health authorities132 because they are involved in a number of research 
projects with national scope (mainly in relation to data collection). 
Information from the contacted national and regional institutions and the other sources listed 
above was used to assemble a database of 58 projects dedicated to or (potentially) related to 
drug research according to the EMCDDA criteria in the period from 2000 to the present. 
Table 13.1 presents this information organised according to these criteria.   
Table 13.1: Summary of research projects based on EMCDDA criteria (NMCD and General Secretariat, 2007) 
Description of project Number of projects 
Total number of projects  58 
Of which, projects dedicated primarily to drug research 40 
 -  projects partly dedicated to drug research 12 
Projects with only a marginal relationship to drug research 2 
Insufficient identifying data  4 
 
The survey provided an overview of drug-related research projects carried out in the 2000–
2006 period. It also confirmed the diversity of institutions and the tendency for grouping and 
cooperation of researchers, which reflects the multidisciplinary character of the drug 
phenomena and also increases the chances of obtaining funding for further research. The 
acquired data revealed the structure of main research institutions – especially those attached 
to the key ministries. It cannot however be considered as official and comprehensive 
structure because it is based on limited survey data. 
 
13.1.3.1 Institutions under the Ministry of Health that carry out drug research 
 
The institutions under the Ministry of Health undertake mainly research into basic and 
applied biomedical research and development in the field of public health related to the drug 
problem. 
 
A. The Institute of Drug Dependencies at the Centre for the Treatment of Drug 
Dependencies in Bratislava  
This institution has a special status in research activities relating to treatment of drug 
dependencies and also carries out training, therapy and coordination activities relating to the 
problem of drug dependencies.  
• It cooperates with the Faculty of Pharmacy of Comenius University (hereinafter referred 
to as “FPHARMA CU”) in Bratislava and the Toxicology and Antidumping Centre133 of 
FPHARMA CU on several research projects in the area of laboratory toxicological 
diagnosis, the results of which have been used in practice in the treatment of patients 
with drug addictions.  
• Since 2006 the CTDD has been the leader organisation in the European research project 
Improvement of access to treatment for people with alcohol- and drug-related problems – 
IATPAD (For more information on this project see 13.2 – Main recent studies and 
publications).  
  
 
                                                 
132 The managing authority is the Public Health Authority 
133 The Toxicology and Antidoping Centre was a centrally financed component of Comenius University in 
Bratislava until 1.9.2006. A change in the Statutes of Comenius University attached the centre to the Faculty of 
Pharmacy. 
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B. Public health authority  
It carries out its own research in the area of public health and health awareness, including 
that of schoolchildren as part of the WHO HBSC survey134, current cycle 2006–2007. 
Regional branches of the PHA are responsible for collecting data for two national school 
surveys (ESPAD and TAD), relating to, amongst other things, alcohol, smoking and the 
consumption of illegal drugs. Individual (regional) public health authorities also carry out their 
own local/regional survey and then based on the results design prevention activities for their 
region.  
The national survey “Secondary School Youth Lifestyle Monitoring” was carried by all 
regional authorities in 2004–2005 under the direction of the RPHA in Spišská Nová Ves. Part 
of this survey relating to addictions – smoking, alcohol, slot machines, medicines and drugs – 
among secondary school students was described in the 2006 Report (p. 27). 
C. Slovak Medical University (SMU) 
The SMU primarily provides continuing postgraduate and specialised education for doctors, 
pharmacists and other health workers135. The research base of this university focuses on the 
current problems in preventative and clinical medicine in order to improve health and quality 
of life, e.g. relating to socially significant infections (HIV/AIDS, viral hepatitis) and the 
pharmacodynamic and pharmacokinetic properties of pharmaceuticals.  
In addition to its research activities it maintains 11 National Reference Centres or 
Laboratories of which three are involved in the monitoring of DRID indicators: 
• The National Reference Centre for the Treatment of Chronic Hepatitis (recipient of a 
Ministry of Health grant for “Epidemiological, immunopathogenic and therapeutic aspects 
of chronic hepatitis C 2005–2008”. Based on the results of the epidemiological study of 
the prevalence of hepatitis C in Slovakia, a programme was launched to find patients in 
the high-risk category of former drug addicts and haemodialysis patients.  
• The National Reference Centre for the Prevention of HIV/AIDS – has carried out 
surveillance studies for HIV/AIDS infections in selected groups with high risk behaviour, 
e.g. Bordernet – Prevention, diagnosis and therapy for HIV/AIDS and other sexually 
transmitted diseases in EU border regions; or EUROSUPPORT – improvement in sexual 
and reproductive health for persons living with HIV/AIDS infections (both are EU 
community programmes).  
• The National Reference Centre for Viral Hepatitis  
D. Faculty hospitals  
The faculty hospitals are at the same time training facilities of medical faculties in Slovakia.   
• The psychiatric clinic and the children’s psychiatric clinic of the Faculty of Medicine of 
Comenius University136  in Bratislava – focussed joint programmes on research into the 
consumption of psychoactive substances among students of the faculties of Comenius 
University in Bratislava and a population survey of the prevalence of addiction to nicotine 
and alcohol in the Slovak population.  
• The children’s psychiatric clinic of the Faculty of Medicine in Bratislava and the Children’s 
Faculty Hospital and Medical Centre in Bratislava are the only national medical 
institutions specialising in the treatment of mental disorders of children and young people. 
The conduct research projects focussed on the development of antisocial personality as 
a result of abuse and neglect in childhood, children with hyperkinetic disorders and 
attention disorders and children with ADHD.  
                                                 
134 Health Behaviour of School aged Children 
135 For example, in the field of drug addiction medicine, psychotherapy… 
136 The clinic is also the Department of Child and Adolescent Psychiatry of the SMU 
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From 2007 a project of the Faculty of Health Care of the Catholic University in Ružomberok 
will analyse the health condition and lifestyle of the Roma ethnic group in selected locations 
in Central and East Slovakia. Because of the orientation of the faculty and the information 
obtained regarding the project it is included under the Ministry of Health. Although 
information was not provided on research activities in the Centres for the Treatment of Drug 
Dependencies in Slovakia (other than the Bratislava CTDD) these may become important 
partners for the implementation of drug research in future.  
 
13.1.3.2 Institutions under the Ministry of Education that carry out drug research 
 
A.  The Research Institute for Child Psychology and Pathopsychology 
This institute carries out basic and applied research in issues of psychological prevention 
and counselling for children and young people with behaviour disorders.  It is currently the 
coordination centre for school surveys related to drugs: the school survey of the use of legal 
and illegal drugs amongst pupils of elementary school, students of secondary schools and 
their teachers (TAD) and the European School Survey Project on Alcohol and Other Drugs 
(ESPAD).  
Its research role for the years 2006–2008 is to study the content and methodologically 
analyse methods used to evaluate counselling and prevention programmes in the integrated 
system of psychological prevention and counselling services for children and young people 
(see Concept of counselling services in chapter 3 – Prevention), which partly relates to the 
drug problem. 
 
B.  The Institute of Information and Prognoses of Education 
Into the database of surveys for the period 2000-2006 9 projects/tasks of IIPE were included. 
The IIPE however carries out continuous research projects since 1995. These monitor the 
basic problems of smoking and the consumption of alcohol and illegal drugs amongst young 
people aged 15–26 in a different context (see for example chapter 2.2.2 – Youth surveys). 
 
C.  Universities 
Since 2000 they have carried out most (28 of 58) research projects in the field of drug issues. 
• The Faculty of Pharmacy at Comenius University (Department of Chemical Theory of 
Drugs and the Toxicology and Antidoping Centre) carried out 10 research projects 
according to the provided information. 
• The Faculty of Humanities at Matej Bel University in Banská Bystrica and the Faculty of 
Natural Sciences at Žilina University in Žilina carried out drug research aimed at 
obtaining information on the consumption of narcotic substances amongst university 
students and secondary school students in selected schools in relation to drug 
prevention.  
• The Pedagogical Faculty of Prešov University in Prešov – research focussed on the issue 
of primary prevention of problems with psychoactive substances amongst schoolchildren 
and the prevention of problems with psychoactive substances in schools and 
establishments for intellectually handicapped children focussing in particular on children 
coming from socially disadvantaged and less stimulating environments137  
• The content of research projects of P. J. Šafárik University in Košice focus on monitoring 
individual, interpersonal, social and societal factors in the risk behaviour of adolescents 
                                                 
137 Research into pupils from certain Roma settlements in East Slovakia – see chapters 2 and 11 of the 2006 
Report  
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and young adults and the effectiveness of drug addiction and AIDS prevention 
programmes in the university student population138. 
• The Pedagogical Faculty of Matej Bel University in Banská Bystrica – prevention of drug 
addiction in schools, the family and society in relation to young people who do and do not 
participate in sports.  
• The Faculty of Natural Sciences of Matej Bel University in Banská Bystrica – preparation 
of the content of education for future teachers of science subjects with regard to the 
prevention of drug addiction. 
• The Faculty of Arts of Prešov University in Prešov – Institute of Education Studies and 
Social Work – longitudinal monitoring of selected factors reducing the quality of life for 
persons abstaining from alcohol and non-alcoholic drugs in the context of the research 
project Quality of Life in the Social Contexts of Globalisation and Performance Society.  
• University of SS. Cyril and Methodius in Trnava – a research project on crime prevention 
amongst children and young people. The project studies possible criminal activity 
amongst children and young people, their behaviour, the influence of the social 
environment and the family, it identifies possible free time activities, the influence of the 
police on prevention with the aim of developing procedures in the education process to 
eliminate illegal activity. 
 
13.1.3.3 Slovak Academy of Sciences (SAS) 
This institution has an autonomous status as a national scientific research institution that 
carries out research in selected fields of the natural, technical and social sciences in 
accordance with state scientific and technical policy. At present the SAS presents the results 
of scientific, research and development activity in Slovakia through, amongst other means,  
54 scientific and specialist journals. Of these the most relevant to the drug problem are the 
following journals indexed by the ISI Current Contents service: Acta Virologica and Studia 
psychologica. The topic also appears in the periodical Sociológia – Slovak Sociological 
Review. 
• The SAS Cabinet of Social and Biological Communication carried out research in 2000 
into the interaction between use of addictive substances and sexual risk in the specific 
context of basic military service in Slovakia.  
• The SAS Sociology Institute cooperates with the Faculty of Humanities of Comenius 
University in Bratislava on the research project Drugs and Drug Policy in Slovak Society 
(International Context and Perspectives). The project monitors the analysis of 
development and the current situation regarding drugs in Slovakia, legislation, the 
content and structural framework of drug policy in Slovakia focussing on developments 
since 1989, a comparison of Slovak drug policy and drug policies in other European 
countries and projection of possible future developments in drug policy in Slovakia. 
13.1.3.4 Institutions under the Ministry of Labour, Social Affairs and Family that carry 
out drug research 
 
The MLSAF carries out science and research activities through the Institute for Labour and 
Family Research. This institution has not carried out research in the area of drug addiction 
since 2000 however.  
                                                 
138  Research team   
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13.1.3.5. Non-profit organisations and other subjects that carry out drug research 
 
NGOs are working on two extensive research projects. The Open Society Foundation is 
carrying out a research project to evaluate the implementation of selected provisions on 
drugs in the Slovak Penal Code, focussing on an investigation of the effects of 
implementation of the New Penal Code and Code of Penal Procedure with particular 
emphasis on drug users (further information in chapter 13.2 – Main recent studies).  
FÍLIA, n.o. Košice focussed its research project on the effectiveness of drug prevention 
programmes, improvements in communication and cooperation between interested parties in 
the area of drugs in the Košice region.  
During the preparation of the concept of regional drug policy for the Prešov region, a 
research project has been in progress since 2006 to analyse the area of demand reduction 
for drugs in Roma communities. Participants in the project include the regional authority, the 
regional centre for Roma issues in Prešov, the civil association RISEN, the Community 
Foundation in Prešov, the civil association People in Need (Člověk v tísni) and the Centre for 
Anthropological Research and the Faculty of Arts of Prešov University.  
 
13.1.4  Main funding framework 
On the whole, science and research is under funded in Slovakia. In 2006 a total of around 
EUR 210 mil. was spent on science and research. This represents around 0.49% of GDP139, 
which is very little compared to the EU average (0.65% HDP)140. The objective of the 
government141 is that through cooperation with the universities, the Slovak Academy of 
Sciences, centres for research and development, science and technology parks, business 
incubators and technologically-oriented firms and successful use of resources from EU 
funds, financing for science and technology will reach 0.8% of GDP. 
The Ministry of Education acts as the central body with general responsibility for the area of 
science and technology. The ministry creates conditions for the implementation of science 
and research programmes, coordinates the activities of central state administrative bodies, 
the Slovak Academy of Sciences and the universities in preparing and implementing the 
state science and technology policy. 
Funding for science and research in Slovakia is provided from the state budget through the 
relevant budget chapter of the Ministry of Education. Funds are provided in the form of grants 
which may be for a specific purpose or may be institutional. A budgetary organisation of the 
Ministry of Education – the Slovak Research and Development Agency (APVV) – has 
become the dominant instrument for the support of research and development in Slovakia142. 
Another Ministry of Education agency for EU structural funds was established in 2007 with 
the primary role of ensuring the process for the implementation of assistance from EU 
structural funds in the 2007–2013 programming period. The agency will carry out activities 
within the scope of tasks delegated to the Ministry of Education as the managing authority 
under the operational programmes Education and Research and Development.  
VEGA – the science grants organisation – is a grants organisation run jointly by the Ministry 
of Education and the Slovak Academy of Sciences.  
Specific activities relating to drugs may also use funding provided from the Anti-Drug Fund 
and in 2007 also the Grant Scheme of the project Support to the Implementation of the 
                                                 
139 http://portal.statistics.sk/showdoc.do?docid=1797 
140 http://www.itapa.sk/index.php?ID=1903 accessed 12.8.2006 
141 http://www-8.vlada.gov.sk/index.php?ID=1689  Government manifesto  - section 5 – Science and Technology  
142 This was facilitated by Act 172/2005 which placed the agency on a higher level of quality on a par with 
standard grant agencies in EU countries (Annual report of the SRDA for 2006) 
 112
2004–2008 NPFD. Findings show that foreign and domestic donors and sponsors also 
contributed to the funding of research projects.  
Out of a total of 58 research projects in the database, 20 provided information on their total 
budgets, which amount to  EUR 1,287,734 (SKK 47,965,515143). A partial or approximate 
budget can be determined in the case of 7 research projects, amounting to EUR 362,518. 
Individual research projects were usually financed from a number of sources of funding (own 
resources and grants). Budgets were/are composed for the full duration of the project.  
 
13.2 Main recent studies and publications  
The recent studies presented in this section were chosen according to the criterion of size of 
research budget. 
 
13.2.1 Main recent studies  
 
Name of project: IATPAD - Improvement of Access to Treatment for People with 
Alcohol- and Drug- Related Problems 
Institution: The Institute of Drug Dependencies at the Centre for the Treatment of 
Drug Dependencies in Bratislava (project coordinator) 
Partners: Bulgarian Methadone Treatment Association, National and Kapodistrian 
University of Athens in Greece, Universitá degli Studi di Roma “La 
Sapienza” in Italy, Psychiatric and Neurological Institute (Instytut 
Psychiatrii i Neurologii)  - Poland, University of Ljubljana  Slovenia, 
Local Health Institute – Spain (Institut Municipal d´Assistencia 
Sanitária), University of Dundee – Great Britain 
Duration: December 2006 – December 2009 (36 months) 
Level of budget 
and funding: 
EUR 853 000, of which funding from the European Commission 
represents EUR 678 000 
 
Description (objectives, methods, results and conclusions): 
Objective: to improve access to treatment for people with alcohol and drug 
problems; to prepare an international comparative study focussed on the 
attitude of health workers to addicts and their attitude to addictions as 
such as a factor influencing access to treatment. 
Further specific objectives of the project are given below 
 - Identifying barriers that limit access to treatment for problems related 
to psychoactive substances through a qualitative analysis of the 
treatment system in partner countries 
 - identification of attitudes of health professionals to users of 
psychoactive substances by means of a survey of primary health 
care facilities and specialised health care units and identification of 
the availability of treatment as it is perceived by its users 
 - an analysis of the effect of health workers’ attitudes to users and the 
effect of systematic barriers to the availability of treatment making 
use of multivariate statistical methods and qualitative approaches 
                                                 
143 Amounts are calculated at the average exchange rate for 2006 according to the National Bank of Slovakia 
(SKK 37.248/EUR) and rounded to thousands,  http://www.nbs.sk/ 
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 - collection and dissemination of examples of good practice in 
facilitating access to treatment 
 - Preparation of recommendations to strengthen positive attitudes to 
users of psychoactive substances amongst health professionals and 
the definition/development of aspects of the treatment system to 
support easy access to treatment. 
Methods: The first phase of research – the analysis of the current situation in the 
health care system with regard to barriers to access to treatment will be 
carried out through an analysis of relevant documents on national health 
care policy, interviews with providers of health care and other methods, 
qualitative data analysis.  
 The second phase of the project – testing of hypotheses on barriers to 
access to treatment in relation to attitudes to clients with problem 
dependency – questionnaire method.  
References of main publications: 
 
results and publications are not yet available; the project is referenced 
on the websites of the European Union144 , the EMCDDA and another 
45145 web sites 
                  
 
 
Name of project: Individual, interpersonal, social and societal factors in risk 
behaviour in adolescence and young adulthood 
Institution: The Institute of Social Sciences in the Faculty of Natural Sciences of P J 
Šafárik University in Košice 
Partners: University of Groningen in the Netherlands 
Duration: May 2006 – April 2009 
Level of budget 
and funding: 
The total budget is not known. EUR 196 800 - APVV, other funding 
provided by the University of Groningen in the Netherlands and the Anti-
drug Fund. 
 
Description (objectives, methods, results and conclusions): 
Objective: to monitor drug use, to investigate risk/protective factors in drug use, the 
effectiveness of prevention strategies in adolescence and young 
adulthood. 
The first six sections of the project are dedicated to the investigation of 
individual, interpersonal, social and societal factors in drug use. Another 
four sections are dedicated to the prevention of drug addiction, overall 
analysis of the results obtained on drug use, conclusions, 
recommendations and dissemination of the acquired knowledge.  
The project will facilitate cohort comparisons and longitudinal study of 
changes in drug use in adolescents and young adults and a comparison 
of drug use amongst specific sub-groups of adolescents (3 regions of 
Slovakia, socially disadvantaged groups). 
                                                 
144 http://ec.europa.eu/health/ph_projects/2005/action3/action3_2005_22_en.htm: 
145 Situation at 15.9.2007 – keyword IATPAD 
 114
Note: From August 2006 to October 2009 UPJŠ in Košice is carrying out the second 
part of the project under the same name. The partner of the Institute of Social 
Sciences of the Faculty of Natural Sciences of UPJŠ is the University of Groningen in 
the Netherlands. The University of Groningen in the Netherlands is providing funding 
for the project amounting to EUR 120 000. Other sources of funding are the APVV 
and the Anti-Drug Fund.  
References of main publications: See section 13.2.2 
  
 
 
Name of project: Drugs, addictive substances and other xenobiotics negatively 
affecting human health (biomedical project) 
Institution: Department of Chemical Theory of Drugs FPHARMA CU in Bratislava 
Partners: University of Veterinary and Pharmaceutical Sciences in Brno (CZ), 
Department of Environmental and Life Science, ARC Seibersdor 
research GmbH. (Austria), CTDD in Bratislava 
Duration: 2005–2007 
Level of budget 
and funding: EUR 179 700, of which an APVV grant – EUR 78 900 
 
Description (objectives, methods, results and conclusions): 
Objective: The development of specific methods for the precise identification and 
detection of drugs, psychotropic and other abused substances in 
biological material; their use in clinical and toxicological practice, in 
particular in improving diagnosis, treatment methods for drug addiction 
and in testing for the use of banned substances in sport. 
The project concentrated on: 
 - Development and validation of analytical procedures to detect 
specific markers for the origin of opiates and amphetamines in bodily 
fluids using HPLC and CG/MS 
- evaluation of the pharmacokinetics of methamphetamine and its 
metabolites in urine and blood plasma using a specific GC/MS 
method in relation to the level of methadone in blood plasma in 
patients treated for drug addiction 
- introduction of new stereoselective analyses of individual isomers of 
chiral compounds and their use in identifying and evaluating the 
pharmacokinetics, metabolism and toxicological profile of addictive 
and abused substances.  
- preparation of a GC/MS method for detecting anabolic steroids and 
their metabolites in biological samples 
- monitoring of changes in the level of endogenous steroid hormones 
in patients with hormone production defects  
- introduction of screening methods to detect a broad range of anabolic 
substances in doping tests for sports persons and to analyse 
nutritional supplements containing illegal steroid hormones 
References of main publications: n.a. 
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Name of project: Chiral drugs – stereo specific aspects of their biological effect, 
pharmacokinetics and metabolism 
Institution: Department of Chemical Theory of Drugs FPHARMA CU in Bratislava 
Partners: Department of Pharmacy King’s College in London (UK), CTDD in 
Bratislava 
Duration: 2004–2006 
Level of budget 
and funding: EUR 51 300 - VEGA   
 
Description (objectives, methods, results and conclusions): 
Objective: the project aimed to develop stereo specific analytical methods to isolate 
the identification of chiral drugs in biological media and to use them to 
track the stereo selectivity, pharmacokinetics, metabolism and 
toxicological profile of drugs frequently used in therapeutic practice and 
also drugs from the group of abused addictive substances. In the group 
of addictive substances for opiates attention was given to the 
possibilities for analytical discrimination of opiate abuse from the use of 
substitute and other drugs in the event of positive tests for morphine and 
amphetamines in the urine of patients undergoing treatment for drug 
addiction. 
References of main publications: See section 13.2.2 
 
 
Name of project: Project of Evaluation of the implementation of certain sections 
relating to drugs in the Slovak Penal Code 
Institution: Open Society Foundation 
Partners: Public Policy Institute, Department of Social and Economic Sciences, 
Comenius University, Bratislava; National Monitoring Centre for Drugs; 
Department of Psychology, Palacký University in Olomouc 
Duration: January 2007 – July 2009 
Level of budget 
and funding: 
USD 51 380 (SKK 1 527 200146), source of financing: International 
Harm-reduction Development Program Open Society Institute 
 
Description (objectives, methods, results and conclusions): 
Objective: to investigate the effects of the implementation of the new penal law 
provisions on the cultivation of drugs, especially on drug users. The 
project is made up of two qualitative and one quantitative sub study: 
- Sub-study 1 – focuses on an analysis of the practical application of 
selected drug-related sections of the Penal Code and a primary study 
of case files for selected drug-related prosecutions  
- Sub-study 2 – focussed on an analysis of the effects of selected 
sections relating to drugs on drug users and on the representatives of 
organisations providing services to drug users (centres for the 
prevention and treatment of drug dependency and the helping 
                                                 
146 Calculated at the average exchange rate 2006 according to the National Bank of Slovakia - SKK 29 724/USD 
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professions). 
The qualitative part of the research makes use of semi-structured expert 
interviews, expert focus groups and documentary analysis. 
- Sub-study 3 – analysis of the epidemiological situation, analysis of 
the situation in the Slovak drug scene, trends in drug use, in their 
availability, patterns of use through available epidemiological 
indicators and other trends with regard to the application of the law 
on drugs using the statistics of the law enforcement and judicial 
authorities. 
References of main publications: At the present stage in the implementation of the 
project there are not yet any results or publications  
 
13.2.2 Publication147 activity relating to research for 2006 and 2007  
 
A. Neuroendocrinology Letters148 
Valentová, J., Horáková, R., Pechová, I., Okruhlica, Ľ., Devínsky, F: Stereoselective 
determination of methadone and its main metabolite in serum and urine from methadone 
maintenance patients, In: Neuroendocrinology Letters. 27, (2006), p.130-133. 
 
B. Československá psychologie149  
Orosová, O., Gajdošová, B., Madarasová-Gecková, A., Van Dijk, Jitse P. (2007). Rizikové 
faktory užívania drog dospievajúcimi (Risk factors in adolescent drug use). Československá 
psychologie, 51, 1, p.32-47 .  
 
C. Heroin Addiction  & Related  Clinical  Problems – Official Journal of EUROPAD  
In previous years articles were published on the joint research activity of the Faculty of 
Pharmacy (Department of Chemical Theory of Drugs), the Toxicological Laboratory and the 
CTDD. In 2006, the following article was published: 
Klempová D., Okruhlica L.: No intrauterine growth retardation in babies of mothers stabilized 
on methadone before conception and throughout their pregnancies 2006; 8(1):25-30 
 
D. EUROPEAN JOURNAL OF PUBLIC HEALTH150 
Kalina O., Madarasova Geckova, A. Orosova O., Salonna F., Jarcuska P., van Dijk P. Jitse, 
Reijneveld Sijmen A.,: Is later sexual initiation of university students associated with less 
sexual risky behaviour? EUROPEAN JOURNAL OF PUBLIC HEALTH 2006, vol. 16, 
supplement 1 172-172. 
Gajdosova B., Orosova O., Sleskova M., Sarkova M., Salonna F., Madarasova-Geckova A. 
van Dijk Jitse P: Analysis of adolescents’ strength of reasons for smoking and alcohol 
drinking, EUROPEAN JOURNAL OF PUBLIC HEALTH 2006, vol. 16, supplement 1 130-131. 
Madarasova-Geckova A., Salonna F., Sleskova M., Orosova O., van Dijk P. Jitse, Psycho-
social mediators of socio-economic differences in self-rated health among adolescents. 
EUROPEAN JOURNAL OF PUBLIC HEALTH 2006, vol. 16, supplement 1100-100. 
                                                 
147 Only some outputs are published for the stated research projects  
148 http://www.nel.edu 
149 2006 impact factor 0.279 
150 http://eurpub.oxfordjournals.org/archive  
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E. PSYCHOLOGY & HEALTH151    
Official Journal of the European Health Psychology Society  
Orosová O., Madarasová A., Humeníková Mária, Kalina Ondrej, Gajdošová Beáta, van Dijk 
Jitse P., Why students participate in drug prevention program,  PSYCHOLOGY & HEALTH 
2006, vol. 21, supplement 1  (1) (2006), 114-114. 
Gajdošová Beáta, Madarasová Andrea, Humeníková Mária, Kalina Ondrej, Orosová Oľga, 
van Dijk Jitse P., Personality as a risk/protective factor in smoking, PSYCHOLOGY & 
HEALTH 2006, vol. 21, supplement 1 (1) (2006), 52-53 
 
13.3 Collection and dissemination of research results 
 
13.3.1 Information flow  
Systematic, centralised collection and dissemination of the results of drug research has not 
yet been fully introduced in Slovakia. The National Monitoring Centre for Drugs is the 
managing institution for the drug information system in Slovakia and works with a network of 
experts, partner institutions and has its own information portal to collect and disseminate 
information. The survey of activities in drug research carried out by the NMCD and the 
General Secretariat for the purposes of this chapter and the requirements of the Pompidou 
Group is the first relatively complex activity in this area. A list of research, including 
bibliographic references will be published on www.infodrogy.sk). In the future the NMCD 
could play a key role in the documentation of scientific research and the dissemination of 
information of this type.  
13.3.2 National scientific journals dedicated to drug research 
At present research work is primarily published and disseminated within the institution that 
the research is carried out and subsequently submitted by its authors to specialised and 
thematically relevant periodicals. 
A. Alkoholizmus a drogové závislosti (Alcoholism and drug addictions) 
Alkoholizmus a drogové závislosti is a specialised journal of the Ministry of Health and the 
drug addictions department of the psychiatric society of the Slovak Medical Association. It is 
the only specialist journal in Slovakia directly dedicated to the issue of addiction to 
psychoactive substances. It was first published as a magazine covering the whole of 
Czechoslovakia Protialkoholický obzor (Anti-alcoholic horizon).  It publishes original work, 
contributions from practice (surveys, clinical studies), reports by participants in foreign and 
domestic conferences, reviews of publications, abstracts from foreign magazines and 
information on interventions and policies.   
Original works are peer reviewed and include an abstract in English.  
In 2006 the journal published the following original works by Slovak authors: 
- Martinove,M: Buspiron a liečba úzkostných porúch u závislých (Buspiron and Treatment 
of anxiety disorders in addicted patients) vol. .41-3 pp. 153-160 
- Bušová,Z. Kovácsová E., Okruhlica Ľ: Užívanie drog v rekreačnom prostredí (Drug Use 
in the Recreational Setting) vol.  41, no. 4 – 2006  pp. 231-237 
- Kiššová L., Mravčík V.: Prevalenčný odhad problémových užívateľov drog na Slovensku  
(Prevalence estimates of Problem Drug Use in Slovakia) vol. 41, no. 5 – 2006  pp. 259-
272 
                                                 
151 2006 impact factor 1.636 
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B. Bratislavské lekárske listy (Bratislava medical journal) 
This is an international specialised journal for biomedical sciences and clinical medicine. It 
has been published since 1921 by the Faculty of Medicine of Comenius University in 
Bratislava and currently appears monthly in English. It can be accessed on-line at 
http://www.bmj.sk Abstracts from the journal are published in Medline PubMed. The index for 
2006 does not include any articles related to drugs.  
In 2002 an article was published by the authors: Valentová, J., Klempová, D.,Vlčková, Z., 
Okruhlica, Ľ.,Devínsky, F.: Plasma Methadone measurements and their Role in Methadone 
Maintenance Treatment, Bratislavské lekárske listy. 103, (2002), 299. on research carried 
out by the Faculty of Pharmacy of Comenius University in Bratislava, containing a database 
of research ( NMCD a General Secretariat, 2007)    
 
C. Studia psychologica152 
An international journal of research and theory in psychology published 4 times a year in 
English, indexed in Psychological Abstracts, Current Contents, Ergonomic Abstracts, Child 
Development Abstracts and Bibliography. It is published by the Experimental Psychology 
Institute of the Slovak Academy of Science.  
 
D. Other specialist periodicals and journals 
The topic of the use of psychoactive substances appears in other Slovak specialist 
periodicals published by the Slovak Medical University Lekárske listy153 (Medical Journal), 
Farmaceutický obzor154 (Pharmaceutical Horizon), Ošetrovateľstvo (Nursing) and the 
internet journal Verejné zdravotníctvo (Journal of Public Health 
http://www.szu.sk/ine/verejnezdravotnictvo/index-1.htm.  
The Research Institute for Child Psychology and Pathopsychology publishes the journal 
Psychology and patopsychology of child , 4 x per year, in Slovak, with abstracts in 
English and German.  The Institute of Information and Prognoses of Education publishes the 
journal Prevencia (Prevention).     
 
Adiktologie (Addictology)  
This periodical was launched in the Czech Republic in 2001. Adiktologie is a journal 
specialising in prevention, treatment and research into addiction and a member of the 
International Society of Addiction Journal Editors. It is published in Czech. Articles by Slovak 
authors are published in the original. Foreign authors are published in English. It contains 
English abstracts; the abstracts can be accessed  on-line at www.adiktologie.cz in Czech 
and English.   
In 2006 the journal published the following works by Slovak authors in various issues:  
- Okruhlica,Ľ.: Zistenie alkoholémie sa pri závislosti iba parciálne kryje s diagnózou 
opitosti i v prípadoch korektne stanovených, (Finding Alcohol in Blood in Alcohol 
Dependent Patients only partially overlaps with the diagnosis of Alcohol intoxication in 
correctly assesed cases no. 2- 2006  
- Halama,P. Klimas J.,: Nápomocné faktory zmeny závislých klientov v procese 
resocializácie (Factors conductive to change in addicted clients undergoing the process 
of resocialisation) . no. 3 - 2006. 
                                                 
152 2006 impact factor 0.410 
153 Reviewed journal – containing English abstracts 
154 Brief abstracts and keywords are given in English.  Abstracts of original experimental work are published in 
Chemical Abstracts, International Pharmaceutical Abstracts a Embase/Excerpta Medica Database. 
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- Oláh Z.: Ovplyvnenie oka a zrakových vnemov psychotropnými látkami (Effects of 
psychoactive substances on the eye and visual functionning). No.4-2006 
A supplement of Adiktologie was planned as a compilation of abstracts from the XII National 
Conference of the Association for Addictive Diseases and 45th Conference of the AT Section 
of ČLS JEP “The Bio-psycho-socio-spiritual model of addiction”. The compilation includes 
papers by  Ľ. Okruhlica, S. Slezáková  and P. Ondrejkovič. 
 
Československá psychologie (Czechoslovak Psychology)   
A specialist journal of psychological theory and practice published by the Psychological 
Institute of the Czech Academy of Sciences, indexed by the ISI Current Contents service, 
published in Czech with English abstracts http://cspsych.psu.cas.cz/index2.html 
 
13.3.3 Other means of disseminating information 
The results of research activities are also presented at various specialist events in Slovakia 
and abroad, organised by research institutions themselves, universities and relevant 
professional bodies. In such cases the presentation of the results of research (in the form of 
lectures, presentations and posters) is oriented towards a specialist audience.  Where results 
are relevant to the general public they are presented via the media and web sites, which 
most of the institutions mentioned above possess.  
Part C 
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